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Abstract 
 
This thesis describes the development of a range of isotopically-labelled derivatives of 
(−)-nicotine, their subsequent hyperpolarisation by SABRE, their characterisation and the 
evaluation of their performance. Hyperpolarisation is a method of generating significantly 
enhanced magnetic resonance signals without increased sample size, scan time or 
prohibitively expensive improvements in equipment.  
 
The primary aim of this thesis was to develop a family of (−)-nicotine derivatives as 
potent SABRE substrates with a view unlocking their future biological applications in 
areas such as MRI. (−)-Nicotine is an important biological compound of great interest, 
with potent and well-documented psychoactivity. Initial results in Chapter 2 focuses on 
the isotopic labelling of (−)-nicotine through regioselective lithiation-trapping and 
subsequent catalytic deuterodehalogenation.  
 
Chapter 3 discusses the hyperpolarisation of (−)-nicotine and its isotopologues derivatives 
by SABRE. The relationship between signal enhancement, signal lifetime and a range of 
dependencies such as temperature, field and substrate choice are examined in detail. 
Results show that the interdependencies of such conditions are highly complex but follow 
logical patterns.  
 
The results shown in Chapter 4 highlight the efforts made to understand the SABRE 
process itself, specifically the impact of the rate of exchange of substrate molecules onto 
and from the SABRE catalyst. Kinetic models are developed to more accurately describe 
the intricacies of the resulting chiral (−)-nicotine-based complexes, and they shed light 
on significant flaws in existing SABRE exchange models. 
 
Collectively, the synthetic 2H-labelling developments and SABRE evaluation involved 
no less than 23 materials, unlocking 1H enhancement levels of up to ~2700-fold 
(equivalent to 9 % polarisation) with magnetic state lifetimes of up to 37 seconds. The 
previously overlooked effects of chirality are identified and rates of ligand loss robustly 
quantified as 3.08 ± 0.07 s-1. In addition, our understanding of the role 2H labelling plays 
in SABRE is secured.  
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1: Introduction 
 
1.1 NMR spectroscopy, MRI and their limitations 
 
Nuclear Magnetic Resonance (NMR) spectroscopy is amongst the most important and 
widely used procedures in science. Magnetic Resonance Imaging (MRI), a biological 
application of NMR, is one of the most prominent procedures in healthcare. However, the 
relative insensitivity inherent to all NMR techniques severely restricts their diagnostic 
potential. 
 
Signal strength in an NMR experiment is dependent on the bulk magnetic moment (often 
also known as the nuclear spin polarisation, P) of all the nuclei in the sample when a 
magnetic field is applied. This is in turn derived from the Boltzmann population of nuclear 
spin energy levels, specifically the population difference between them. For the I = ½ 
nuclear spin system (to which 1H, 13C, 15N, 31P, 19F and many others belong), the nuclear 
spins can either align with the applied magnetic field (I = + ½) or against it (I = − ½) 
(Figure 1). 
 
Figure 1: Populations of nuclear spin energies at thermal equilibrium for I = ½  
 
The difference in energy between each of these spin energy levels for spin I = ½ is given 
by ∆𝐸 = 𝛾ℏ𝐵0, ie. it is proportional to the strength of the magnetic field. At field strengths 
possible for an NMR magnet, this energy difference is very small, far smaller than the 
ambient thermal energy (kT, the energy of molecules colliding with each other) and hence 
the levels are almost equally populated. Indeed, in a normal 400 MHz spectrometer, with 
a field strength of 9.4 T, the population difference between the two levels for 1H is only 
31 nuclei per million, i.e. there are only thirty-one more nuclei in the lower energy level 
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than the higher out of every million observed. This also means that there are only thirty-
one nuclei per million that can be spin-flipped to the higher energy level and thus produce 
a signal when the RF pulse of an NMR experiment is applied.1-3 The problem is 
exacerbated enormously for other even less sensitive nuclei, with 13C having one quarter 
(γ/2π = 10.708 MHz•T-1) of the nuclear spin polarisation as its 1H equivalent (γ/2π = 
42.577 MHz•T-1), and 15N having one tenth (γ/2π = −4.316 MHz•T-1), the vastly reduced 
natural abundances of these isotopes compared to 1H notwithstanding.1,3 Thus, the signal 
intensity produced is comparatively weak compared to that of optical spectroscopy, where 
nearly every atom/molecule observed will contribute to a signal. 
 
Since it can be derived that the population difference 𝑃 ≈ ∆𝐸/2𝑘𝑇 ≡
𝛾ℏ𝐵0
2𝑘𝑇
, then there are 
several ways that the thermal equilibrium population difference can be enhanced.2 The 
most obvious method is to simply increase the strength of the applied field with a more 
powerful magnet, giving a greater difference between the nuclear spin energy levels and 
reducing the likelihood that the ambient thermal energy of the molecules will promote 
them into the higher energy level. However, increasingly powerful magnets rise 
dramatically in cost and can only improve P so much – indeed, even with a very strong 
(and very expensive) 21 T magnet, the population difference at equilibrium will still only 
be 70 ppm.3  
 
Alternatively, a lowered temperature will reduce the ambient thermal energy and result 
in a stronger population bias towards the lower spin energy level for similar reasons as 
above. Unfortunately, whilst this has been used successfully with NMR experiments 
already (although gains are still fairly minor), in vivo experiments such as MRI will 
always be limited to around biological temperatures, a minimum of around 300 K. 
 
The third, and easiest, solution to the weak population difference is simply to increase the 
number of nuclei observed so that their net signal is stronger. In practical terms, this only 
means increasing the concentration of the sample and/or increasing the number of scans 
performed (which achieves the same result). Regrettably, there are once again practical 
limits to what these approaches can achieve. There is only a finite quantity of substrate 
that can be dissolved in a given amount of solvent, so increased concentration can only 
offer a finite improvement. It would also be totally impractical for research and diagnosis 
if every NMR experiment and MRI scan ever performed took hours or days rather than 
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minutes because of the increased number of scans needed. More importantly for 
biological applications, there is a limited timeframe before an injected contrast agent will 
be excreted from the body by the kidneys and so waiting hours to collect a great number 
of scans is not feasible. There is also the problem of how harmful these contrast agents 
are for the body: for example, the existing agents are based on the extremely toxic heavy 
metal gadolinium – while ionic cyclic gadolinium (III) chelates are relatively safe 
compared to other forms,4 it would be ill-advised to inject more harmful material than 
absolutely necessary into a patient to achieve a better signal. 
 
With these problems, it is obvious that an alternative approach is needed to improve the 
sensitivity of NMR and, by extension, the sensitivity of MRI. 
 
1.2 Signal enhancement and hyperpolarisation 
 
Signal enhancement is the production of a non-Boltzmann distribution of spins, i.e. 
selectively populating certain spin-states (Figure 2) and thereby increasing the number of 
spin-flips possible in an NMR experiment. As the NMR signal for a given sample is 
derived from the sum of these observable transitions, this hyperpolarised state will result 
in significantly increased signal strength. 
 
 
Figure 2: Hyperpolarised populations of nuclear spin energies for I = ½ 
 
There are several methods for available for production of a hyperpolarised state, including 
‘brute force’5,6, optical pumping of gases7, Dynamic Nuclear Polarisation8 and the use of 
a material called para-hydrogen.9 These will be discussed in detail below. 
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1.2.1 Brute force 
 
Brute force is a simple hyperpolarisation method, originally proposed in the 1960s but 
now considered antiquated.5,6 It is essentially a more-extreme version of the physical 
improvements described in Chapter 1.1 – a sample is exposed to a strong magnetic field 
and ultra-low temperatures, the former increasing the energy gap between spin states and 
the latter reducing/eliminating transitions via ambient thermal energy. Over time, a 
hyperpolarised state is very gradually produced.7 An increase in polarisation of 1000-fold 
was observed by cooling a sample to 4 K in a 20 T field.10 An extremely low temperature 
of 7 milli-kelvin and a magnetic field of 16 T was reported by Owers-Bradley et al. to 
yield a signal enhancement of ~200,000 fold versus the same sample at 310 K and 3 T, 
although the enhancement needed to be mediated by nanoparticles.11  
 
Such enormous signal comes at a price, the cost of such powerful magnets 
notwithstanding. Firstly, the hyperpolarised state only exists at super-low temperatures, 
degrading rapidly back to Boltzmann equilibrium when warmed to temperatures more 
useful for diagnostic purposes. Secondly, the hyperpolarised state takes an inordinate 
amount of time to form, as the T1 relaxation times of samples become extremely long at 
low temperatures. As transitions between spin states are either an excitation or relaxation 
(in this case the latter), the gradual production of a hyperpolarised state by long relaxation 
will invariably be very slow. Due to the demanding conditions required, there has been 
minimal research done into a practicable application for brute force and other methods 
are far more prominent. However, recent work by Hirsch et al. with new protocols for the 
polarisation and subsequent warming of samples with minimal loss of polarisation 
indicates brute force may become a relevant technique again.12 
 
1.2.2 Optical pumping of gases 
 
Optical pumping is a technique first developed for medical imaging by Albert et al., in 
1994.13 A noble gas, typically 129Xe or 3He, is combined with alkali metal vapour 
(typically rubidium) and nitrogen in a gas cell. Circularly polarised light of a specific 
wavelength is produced by a laser shining through a quarter-wavelength metal plate and 
passed through the mixture. The gas is hyperpolarised by spin exchange from the alkali 
metal in a Helmholtz coil-generated magnetic field – the alkali metal is itself polarised 
by absorbing the angular momentum of the laser light. A small sense coil monitors 
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completion of the hyperpolarisation process, subsequently the alkali metal is condensed 
and the hyperpolarised gas extracted to a gas bag for diagnostic use (Figure 3).5,14  
 
 
Figure 3: Apparatus for polarizing gas (in this case 3He) outside the body. Figure taken from 
Kadlecek et al., 200214 
 
Hyperpolarised gases have primarily been used for the imaging of the lungs. Normal 
proton MRI of the lungs is very difficult, as they are predominantly filled with gas spaces 
and devoid of the blood (i.e. water) needed for proton MRI to work. There are also 
susceptibility issues encountered with air/tissue interfaces, where gradual magnetisation 
of the lung membranes generates image artefacts.15 However , 129Xe has shown much 
diagnostic promise beyond lung imaging, as its lipophilic nature allows it to dissolve in 
both fatty tissues and blood.16  The technique has developed to allow full imaging of 
human lungs,17 the human oral cavity18 and easy distinction between healthy lungs and 
those with asthma, cystic fibrosis or chronic obstructive pulmonary disease (COPD).19 In 
the latter study, overlay of 1H and 129Xe MRI spectra allowed for a complete picture of 
the lungs to be obtained (Figure 4). 
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Figure 4: Hyperpolarised 129Xe MRI images (red) overlaid with the corresponding 1H MRI images 
of the thoracic cavity. Images are from healthy participants and those with asthma, chronic 
obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Image taken from Shukla et al.19  
 
The chief flaw in the use of hyperpolarised gases is generally poor signal intensity 
compared to other hyperpolarisation techniques.20 Research has therefore focused on 
applications for which non-gaseous agents would be ill-suited, such as perfusion of gas 
into tissues21-24 and studies into brain function by perfusion tracking.16 
 
1.2.3 Dynamic Nuclear Polarisation 
 
 Dynamic Nuclear Polarisation (DNP) is a method that transfers polarisation from lone 
electron pairs to create a non-Boltzmann distribution of nuclear spins.7 Such a transfer is 
affected by applying GHz-wavelength microwave radiation at very low temperatures (1-
2 K) and in a relatively high magnetic field (~3 T). Electrons have a much higher 
gyromagnetic ratio  (1.76x1011 rad T s-1) than typical nuclei (2.68x108 rad T s-1 for a 
hydrogen nucleus),25 hence polarisation of an electron spin is 657 times greater magnitude 
than proton spin under the same conditions.26  
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Figure 5: differences in polarisation between electrons (green) and proton nuclei (black) in a 14 T 
magnetic field and the temperature dependence of each. DNP is the process of transferring 
polarisation from electrons to nuclei, as indicated by the orange arrow. Image taken from Bridge12 
Technologies27 
 
The microwave polarisation transfer in DNP can be effected in four different methods - 
solid-effect (SE), the cross-effect (CE), thermal-mixing (TM) and the Overhauser effect 
(OE).28 The first three methods have been predominantly used to hyperpolarise in the 
solid state, with notable research including ribosome structural biology29 and bacterial 
cell interactions.3,30 The chief limitation of solid-state DNP is that it is difficult to utilise 
low-temperature solids in in vivo or in vitro applications. 
 
Dissolved-phase or dissolution DNP is a more promising method, in which nuclear spins 
are still hyperpolarised in the solid state at very low temperature but are then warmed 
within seconds to a liquid with minimal loss of polarisation. This method was first 
successfully completed for a urea sample with a resulting polarisation of 37% for 13C and 
7.8% for 15N.3 
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An important development in recent years has been the successful hyperpolarisation of 
water. Water is an appealing target, as protons can yield high levels of magnetisation due 
to one of the highest gyromagnetic ratios of all nuclei. Secondly, water is not only 
completely biocompatible, but also crucial in a wide variety of metabolic processes.31  
Water hyperpolarisation has been achieved using both Overhauser-effect solid-state32 and 
dissolution DNP33, with the latter exhibiting greater and longer-lived enhancement. An 
example of hyperpolarised water used in imaging is shown in Figure 6.  
 
 
Figure 6: In vivo angiographic images in a rat after a tail vein injection of hyperpolarised water. The 
numbers represent time after injection in seconds. Image taken from Ardenkjær-Larsen et al., 201133  
 
However, DNP hyperpolarisation of water has significant limitations. The hyperpolarised 
water relaxes back to thermal equilibrium very quickly, as the T1 relaxation time of water 
is only 3.7 seconds. Secondly, creation of the hyperpolarised sample in the first place is 
very slow, typically taking an hour or more.34 The fast relaxation can be alleviated 
somewhat by addition of D2O, although this creates complications as D2O in large 
volumes is considered toxic. 
 
Pyruvate is the other molecule of most interest to DNP studies, with several ideal 
properties for diagnostic imaging. This sample molecule is highly solubility in water, 
exhibits rapid distribution and metabolism in vivo, shows different metabolism in tumour 
cells versus healthy cells and has a relatively long T1 relaxation time when labelled with 
13C.35 In addition, there is highly efficient transport of pyruvate into cells through 
dedicated transport proteins.36 
 
Pyruvate is metabolised to form lactate, alanine and bicarbonate, each which have a 
distinct 13C chemical shift. Tumour cells have been shown to produce more lactate than 
healthy cells, which means a hyperpolarised injection of pyruvate can be used to 
determine the success of chemotherapy in a non-invasive manner. Chemical Shift 
Imaging (CSI) is an imaging technique whereby maps can be produced of the location of 
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each individual pyruvate metabolite signal.37 CSI has been successfully combined with 
DNP for a range of organs in a range of species. Some examples of the images produced 
are shown in Figures 7 and 8. 
 
 
Figure 7: Data from abdominal 13C CSI acquisition of pyruvate metabolite maps in a rat. Different 
metabolites are shown to become concentrated in different tissue. Image taken from Kohler et al., 
200738 ‘Intra’ refers to the intracellular spaces  
 
 
Figure 8: Distribution of hyperpolarised pyruvate in a pig heart, via multiple slices through the short 
axis. Image taken from Lau et al., 201039 
 
DNP has become a well-established hyperpolarisation technique, although it is not 
without its problems. Details of the complex polarisation transfer between electrons and 
nuclei are still not fully understood, and several papers have been published by Vega et 
al. trying to more fully eleucidate the mechanisms.40-42 Diagnostic use requires long 
relaxation times for the hyperpolarised agent to both be injected and reach the site of 
interest without signal intensity diminishing significantly. Slow relaxation has so far been 
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achieved with 13C-labelling of compounds, which adds extra time and cost to the sample 
preparation and also adds requirements to the MRI facility. Using DNP in a clinical 
environment therefore requires the MRI facility to have access to dual tuned (1H/13C) 
coils and a dedicated clean room to house the bulky DNP instrument. The extra equipment 
and facilities required come both at considerable financial cost as well as demanding 
significant space. 
 
1.3 para-Hydrogen 
 
The most recent (and perhaps most promising) source of non-equilibrium polarisation is 
a material known as para-hydrogen (p-H2), a form of molecular hydrogen gas. This gas 
can be employed hydrogenatively in a technique called para-Hydrogen Induced 
Polarisation (PHIP) or non-hydrogenatively in a technique known as Signal 
Amplification By Reversible Exchange (SABRE). 
 
A (di)hydrogen molecule (H2) consists of two covalently-bonded hydrogen atoms, each 
of which possess a nuclear spin angular quantum number of ½.43 In an external magnetic 
field, these spin numbers will take the values of + ½ or - ½, typically referred to as α or 
β states respectively, where α is a spin parallel to the magnetic field and β is antiparallel 
(in-line with but opposite to the field). Therefore, a hydrogen molecule has four possible 
spin configurations, αα, αβ, βα and ββ. As αβ and βα are energetically identical (the 
individual spins are indistinguishable and so cannot be separated), a linear combination 
of addition and subtraction is used to instead give two new terms, (αβ + βα) and (αβ - βα). 
αα, ββ and αβ+βα are symmetric with respect to inversion (exchange of nuclei) and form 
the triplet spin isomers collectively known as ortho-hydrogen. The fourth configuration 
(αβ - βα) is anti-symmetric with respect to inversion and forms a singlet state known as 
para-hydrogen (Figure 9).44,45  
 
 
Figure 9: the four spin isomers of hydrogen. The three isomers in green are known as ortho-hydrogen, 
whereas the isomer in blue is known as para-hydrogen 
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The Pauli exclusion principle requires the overall wave function (Ψ) of H2 to be 
antisymmetric. The wave function is a combination of translational, electronic, 
vibrational, rotational and nuclear contributions (Equation 1).46  
 
𝛹 =  𝛹𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛𝑎𝑙 ∙  𝛹𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛 ∙  𝛹𝑛𝑢𝑐𝑙𝑒𝑎𝑟 ∙  𝛹𝑟𝑜𝑡𝑎𝑡𝑖𝑜𝑛  ∙  𝛹𝑣𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 
 
Equation 1: components of a molecular wavefunction46  
 
 The translational, electronic and vibrational wavefunctions are always symmetrical, 
hence one of the nuclear and rotational components must be antisymmetric (and the other 
symmetric) for the overall wavefunction to be antisymmetric as required. Therefore, 
ortho-hydrogen symmetric nuclear spin states have an antisymmetric rotational state (J = 
1, 3, 5…). In contrast, the para-hydrogen isomer that has an antisymmetric nuclear spin 
configuration (αβ – βα) occupies symmetric rotational states (J = 0, 2, 4…). At room 
temperature all four spin combinations are equally populated (i.e. 75% ortho-hydrogen 
and 25% para-hydrogen), as the energy differences between each form are very small. 
As it can occupy the lowest-energy rotational state (J = 0), the percentage of para-
hydrogen increases as temperature decreases. At 20 K, the proportion of para-hydrogen 
is greater than 99.8 %.9 
 
Temperature (K) % ortho-hydrogen % para-hydrogen 
>273 75.00 25.00 
273 74.87 25.13 
150 71.46 28.54 
75 48.14 51.86 
20 0.18 99.82 
0 0.00 100.00 
 
Table 1: variation in hydrogen isomer populations with temperature, adapted from Duckett et al., 
19999 
 
The interconversion between the two isomers is formally spin-forbidden, therefore a 
paramagnetic catalyst is required to produce para-hydrogen2,47-50 Charcoal, iron (III) 
oxide and iron (III) hydroxide have proven suitable catalysts for interconversion, over 
which ultra-pure hydrogen gas is passed at 20 K or less to produce pure para-hydrogen 
(Figure 10). 
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Figure 10: schematic representation of a para-hydrogen generator as used by the Duckett group. 
Taken from Duckett et al. website51 
 
The upside to the difficulties associated with production of para-hydrogen is that the 
formally forbidden interconversion makes the pure para-hydrogen very stable even when 
warmed back to ambient temperatures. Therefore, it is relatively easy to store for extended 
periods without loss of purity. 
 
1.3.1 para-Hydrogen Induced Polarisation (PHIP) 
 
Para-hydrogen itself is completely NMR silent, as the antiparallel nuclear spins cancel 
each other out and the molecule has no net spin angular momentum. However, reaction 
of para-hydrogen with other molecules typically result in non-Boltzmann nuclear spin 
state populations when the (anti)symmetry of the para-hydrogen is broken. Para-
Hydrogen Induced Polarisation (PHIP) is a technique where para-hydrogen is added 
across unsaturated bonds in a hydrogenation reaction, thereby breaking the hydrogen 
molecule’s symmetry and creating a strong non-equilibrium spin population.47,48 Only the 
the αβ and βα configurations are populated in  para-hydrogen derived hydrogenation 
products, hence transitions between energy levels are not cancelled out and significantly 
stronger NMR signals result. (Figure 11) Because transitions from the αβ and βα states 
can be either in absorption or emission, a characteristic pair of antiphase doublets are 
observed in the associated NMR spectra. 
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Figure 11: Schematic representation of nuclear spin states in natural abundance hydrogen (left) and 
para-hydrogen (right) derived hydrogenation products and the corresponding NMR spectra of the 
labelled transitions between states. The thickness of the lines in the top images reflect the population 
of that spin state. Adapted from Duckett et al., 2012 47 
 
The first instances of successful PHIP were reported by Bowers and Weitekamp in 1987, 
in which para-hydrogen and Wilkinson’s catalyst (tris(triphenylphosphine)rhodium (I) 
chloride) were used to hydrogenate acrylonitrile (CH2CHCN) to propionitrile 
(CH3CH2CN).
52,53 The 1H NMR spectrum acquired of the product showed significantly 
enhanced signals for new propionitrile C-H resonances and in the hydride region of the 
hydrogenated catalyst (Figure 12). 
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Figure 12: First demonstration that hydrogenation with para-hydrogen yields significantly stronger 
NMR signals. (a) is immediately prior to para-hydrogen addition (i.e. acrylonitrile starting material), 
(b) is immediately after parahydrogen addition, (c) is the spectrum of the sample left to equilibrate 
and (d) is the predicted line shape according to theory, which closely matches that in (b). Images 
taken from Bowers and Weitekamp, 198753 
 
These first PHIP experiments by Bowers and Weitekamp were performed in a relatively 
strong magnetic field inside the NMR magnet at ~200 MHz53 and they coined the name 
Parahydrogen And Synthesis Allow Dramatically Enhanced Nuclear Alignment 
(PASADENA) for such para-hydrogen hydrogenation experiments in high field. 
However, Weitekamp went on to prove with Pravica et al. that incorporation of 
parahydrogen into the sample can still occur in the absence of a strong magnetic field 
(e.g. in Earth’s relatively weak magnetic field).54 This variation of PHIP was named 
Adiabatic Longitudinal Transport After Dissociation Engenders Net Alignment 
(ALTADENA) due to the adiabatic transfer of the sample from a weak to a strong 
magnetic field after the addition of para-hydrogen. When the hydrogenation occurs in a 
weak magnetic field, para-hydrogen remains in the singlet state, despite breaking the 
physical symmetry of the molecule. Subsequent transfer into a high field full breaks the 
nuclear spin symmetry but only the lower-energy βα spin state is populated and the 
resulting NMR signals therefore appear as a single line in absorption and a single line in 
emission of equal intensity (Figure 13).55 
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Figure 13: Schematic representation of reaction product nuclear spin states using para-hydrogen 
under PASADENA and ALTADENA conditions and the corresponding NMR spectra of the labelled 
transitions between states. The thickness of the lines in the top images reflect the population of that 
spin state. Adapted from Natterer et al., 199755 
 
While there has been work using PHIP to investigate reaction intermediates56-58, the most 
significant use of the technique so far has been hyperpolarised in vivo signals in MRI. 
These studies have typically focused on 13C nuclei to take advantage of its significantly 
longer hyperpolarisation lifetimes (usually in the tens of seconds) when compared to most 
1H nuclei (a few seconds) and to take advantage of no observable background signal in 
the body. The first example of in vivo PHIP imaging was the (para)-hydrogenation of 
acetylenedicarboxylic acid dimethyl ester to maleic acid dimethyl ester, with a 13C-
labelled carbonyl group and a rhodium catalyst (Figure 14).59 
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Figure 14: Reaction between acetylenedicarboxylic acid dimethyl ester with parahydrogen in the 
presence of a rhodium catalyst to give maleic acid dimethyl ester. The * represents a 13C isotope. 
Adapted from Golman et al., 200159  
 
Proton images were taken of an anaesthetised rat with a scan time of 5.4 minutes. 
Subsequently, 3 mL of hyperpolarised maleic acid dimethyl ester solution was injected 
into the tail vein and a 13C single-shot sequence was used to generate an image one second 
after injection (Figure 15).  
 
 
Figure 15: MRI images of a rat (generated at 2.4 T). (a) Conventional 1H image with a scan time of 
5.40 min, (b) 1H image with a scan time of one second, (c) 13C single shot image generated in one 
second. All images are superimposed onto a photograph of a rat to demonstrate the field of view. 
Images taken from Golman et al., 200159  
 
Figure 15 demonstrates that hyperpolarised 13C can yield detailed structural blood vessel 
information after only one second, whereas conventional proton imaging is unable to 
show anywhere near this level of detail after a much longer scan. The level of polarisation 
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was estimated at only 0.3%, which although small is clearly sufficient in the absence of 
a 13C background signal in vivo.  
 
The chief problem with PHIP is the requirement for relatively prefunctionalised 
substrates with unsaturated moieties incorporated and frequently 13C labels also. This 
severely limits the scope of viable compounds and presents synthetic challenges to create 
suitable unsaturated precursors, particularly biologically-compatible examples.  
 
1.3.2 Signal Amplification By Reversible Exchange (SABRE) 
 
A more recent and promising form of PHIP is known as Signal Amplification By 
Reversible Exchange (SABRE), with the first results published in 2009.1,2,60 It allows 
interaction of the para-hydrogen molecule and the target substrate without permanently 
binding the two together, instead temporarily binding through a transition metal catalyst 
intermediary. The temporary binding still allows great increases in NMR signal intensity 
but allows for a much wider scope of substrates to be investigated.47,49,61-63 
 
When para-hydrogen binds to the aforementioned transition metal complex, it is broken 
in two to form a two hydride ligands. Concurrently, the substrate also binds to the metal 
complex. During the time that both the para-hydrogen-derived hydrides and the substrate 
are bound, long-range scalar coupling across the transition metal centre facilitates 
polarisation transfer from the hydride ligands to the substrate ligands. The binding of 
hydrogen and substrate is reversible, leading to dissociation of the hydrides to form 
ordinary molecular hydrogen and dissociation of the now-hyperpolarised substrate into 
solution. ‘Fresh’ para-hydrogen and substrate molecules can then bind to the now-vacant 
catalyst binding sites and the process repeats to gradually build-up a population of 
hyperpolarised substrate free in solution. A simplified schematic representation of the 
SABRE method is shown in Figure 16.  
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Figure 16: Schematic representation of the magnetisation transfer process in SABRE. [M] represents 
the transition metal complex with other ligands, blue represents non-hyperpolarised species, red 
represents hyperpolarised species and orange represents species exchanging polarisation. Image 
adapted from Adams et al., 20091  
The transition metal template employed is iridium with an electron donating group 
attached, typically either a phosphine or carbene-based ligand. It is converted from a 
stable precatalyst to an 18-electron octahedral active form in situ upon the addition of 
hydrogen. There are two hydride ligands, three substrate ligands and the 
phosphine/carbene ligand. Figure 17 demonstrates production of this active catalyst 
complex with pyridine as the substrate and IrCl(COD)(IMes), an effective SABRE 
precatalyst reported by the Duckett group and others and the basis of all catalysts used in 
this project.62-64 First, the substrate coordinates to the transition metal precatalyst (I→II). 
Hydrogen is added to give the active catalyst III. For reference, the addition of para-
hydrogen to III to give intermediate IV is a more explicit description of the process 
previously described. 
 
  
Figure 17: SABRE precatalyst acitvation and subsequent hyperpolarisation of substrate. ‘Py’ refers 
to pyridine, a common SABRE substrate. Those species highlighted in red are hyperpolarised 
 
Pyridine has commonly been employed as the substrate molecule, exhibiting ideal ‘soft’ 
binding to the iridium centre. Cowley et al. observed a 6000-fold signal enhancement of 
pyridine using the IrCl(COD)(IMes) precatalyst after optimisation of conditions (Figure 
18).64  
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Figure 18: 1H NMR spectra of pyridine, 7 – 9 ppm region shown only. The top trace is conventional 
1H NMR (i.e. thermally polarised) but magnified 32 times. The lower trace is for SABRE-enhanced 
pyridine. Adapted from Cowley et al., 201164   
 
The pyridine signals in the enhance NMR spectrum were observed as in-phase multiplets 
(unlike that seen with PHIP), although a 180 ° phase difference was exhibited between 
some resonances. The phase difference was found by Cowley et al. to be dependent on 
the magnetic field where the hyperpolarisation takes place. 
 
SABRE has proven successful with a wide variety of substrates including pyridine, 
nicotinamide, methyl nicotinate, pyradizine, quinolone, quinoxaline, dibenzothiophene 
and nicotine.1,65,66  
 
The great advantage of SABRE over classical PHIP is that a hydrogenation of an 
unsaturated bond is not required. Therefore, the substrates need not be as heavily 
prefunctionalised and so substrate scope is much wider. The scope of SABRE is chiefly 
limited to substrates which possess ideal binding to the SABRE catalysts, typically soft 
nucleophiles such as those with a pyridine moiety. Another significant advantage is that 
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the reversible mechanism means para-hydrogen is the only reactant consumed.  
Consequently, substrate molecules can be repeatedly polarised within an experiment with 
a sufficient para-hydrogen reservoir in situ and the entire method is repeatable on a single 
sample solution if the para-hydrogen can be replenished. 
 
In recent years, much effort has been expended on prolonging the SABRE response 
before it decays back to thermal equilibrium. A long hyperpolarised lifetime would be 
critical for imaging applications, as it takes time for an agent to be injected into a patient 
and reach the diagnostic site of interest and there is little purpose in doing so if the signal 
has significantly decayed in the process. 
 
A well-documented route to improve the lifetime and efficacy of hyperpolarisation 
methods is the partial and selective deuteration of the substrate, first reported by 
Allouche-Arnon et al. and applied to DNP.67 Deuteration reduces the effect of scalar 
coupling as a relaxation pathway for the 1H hyperpolarised signal – deuterium and proton 
nuclei have different nuclear spins and so cannot couple to each other.68 When applied by 
Rayner et al. to SABRE, significant gains in both magnetic lifetime (measured by T1 
relaxation time) and signal enhancement were obtained. For example, methyl 4,6-
nicotinate-d3 exhibited up to four-fold increases in hyperpolarised signal and up to five-
fold increases in magnetic lifetimes when compared to the non-deuterated methyl 
nicotinate (Figure 19).63-65 Similar improvements were achieved with labelling of 
nicotinamide, isoniazid and others.69,70 This route will be investigated and discussed 
further in Chapter 3. 
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Figure 19: Methyl nicotinate and isotopologues methyl 4,6-nicotinate-d2 comparisons of T1 relaxation 
times and polarisation by SABRE. 1H NMR thermal (top) is expanded 64 times compared to the 
hyperpolarised spectrum (bottom). Image adapted from Rayner et al., 201866 
 
A more recent development to improve SABRE magnetic lifetimes is the creation of a 
pseudo-singlet state in the substrate. As described previously, the hydrogen nuclei in  
para-hydrogen itself exist in a singlet state, i.e. non-magnetic spin isomers of a coupled 
spin pair. This prevents external dipolar coupling from affecting the molecule. It is 
possible to temporarily create an approximation of a singlet state from two similar, 
mutually-coupled but magnetically inequivalent protons in substrate molecules, first 
reported by Levitt et al.71,72 A symmetrical singlet state can be imposed by application of 
a sequence of composite pulses specific to the coupling and chemical shift difference 
between the protons. It is maintained by a ‘spin lock’ and the signal can be observed by 
application of a final 90˚ RF pulse at specific time (Figure 20).73,74 
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Figure 20: pulse sequence used to create, maintain and observe singlet states. J is the scalar coupling 
constant and Δν is chemical shift difference between the two protons, both in Hz. Note notation for 
RF composite pulses – 90(90) and 90(0) denote RF pulses of 90˚ duration but 90˚ and 0˚ phase, 
respectively. Adapted from Roy et al., 201673 
 
SABRE can be applied in conjunction with such a state, where a substrate is 
hyperpolarised immediately before imposing the singlet state. Successful storage of 
hyperpolarisation was observed in the strongly-coupled pair of protons in 2-
aminothiazole75 and in nicotinamide and pyrazinamide derivatives selectively-deuterated 
to isolate coupled proton pairs.73 Hyperpolarised pseudo-singlet states of several minutes 
have been reported for pyradizine derivatives, with observable signal still detected fifteen 
minutes after storage in one example (Figure 21).76  
 
 
Figure 21: examples of molecules successfully hyperpolarised with SABRE and subsequently 
converted to a pseudo-singlet state. Pairs of similar, mutually-coupled but inequivalent protons are 
highlighted in red – selective deuteration is used to isolate the pairs except in the case of the 
pyradizine derivative (right) where it is used to break the symmetry of the molecule 
 
1.4 Project outline 
 
The primary aim of this thesis was to develop a family of (−)-nicotine derivatives as 
potent SABRE substrates with a view unlocking their future biological applications in 
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areas such as MRI. Focus has been on synthesis of small isotopically-labelled, 
biologically-appropriate organic molecules with long magnetic lifetimes (T1 relaxation 
times) which were then hyperpolarised with para-hydrogen in SABRE. To this effect, 
several deuterium-labelled derivatives of (−)-nicotine 1 have been prepared and tested. 
As SABRE enhancements are affected by numerous variables, such as the field for para-
hydrogen binding and the kinetics of molecule exchange, a key focus of this report is on 
the optimisation of these complex variables to give superior performance. A second key 
effort was made to better characterise the SABRE process through assessment and 
quantification of the critical exchange of substrate molecules. 
 
(−)-Nicotine 1 and isotopologue derivatives were selected for these studies, as it is known 
that the iridium hyperpolarisation catalysts used in SABRE bind readily to pyridyl 
moieties.6  1 also has a significant degree of biological compatibility in humans, albeit in 
very small quantities as a potent psychostimulant. It is also known to cross the blood-
brain barrier with ease,77 making it of particular interest in imaging applications of the 
brain. (−)-Nicotine 1 has been very widely cited for the last century as highly toxic with 
a human oral LD50 of 0.5-1.0 mg/kg (corresponding to 40-60 mg ingested for an adult), 
although recent scrutiny of past experiments and notable case study exceptions 
(summarised in a review by Mayer78) suggest the lethal dose is around 500 mg or higher. 
Therefore, small amounts of 1 and its isotopologue derivatives should be theoretically 
safe to use. 
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2: Synthesis of isotopically-labelled nicotines 
 
2.1 Synthetic strategy and design 
 
The focus of this project is the synthesis and evaluation of (−)-nicotine 1, its derivatives 
and its isotopologues. In order to achieve the goal of improved NMR/MRI detectability 
of (−)-nicotine 1 and its derivatives, synthetic strategy is first required to prepare a range 
of 2H-labelled isotopologues of (−)-nicotine 1.  
 
The general synthetic plan will be to regioselectively introduce chlorine substituents into 
the pyridine ring of (−)-nicotine 1, followed by hydrogenolysis with deuterium gas and a 
metal catalyst to give the deuterium-labelled compounds (Scheme 1). Work by Comins 
et al. on regioselective pyridine and nicotine lithiations formed the basis for the planned 
routes.79-82 The targeted isotopically-labelled nicotine analogues were selected based on 
their expedient synthesis via these established literature procedures, but also to provide a 
variety of structures to probe the somewhat poorly-understood mechanism of 
hyperpolarisation transfer about the pyridine ring. The methods employed here use 
different organolithium bases to introduce the chlorine substituents at different positions 
on the ring, which variously use sterics, coordination to nitrogen(s) and/or directed ortho 
metalation (DoM) effects to achieve the observed regioselectivity.83-85 
 
 
 
Scheme 1: general synthetic route to deuteronicotines 
 
The starting point of this work was the preparation of the different regioisomers of mono- 
and dichloronicotines using a range of procedures which are available from the literature. 
An overview of the synthetic approaches is shown in Scheme 2. A literature route for the 
regioselective chlorination of (−)-nicotine 1 to give 6-chloronicotine 2 is known, with 2-
chloronicotine 3 as a minor product.79 Hydrogenolysis of 2 would give 6-nicotine-d1 4. 
Additionally, treatment of 6-chloronicotine 2 with a variety of organolithium bases has 
been reported to give regioisomers 5,6-dichloronicotine 5, 4,6-dichloronicotine 6 and 2,6-
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dichloronicotine 7.80 Subsequent deuterogenolyses of these dichloronicotines would give 
5,6-nicotine-d2 8, 4,6-nicotine-d2 9 and 2,6-nicotine-d2 10, respectively. 
 
 
Scheme 2: full synthetic route to nicotine isotopologues 
 
2.2 Synthesis of halonicotines 
 
To start with, a chlorine substituent was introduced in the 6-pyridyl position of (−)-
nicotine 1, as it would be a precursor to 6-deuteronicotine 4 and it was planned that it 
would  act as an ortho-directing group for further lithiations at the 5-pyridyl position. 
Regioselective lithiation was achieved using n-BuLi·LiDMAE, a ‘superbase’ complex of 
n-butyllithium and lithiated 2-dimethylaminoethanol (DMAE), via a protocol previously 
reported by Comins.79 Using Comins’ procedure on a 1 mmol initial scale, 3.0 eq. of 
DMAE in n-hexane was treated with 5.4 eq. of n-BuLi at 0 °C for 30 min to produce 3.0 
eq. of LiDMAE  in situ with 2.4 eq. n-BuLi left over. The n-BuLi/LiDMAE mixture was 
then used to lithiate (−)-nicotine 1 at −20 °C for 1 h. Subsequent trapping with a solution 
of 4 eq. of hexachloroethane in n-hexane at −78 ºC for 1 h gave 6-chloronicotine 2 in 
moderate yield (51%), along with a small quantity of 2-chloronicotine 3 (6%) and a 40:60 
mixture of 2 and 3 (5%) (Scheme 3). The regioisomers were primarily identified by their 
pyridyl proton splitting patterns in their 1H NMR spectrum, with 2 exhibiting its most 
downfield peak (i.e. adjacent to the pyridyl nitrogen) as a doublet (J = 2.0 Hz) and 3 
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instead exhibiting a peak of near-identical chemical shift but doublet of doublets splitting 
(J = 4.5, 2 Hz) (Figure 22).  
 
 
Scheme 3: reagents and conditions to produce 6-chloronicotine 2 and 2-chloronicotine 3 
 
 
Figure 22: Chemical shifts and splitting patterns in the 1H NMR spectra for 6-chloronicotine 2 and 
2-chloronicotine 3 
 
To explain the regioselectivity, the n-BuLi·LiDMAE complex is believed to coordinate 
to the pyridyl nitrogen, abstracting an adjacent proton. Steric clashing between the 
complex and the pyrrolidine ring hinders formation of the 2-lithiated intermediate 11 
(Figure 23). Instead, preferential lithiation takes place α to nitrogen but away from the 
pyrrolidine ring, giving the 6-lithiated intermediate 12 as the major regioisomer.79 n-
Hexane was used as the solvent, as a non-coordinating and apolar solvent was reported 
by Gros86-88 to be essential to the integrity of the superbase-nicotine aggregate. Common 
coordinating solvents such as THF or diethyl ether would break up this aggregate and 
likely lead to reduced regioselectivity.  
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Figure 23: major and minor pathways for lithiation adjacent to nitrogen in (−)-nicotine 1 
 
Separation of regioisomers 6-chloronicotine 2 and 2-chloronicotine 3 proved problematic, 
as despite reasonable separation indicated by TLC (RF 0.26 for 3 vs 0.14 for 2 in EtOAc), 
their elution in flash column chromatography led to a large proportion of overlapped 
fractions. Numerous variations in conditions to separate the two regioisomers, including 
the use of reverse phase column chromatography, preparatory HPLC and alumina in place 
of silica gel, reduced the overlapped fractions to an extent, but ultimately mixed fractions 
of 2 and 3 were always obtained. The mixture varied in its ratio from column to column, 
but was always between 70:30 and 40:60 of 2 and 3. The mixed material did, however, 
find use later on (see Scheme 13) and so was not wasted. 
 
Scale up of the synthesis to 3 mmol of (−)-nicotine 1 also proved challenging. Use of 
otherwise identical lithiation and trapping conditions in n-hexane to those described 
above gave a significantly poorer yield of the desired 6-chloronicotine 2 (20%) and large 
quantities of recovered starting material (−)-nicotine 1 (44%) (Scheme 4). There was 
evidence of trace quantities of 2-chloronicotine 3 in the 1H NMR spectrum of the crude 
product, but it was not isolated after column chromatography. 
 
 
Scheme 4: failed reagents and conditions to produce pure 6-chloronicotine 2  
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It became apparent that with the larger quantities of reagents involved, the 
hexachloroethane electrophile was poorly soluble in n-hexane, even at room temperature. 
Therefore, the hexachlorethane was likely completely insoluble in the sub-zero reaction 
mixture, crashing out of solution upon addition. With minimal electrophile in solution, 
most of the unreacted lithiated intermediate would be converted back to (−)-nicotine 1 
upon quenching. Merely increasing the volume of n-hexane to alleviate the poor 
electrophile solubility would have required an impractically large quantity. Therefore, the 
effect of dissolving the electrophile in a co-solvent with similar properties to n-hexane 
was investigated. Treatment of 6 mmol of (−)-nicotine 1 with 5.4 eq. of n-BuLi and 3.0 
eq. DMAE in n-hexane with subsequent trapping with a solution of 4 eq. of 
hexachloroethane in toluene gave full conversion and a much improved yield of 6-
chloronicotine 2 (51%). In addition, 2-chloronicotine 3 (5%) and a 70:30 mixture of 2 
and 3 (26%) were also isolated. The overall yield of trapped products was 81% (Scheme 
5).  
 
 
Scheme 5: superior reagents and conditions to produce 6-chloronicotine 2 and 2-chloronicotine 3 
 
Multiple repetitions up to 20 mmol scale gave similar results, with 6-chloronicotine 2 
always the major product by far. Overall yields of both regioisomers were consistently in 
the 70-75% range. In one instance, 46 mmol of (−)-nicotine 1 was treated under these 
conditions (the largest quantity that can be treated with 5.4 eq. of n-BuLi and a full 100 
mL bottle of 2.5 M n-BuLi solution in hexane) to produce 6-chloronicotine 2 (43%), a 
small quantity of 2-chloronicotine 3 (1%) and a 35:65 mixture of 2 and 3 (21%) (Scheme 
6). However, this result necessitated two extremely large flash column separations taking 
considerable time and using in excess of ten litres of solvent. It was therefore deemed 
impractical to regularly synthesise these compounds on such a large scale. 
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Scheme 6: large-scale preparation of 6-chloronicotine 2 and 2-chloronicotine 3 
 
The relative quantities of reagents (n-BuLi, DMAE, C2Cl6) to produce 6-chloronicotine 
2 and 2-chloronicotine 3 were derived directly from the work by Comins79,81 and 
remained unchanged thus far because the synthesis demonstrably worked. However, such 
a large excess of n-BuLi·LiDMAE and electrophile represented a practical concern as 
they are relatively expensive and wasteful, particularly with large-scale preparations. To 
overcome this, the effect of reducing these excesses was investigated. Initially, the 
quantity of hexachlorethane electrophile was reduced from four to two equivalents with 
no significant changes in yields of products observed (<5% reduction of all regioisomers) 
(Scheme 7). 
 
 
Scheme 7: reagents and conditions to produce 6-chloronicotine 2 and 2-chloronicotine 3 with reduced 
electrophile quantity 
 
The initial success was then expanded to also reduce the quantity of n-BuLi·LiDMAE 
from three ‘equivalents’ (i.e. 5.4 eq. n-BuLi and 3 eq. DMAE) to two (i.e. 3.6 eq. n-BuLi 
and 2 eq. DMAE), again yielding similar results to previous conditions (Scheme 8). 
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Scheme 8: reagents and conditions to produce 6-chloronicotine 2 and 2-chloronicotine 3 with reduced 
reagent excesses 
 
With 6-chloronicotine 2 in hand, 5,6-dichloronicotine 5 was synthesised by a directed 
ortho lithiation.80,85,89 Following a different Comins procedure, 6-chloronicotine 2 was 
treated with 1.1 eq. of LiTMP (formed in situ from n-BuLi (1.1 eq.) and 
tetramethylpiperidine (TMP, 1.1 eq.)) in THF. Subsequent trapping with a solution of 
hexachloroethane in THF gave 5,6-dichloronicotine 5 in 60% yield with no other 
detectable regiosiomers (Scheme 9). The observation of only two mutually-coupled 
aromatic signals (J = 2.5 Hz) in the 1H NMR spectrum, corresponding to a slightly 
deshielded 4-pyridyl proton and a slightly shielded 2-pyridyl proton (Figure 24), was 
consistent with insertion of a chlorine at the 5-pyridyl position. The reaction was 
successfully scaled up to convert 5.44 mmol of 2 into 5 with only a slight reduction of 
yield to 53%. 
 
 
Scheme 9: reagents and conditions to produce 5,6-dichloronicotine 5 
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Figure 24: Chemical shifts and splitting patterns in the 1H NMR spectrum for 5,6-dichloronicotine 5 
 
As chlorine substituents are only moderate ortho-directing groups,83-85 it is believed that 
the steric bulk of the LiTMP base also contributes to the high regioselectivity observed. 
Steric clashing of the approaching base and the pyrrolidinyl N-methyl group prevents 
coordination to the pyrrolidine nitrogen and makes deprotonation at either the 2- or 4-
position unfavourable. Instead, coordination to the 6-chloro substituent occurs to effect 
lithiation at the 5-position, exclusively giving the 5-lithio-6-chloronicotine intermediate 
13 (Figure 25).  
 
 
 
Figure 25: steric clashing between the bulky base and pyrrolidinyl ring combines with coordination 
to chlorine to effect DoM 
 
Synthesis of regioisomeric 4,6-dichloronicotine 6 was then attempted using a different 
base, reported by Comins.80,81 4,6-dichloronicotine 6 was successfully produced by 
treating 6-chloronicotine 2 with 1.1 eq. n-BuLi in THF at −78 ºC. The lithiated 
intermediate was subsequently trapped with a solution of hexachloroethane in THF at −78 
ºC, giving 4,6-dichloronicotine 6 in 76% yield (Scheme 10). Two singlet aromatic proton 
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peaks with chemical shift closely corresponding to the 2-pyridyl and 5-pyridyl protons in 
2 indicated that the 4-pyridyl proton had been replaced by a chlorine substituent without 
any other changes to the pyridine ring (Figure 26). This result was noticeably superior to 
the 63% yield obtained and published by Comins et al. on a similar scale. The reaction 
was also successfully scaled up to convert 10.4 mmol of 2 into 6 in 75% yield. 
 
 
 
Scheme 10: reagents and conditions to produce 4,6-dichloronicotine 6 
 
 
 
Figure 26: Chemical shifts and splitting patterns in the 1H NMR spectrum for 4,6-dichloronicotine 6 
 
Due to issues encountered in the initial stages of the synthesis of 4,6-nicotine-d2 9 (as 
described in Chapter 2.3), two other 4,6-halonicotines 14 and 15 were produced as 
alternative deuteration precursors. They were synthesised from 6-chloronicotine 2 with 
the same Comins-derived conditions79-81 using n-BuLi organolithium species but a 
different electrophile was employed to introduce 4-bromo and 4-iodo substituents 
(Scheme 11). It was hoped such substituents would be more easily and quickly exchanged 
for deuterium. Both products 14 and 15 were produced in moderate to poor yields, 
although the bromochloronicotine 14 showed itself to be so unstable that even after it was 
stored in a freezer under argon, it decomposed completely after two days. The problems 
with the synthesis of 4,6-nicotine-d2 9 were ultimately solved (as described in Chapter 
2.3) and consequently, no further studies with analogues 14 and 15 were carried out. 
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Scheme 11: reagents and conditions to produce 4-bromo-6-chloronicotine 14 and 4-iodo-6-
chloronicotine 15  
 
In contrast to the regioselectivity to produce 5,6-dichloronicotine 5, it is believed that the 
relatively small n-BuLi molecule coordinates to the pyrrolidine nitrogen, thus 
overcoming the moderate ortho-directing effect of the 6-chloro substituent in 6-
chloronicotine 2 (Figure 27).18,22 The pyrrolidine ring itself acts as a CHNR2 ortho-
directing group, with strong directing power resulting from strong coordination to the 
organolithium base. The relative strengths of the two ortho-directing effects is most 
apparent insofar as no production of 5 is observed at all. 
 
 
Figure 27: comparison of effects of CHNR2 and Cl as ortho-directing functional groups 
 
2,6-Dichloronicotine 7 was also prepared from 6-chloronicotine 2.18 Following the same 
Comins procedure79,80 used to produce 6-chloronicotine 2, further treatment of 2 with n-
BuLi·LiDMAE (5.4 eq. n-BuLi and 3.0 eq. DMAE) in n-hexane at −20 ºC and trapping 
with a solution of hexachloroethane in toluene afforded 2,6-dichloronicotine 7 in 
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moderate yield (52%) (Scheme 12). The 1H NMR spectrum contained mutually-coupled 
doublet signals (J = 8.0 Hz) with chemical shifts corresponding to the 4-pyridyl and 5-
pyridyl protons in 6-chloronicotine 2 and this confirmed the regiochemistry (Figure 28). 
As conditions to produce 2,6-dichloronicotine 7 were essentially identical to those used 
previously for synthesis of 2, an idea to use otherwise wasted material was formed. 
 
 
Scheme 12: reagents and conditions to produce 2,6-dichloronicotine 7 
 
 
 
Figure 28: Chemical shifts and splitting patterns in the 1H NMR spectrum for 2,6-dichloronicotine 7 
 
It was theorised that a mixture of regioisomeric 2-chloronicotine 3 and 6-chloronicotine 
2 could be used as starting material for this reaction, with a chlorine substituent being 
incorporated at the unsubstituted α-position in each regioisomer to give 2,6-
dichloronicotine 7. This would give a use for the mixed material consistently produced 
by the incomplete separation of 2 and 3, instead of it requiring further purification. A 
slight modification was made to the conditions originally used to produce 6-
chloronicotine 2 and 2-choronicotine 3- the entire reaction was carried out in toluene at 
−78 °C rather than a n-hexane/toluene mixture at warmer temperatures. Treatment of an 
80:20 mixture of 2 and 3 with n-BuLi·LiDMAE (5.4 eq. n-BuLi and 3.0 eq. DMAE) in 
toluene and trapping with a solution of hexachloroethane provided 2,6-dichloronicotine 
7 in excellent yield (83%) (Scheme 13). 
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Scheme 13: reagents and conditions to produce 2,6-dichloronicotine 7 using chloronicotine mixture 
as starting material 
 
It was theorised that a different isotopologue precursor, 2,4-dichloronicotine 17, could be 
produced by treating 2-chloronicotine 3 with n-BuLi (Scheme 14), analogous to the 
conversion of 6-chloronicotine 2 into 4,6-dichloronicotine 6. The chief problem with this 
strategy was that 3 was very difficult to isolate in quantity with the established synthetic 
methodology. It was only obtained as a minor by-product in the synthesis of 6-
chloronicotine 2 or as a ~35:65 mixture of 2 and 3. 
 
 
Scheme 14: proposed synthesis of 2,4-dichloronicotine 17 
 
It was therefore decided to use the 35:65 mixture of 6-chloronicotine 2 and 2-
chloronicotine 3 as the starting material with a view to attempting separation of the two 
products that would be formed. Treatment of the 2/3 mixture with 1.1 eq. n-BuLi in THF 
at −78 ºC and subsequent trapping with hexachloroethane in THF appeared successful, 
with 1H NMR spectroscopic analysis of the crude product showing clean conversion to a 
35:65 mixture of 2,4-dichloronicotine 17 and 4,6-dichloronicotine 6 in 61% crude yield 
(Scheme 15). However, it was discovered that 17 and 6 have almost identical RF values 
in a variety of conditions (e.g. RF 0.57 vs. 0.55 in EtOAc). When separation by flash 
column chromatography was attempted, it proved impossible to successfully isolate each 
regioisomer from one another.  
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Scheme 15: reagents and conditions to produce 2,4-dichloronicotine 17 from chloronicotine mixture 
 
Overall, the synthetic methods outlined in this section were successful in isolating five 
different halogenated derivatives of (−)-nicotine 1. 1H NMR spectroscopy 
characterisation was instrumental in confirming that the desired products had been 
successfully produced (full characterisation data are listed in Chapter 6). The compounds 
were produced with yields ranging from 52 to 83%, which were deemed sufficient for 
further functionalisation. Thus, routes to a range of mono- and dihalonicotines were 
successfully developed using organolithium chemistry. 
 
2.3 Synthesis of deuteronicotines 
 
The conversion of the chloronicotine precursors 2, 5, 6 and 7 into the desired deuterated 
analogues was then attempted. A common preparation in the Duckett group would be to 
treat a halogenated precursor with a palladium catalyst (e.g. Pd/C) and deuterium gas to 
effect the desired deuteration, derived from a preparation by Pavlik et al.90 For this work, 
deuterium gas and palladium on activated carbon were combined to effect a catalytic 
reaction that was applicable to all substrates. Potassium carbonate was used as an additive 
to scavenge residual protons in the reagents and solvent and ensure complete deuteration 
(Figure 29). 
 
 
Figure 29: general method for production of deuteronicotines from halonicotines 
 
This deuterodehalogenation synthetic route typically requires high pressures in order to 
be effective, requiring use of a Parr compact pressure reactor to maintain a large 
deuterium excess. In turn, a polar solvent with high hydrogen/deuterium solubility was 
needed, typically an alcohol or DMF.91 Ethanol has superior hydrogen and deuterium 
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solubility to methanol92 while remaining inexpensive, relatively safe, easy-to-use and 
readily available. The partially-deuterated ethan-(ol)-D (CH3OD) was selected instead to 
eliminate potential H/D exchange with the ethanol hydroxyl proton, which would lead to 
undesired hydrodehalogenation. Lastly, because industry-supplied deuterated chemicals 
are never guaranteed as 100% deuterated, a base was incorporated to act as a 
hydrogen/proton scavenger and ensure only deuterium was incorporated into the 
products. 
 
The overall reaction proceeds by a deuterodehalogenation catalytic cycle (Figure 30).91,93 
The cycle begins with oxidative addition of palladium into the carbon-chlorine bond(s) 
of the precursor material and subsequent coordination of deuterium gas onto the metal 
centre. One of the deuterons coordinates directly to the palladium and the other is 
incorporated into the nicotine structure in a rearrangement referred to as ‘deprotonation’. 
Lastly, the remaining ligands on palladium are removed by reductive elimination to 
produce DCl and regenerate the Pd(0) catalyst. 
 
   
Figure 30: deuterodehalogenation catalytic cycle for conversion of halonicotines to the corresponding 
deuteronicotines 
 
The scale of deuteronicotine production was not only limited by the availability of starting 
reagents, but also by the size of the available Parr reactors.  There were two reactor types 
available, a smaller version appropriate for approximately 1-1.5 grams of precursor and 
a much larger version appropriate for 10 or more grams of starting material. The latter 
Parr reactor type was excessive for the quantities of precursor produced throughout the 
project and hence the smaller reactor was used exclusively. It was found that loading the 
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small reactor with more than ~2 grams of halonicotine led to substantially extended time 
required for full conversion to the corresponding deuteronicotine, as the volume of 
hydrogen in the reactor was fixed. 
 
Initial conditions for the deuterodehalogenation of 6-chloronicotine 2 were 10% by 
weight loading of 5% Pd/C catalyst, 8 bar of deuterium and 2 equivalents of potassium 
carbonate base in ethan-(ol)-D stirring at room temperature for 18 h. Reaction progress 
was monitored by LC-MS experiments observing the starting material peak with m/z [M 
(35Cl) + H] 197 disappearing and product peak with m/z [M + H] 164 appearing in its 
place. Purification by chromatography gave 6-nicotine-d1 4 in 50% yield (Scheme 17). In 
addition to mass spectrometry evidence, 1H NMR spectroscopy showed three aromatic 
signals at 8.48, 7.65 and 7.21 ppm, corresponding to the 2-pyridyl, 4-pyridyl and 5-
pyridyl signals respectively in (−)-nicotine 1. A characteristic quaternary C-D 1:1:1 triplet 
at 148.2 ppm (1JCD = 27.0 Hz) was also observed in the 
13C NMR spectrum. 
 
 
 
Scheme 16: reagents and conditions to produce 6-deuteronicotine 4 
 
 
 
Figure 31: Chemical shifts and splitting patterns in the 1H NMR spectrum for 6-deuteronicotine 4 
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Deuterium-incorporation to give 5,6-nicotine-d2 8 was then successfully achieved. This 
involved the use of identical reagents and conditions as for 6-nicotine-d1 4 (10% by 
weight 5% Pd/C catalyst, 8 bar deuterium, K2CO3 (2 eq.) in ethan-(ol)-D) on 5,6-
dichloronicotine 5, although yields of 5,6-nicotine-d2 8 were moderate (46%). The 
reaction time with the original 10% catalyst loading was considerably longer than for 6-
nicotine-d1 4, taking over four days to run to completion. Such a long reaction time was 
deemed impractical, with subsequent reactions successfully run to completion in a few 
hours with the catalyst loading doubled to 20% by weight and no significant change in 
yield (Scheme 18). The expected pair of quaternary C-D 1:1:1 triplets were not resolved 
in the 13C NMR spectrum, but the two singlets at 8.51 and 7.68 ppm in the 1H NMR 
spectrum (corresponding to 2-pyridyl and 4-pyridyl protons) indicated success (Figure 
32). Mass spectrometry analysis confirmed that full deuterodehalogenation had 
successfully occurred, with the starting material peak at m/z [M (35Cl2) + H] 231 being 
replaced first by two peaks for singly-deuterated intermediates at m/z [M (35Cl) + H] 197 
and then exclusively by the product peak at m/z [M + H] 165. 
 
 
 
Scheme 17: reagents and conditions to produce 2,6-nicotine-d2 8 
 
 
 
Figure 32: Chemical shifts and splitting patterns in the 1H NMR spectrum for 5,6-nicotine-d2 8 
 
Next, deuterodehalogenation of 4,6-dichloronicotine 6 was explored. Treatment of 
dichloronicotine 6 using the original set of deuterogenolysis conditions (10% by weight  
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Pd/C catalyst, 8 bar of deuterium) proved slow and problematic, with partial conversion 
to 4,6-nicotine-d2 9 taking several days and formation of an unidentified by-product (m/z 
= 168) preventing isolation of 9. After several failed attempts, 4,6-nicotine-d2 9 was 
successfully produced in moderate yield (43%) by doubling the catalyst loading to 20% 
by weight and drastically reducing the reaction time to only two hours. Careful 
monitoring of reaction progress by buffered LC-MS was needed to stop the reaction once 
full conversion to the desired product was achieved. In this way, over-reaction to the 
unidentified product was prevented (Scheme 19). The singlet aromatic 1H NMR 
spectroscopy signals at 8.52 and 7.25 ppm (corresponding to 2-pyridyl and 5-pyridyl, 
respectively) confirmed successful deuteration at the 4-pyridyl and 6-pyridyl positions 
(Figure 33) and MS analysis confirmed full deuteration with the product peak appearing 
exclusively at m/z [M + H] 165. The two expected quaternary C-D 1:1:1 triplets were, 
however, not well-resolved in the 13C NMR spectrum. To date, the by-product has not 
been identified as it could not be isolated for further analysis. However, it should be noted 
that this reaction was repeated successfully with the increased catalyst multiple times on 
scales up to 9 mmol of 4,6,-dichloronicotine 6 without the m/z 168 by-product being 
observed again at any stage. 
 
 
 
 
Scheme 18: reagents and conditions to produce 4,6-nicotine-d2 9 
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Figure 33: Chemical shifts and splitting patterns in the 1H NMR spectrum for 4,6-nicotine-d2 9 
 
Conversion of 2,6-dichloronicotine 7 into its derivative 2,6-dideuteronicotine 10 was 
achieved using 20% by weight loading of Pd/C catalyst, 2 eq. of K2CO3 and 8 bar of 
deuterium in ethan-(ol)-D. Full conversion was slow in comparison to the three 
dideuteronicotines studied under these conditions, taking a full four hours. In addition, 
despite several repetitions, the yield was consistently poor (Scheme 20). Two quaternary 
C-D 1:1:1 triplets in the 13C NMR spectrum at 149.1 ppm (1JCD = 28.0 Hz) and 148.3 
ppm (1JCD = 27.0 Hz) indicated successful deuterogenolysis. Success was further 
demonstrated by MS analysis and a lone m/z [M + H] 165 product peak and singlet signals 
at 7.67 ppm and 7.23 ppm in the 1H NMR spectrum, corresponding to the 4-pyridyl and 
5-pyridyl protons, respectively (Figure 34). 
 
 
 
Scheme 19: reagents and conditions to produce 2,6-nicotine-d2 10 
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Figure 34: Chemical shifts and splitting patterns in the 1H NMR spectrum for 2,6-nicotine-d2 10 
 
In summary, a number of singly and doubly deuterated nicotine substrates were 
successfully prepared using catalytic deuterogenolysis reactions (Figure 35). With these 
substrates in hand, assessment of their hyperpolarisation properties could begin. 
 
 
 
Figure 35: nicotine isotopologues produced in the project 
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3: NMR spectroscopic studies on nicotine isotopologues 
 
(−)-Nicotine 1 and its isotopologues 4, 8, 9 and 10 were evaluated by NMR spectroscopy 
to determine their potential suitability as MRI contrast agent candidates. This assessment 
was primarily quantified by two parameters, namely the extent to which the proton NMR 
signals intensity could be improved through hyperpolarisation by SABRE and the lifetime 
of this magnetic enhancement, quantified by the T1 relaxation times of protons in the 
molecule. Given that there are a multitude of interdependent factors (detailed throughout 
this chapter) that affect both the signal intensities and lifetimes of hyperpolarised 
systems64, it would be grossly impractical to assess all of the hundreds of possible 
permutations in a reasonable timeframe. The project has therefore sought to streamline 
optimisation of SABRE by eliminating non-ideal combinations and conditions as soon as 
possible and in a sensible order. 
 
3.1 SABRE substrate screen 
 
3.1.1 Screen for enhancement 
 
To achieve polarisation, samples were subject to a series of ‘shake-and-drop’ NMR 
experiments in order to determine their signal enhancement levels when hyperpolarised 
with SABRE. Samples of nicotine 1 and isotopologues 4, 8, 9 and 10 were prepared in 
methanol-d4, along with the [Ir(IMes)(COD)Cl] SABRE precatalyst 18 in 5 mm Young’s 
tap-fitted NMR tubes. The relative concentrations of the substrate and precatalyst were 
set to an intial 5-fold excess of substrate to ensure complete activation of the iridium 
precatalyst. After degassing each sample under vacuum, single-scan thermally-polarised 
1H NMR spectra were recorded as a baseline measure of the compounds’ normal NMR 
signal intensity. The sample tubes were then charged with 4 bar (absolute) of p-H2 and 
shaken vigorously by hand for ten seconds in a 65 G magnetic field to activate the 
polarisation transfer – said field was determined by theory and literature results for 
similarly-structured N-heterocycles to be the likely optimum (discussed in further detail 
in Chapter 3.5).64 The field was assessed by using a gaussmeter to find a point in a 
spectrometer’s stray field where the strength was 65 G and shaking the sample there. 
Immediately after shaking, the sample was placed in the spectrometer and another single-
scan 1H NMR spectrum was recorded. Further scans would be fruitless, as once encoded, 
the hyperpolarisation would at once start to return to thermal equilibrium and each 
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subsequent scan would therefore see a markedly weaker signal). Evaluation of the 
hyperpolarisation signal enhancement was achieved by direct comparison of integrals 
between the activated thermal and hyperpolarised single-scan spectra. Because of the 
inherently inconsistent nature of the shaking to activate (harder shaking gives better 
mixing of contents and effective para-hydrogen concentration, hence better signal), one-
scan spectra were repeatedly recorded with fresh p-H2 until at least three had the same 
measured signal enhancement per proton to within ± 50-fold. Reproducibility is an 
important criterion in learning from comparative measurements. The associated errors are 
estimated in Chapter 7. 
 
The pyridyl proton signals of hyperpolarised unlabelled nicotine 1 had NMR peak 
integrals on average ~200 times larger than their non-hyperpolarised (‘thermal’) 
counterparts, proving the initial conditions were able to successfully facilitate SABRE of 
1. However, a ~200-fold signal enhancement per proton corresponds to less than 0.7% 
polarisation, indicating significant improvements might still be achieved with 
optimisation of conditions. Each pyridyl proton signal (those at 8.43, 8.37, 7.78 and 7.36 
ppm) was noticeably increased in signal intensity – note that these peaks correspond to 
the species free in solution (the identity and characterisation of free and bound species 
peaks is explored in Chapter 4). There did not appear to be any significant enhancement 
for the protons in the pyrrolidine ring (signals between 3.5 and 1.5 ppm), suggesting that 
polarisation does not transfer significantly beyond the pyridine ring, as shown in Figure 
36. Spectra of similar appearance to this were obtained for each of the isotopologues 
tested.  
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Figure 36: thermal (a) and hyperpolarised (b) 1H NMR spectra of (−)-nicotine 1 in the presence of 
the active form of IMes precatalyst species 18. Thermal spectrum (a) intensity scaled up by 64 times 
relative to the hyperpolarised spectrum (b). Peak integrals for species free in solution given in blue, 
red asterisks indicate peaks corresponding to species bound to the catalyst 
 
The increase in signal intensity was not uniform for all resonances − those protons closest 
to the pyridine nitrogen (2-pyridyl and 6-pyridyl) showed significantly stronger 
enhancement (over 240x increase), in line with expectations that protons nearest the 
catalyst binding site (and therefore para-hydrogen) would be polarised most strongly. In 
comparison, the 4-pyridyl proton most distant from the catalyst binding site achieved the 
average enhancement (~200x), while for the 5-pyridyl proton it was noticeably poorer 
(~50x), despite being closer to the nitrogen than 4-pyridyl (Figure 37). The disposition of 
the varying degrees of enhancement indicated immediately that proximity to the para-
hydrogen polarisation source was not the only important factor for good SABRE 
performance.  Polarisation transfer within similar N-heterocycles reported in the literature 
yielded a similar pattern of enhancement, although the precise mechanism of 
intramolecular transfer remains poorly defined.94 
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Figure 37: SABRE hyperpolarised signal enhancements per proton for (−)-nicotine 1 with IMes 18 
precatalyst, relative to thermal signal 
 
Singly-deuterated 6-nicotine-d1 4 showed slightly improved average signal enhancements 
relative to unlabelled (−)-nicotine 1 at ~275-fold per proton. The actual enhancement per 
proton was similarly non-uniform as for 1 – the 5-pyridyl proton again exhibited very 
poor performance (only a ~30x increase). However, the 2-pyridyl and 4-pyridyl protons 
displayed approximately 400x signal enhancements when hyperpolarised (Figure 38), 
corresponding to a substantial ~31% and ~75% increase, respectively, versus their 
equivalents in undeuterated (−)-nicotine 1. Such increases could be attributed to 
polarisation from the limited para-hydrogen supply in the tube being diluted across only 
three protons in 4 versus four protons in 1, but the still-poorly-enhanced 5-pyridyl proton 
once more alluded to other factors being relevant. Testing of other isotopologues would 
shed more light on these as-yet ill-defined factors. 
 
 
 
Figure 38: SABRE hyperpolarised signal enhancements per proton for 6-nicotine-d1 4 with IMes 18 
precatalyst, relative to thermal signal 
 
5,6-Nicotine-d2 8 showed decidedly poorer enhancement than the singly deuterated 4, 
disrupting a potential correlation between the number of deuterium substituents 
incorporated and signal enhancement. Whilst the average signal intensity did increase 
compared to (−)-nicotine 1, the individual signals in 8 were noticeably poorer (~40-45%) 
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than most of the resonances in 1 (Figure 39). The greatly-reduced magnitude of the 2-
pyridyl proton enhancement (~26% worse than in the completely undeuterated (−)-
nicotine 1) despite this proton being directly next to the catalyst binding site demonstrated 
clearly that the deuterium substituents had a dramatic effect on transfer of polarisation 
about the molecule.  
 
 
Figure 39: SABRE hyperpolarised signal enhancements per proton for 5,6-nicotine-d2 8 with IMes 
18 precatalyst, relative to thermal signal 
 
The best performing substrate in this series by far, 4,6-nicotine-d2 9 displayed greatly 
superior signal enhancement levels, both as an average (~750x) and as individual 
resonances – now, the 5-pyridyl proton showed over a 1000-fold increase in signal 
intensity when hyperpolarised (Figure 40). The 5-pyridyl proton’s excellent enhancement 
came as a surprise in light of its isolation from the nitrogen binding site and the dismal 
performance of 5,6-nicotine-d2 8. This further demonstrated the complexity of how the 
polarisation transfers proceeds within the pyridine ring and how substituents affect it. 
However, previous group work on 4,6-deuterio-labelled nicotinamide24 resulted in a 
similar pattern of enhancement; a more weakly enhanced 2-pyridyl proton and a very 
strongly enhanced 5-pyridyl proton, suggesting there is a both a logical mechanism for 
these results and an as-yet unidentified relationship between two protons. 
 
 
 
Figure 40: SABRE hyperpolarised signal enhancements per proton for 4,6-nicotine-d2 9 with IMes 
18 precatalyst, relative to thermal signal 
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The signal enhancements exhibited by 2,6-nicotine-d2 10 were expected to be 
disappointing, as related compounds (pyridine, nicotinamide, etc.) with this deuteration 
pattern reported in literature had generally shown very poor signal enhancements.95  
Transfer of polarisation into pyridyl rings is believed to occur mainly through 4J 1H-1H 
scalar coupling between the catalyst hydride(s) and pyridyl α-protons directly adjacent to 
the catalyst binding site.94,96,97 The absence of both α-protons in a doubly-α-deuterated 
pyridyl system explains why such systems usually exhibit relatively poor enhancement – 
polarisation transfer would be forced along longer and less-efficient pathways.  
 
Surprisingly, the SABRE performance of 10 was not as poor as expected (Figure 41), 
with an average signal enhancement almost identical to that of natural (−)-nicotine 1 at 
just over 200-fold signal enhancement per proton. However, such SABRE performance 
was inferior to every other nicotine isotopologue tested under these conditions. It was 
concluded that the positive aspects of deuterium incorporation (reduced dilution of 
polarisation and fewer relaxation pathways) were countered almost exactly by inhibition 
of polarisation transfer from its source by the α-deuterium substituents. 
 
 
 
Figure 41: SABRE hyperpolarised signal enhancements per proton for 2,6-nicotine-d2 10 with IMes 
18 precatalyst, relative to thermal signal 
 
Therefore, no clear trend between deuteration levels and positions and the signal 
enhancement was observed - though for the most part the labelled nicotines showed 
stronger enhancement for individual proton resonances than the unlabelled nicotine 1. 
However, it was deemed obvious that 4,6-nicotine-d2 9 was by far the best performing 
substrate for signal enhancement under the initial conditions. 
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3.1.2 Screen for T1 magnetic lifetime 
 
The effects of the deuterium labelling on the magnetic lifetimes of these isotopologues 
was the focus of the project. The slower/longer the relaxation process, the longer a 
molecule will retain its signal intensity and so the longer a hyperpolarised contrast agent 
molecule would remain useful for – important when said agent must be polarised before 
entering the patient and reach the area of diagnostic interest with sufficient signal 
remaining. Relaxation occurs through several different pathways such as dipole-dipole 
interactions, chemical shift anisotropy and tumbling98, with a prominent route being via 
through-bond scalar coupling to other nuclei. Removing these through-bond couplings by 
replacing adjacent nuclei with examples which are not coupled to (i.e. non-I = ½ nuclei 
such as I = 1 deuterium in place of an I = ½ proton) was expected to slow down the speed 
at which a nucleus could relax. 
 
The magnetic lifetimes of the isotopologues were quantified with measurement of the 
substrates’ proton T1 relaxation times. T1 is a constant for each system otherwise known 
as the spin-lattice relaxation time, so called because the process radiates excess energy 
from the spins to surrounding nuclei, atoms and molecules (the ‘lattice’). The T1 
relaxation time does not represent full relaxation of nuclear spins back to equilibrium with 
an external magnetic field, instead it is the time for longitudinal magnetization (Mz) to 
recover approximately 63% (specifically, 1-(1/e)) of its initial value (M0) after movement 
into the observable xy-plane (Mxy). By extension, the T1 therefore indicates the time 
elapsed when ~37% of an experiment’s NMR signal would still be observable. The 
exponential decay of observable signal means complete recovery to equilibrium 
magnetisation is only complete at approximately 5(T1).
99,100  
 
The inversion-recovery and saturation-recovery T1 experiments were both employed 
throughout the project as measures of T1 relaxation times. The pulse sequences (described 
fully in Chapter 6) and defining equations vary slightly between the two experiments. 
However, they both involve an initial RF pulse and a subsequent 90° RF pulse after an 
increasing delay to observe the recovery of Mz. The T1 times derived from each are very 
similar, hence the two techniques have been used interchangeably throughout the project. 
Figure 42 shows the equation and recovery of longitudinal magnetisation for the 
saturation-recovery pulse sequence.  
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Figure 42: saturation-recovery of equilibrium magnetisation Mz/decay of observable signal by T1 
a.k.a spin-lattice relaxation. T1 itself is a time constant for a given system and conditions, which 
affects the rate at which Mz is recovered. 
 
By measuring the NMR signal intensity of each proton multiple times over a given period, 
a curve could be plotted from which the T1 relaxation time of that proton could be derived. 
Such T1 relaxation NMR experiments were performed on nicotine and deuteronicotine 
samples in methanol-d4 of identical substrate concentration as for the initial enhancement 
studies. Addition of the IMes precatalyst 18 and hydrogen to simulate the conditions of a 
SABRE experiment is now known to increase the rate of proton relaxation101, primarily 
via through-bond coupling between the substrate and catalyst as shown in Figure 43. 
Therefore, the substrate T1 relaxation times were calculated both for samples with catalyst 
and hydrogen added (hereafter referred to as activated conditions) as well as without 
catalyst and under vacuum (hereafter referred to as unactivated conditions). The activated 
conditions were considered a reasonable approximation of a ‘shake-and-drop’ 
experiment. It should be noted that, as substrate and hydrogen ligands are constantly 
exchanging with the catalyst under experimental conditions, the activated conditions T1 
measurements represent a weighted average of the bound and free forms of the substrate. 
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Figure 43: Major through-bond coupling relaxation pathways in (−)-nicotine 1 under both 
unactivated and activated conditions. Note that, for clarity, not all pathways are shown/duplicated. 
L are the other ligands present on the iridium centre 
 
The protons in unmodified (−)-nicotine 1 were found to have short T1 relaxation times, 
with all four resonances being between 8 and 12 seconds in the absence of catalyst.  
However, the same protons were found to have even shorter T1 times under activated 
conditions, with no proton T1 exceeding four seconds (Figure 44). The decrease was most 
apparent near the catalyst binding site, with the 2-proton and 6-proton exhibiting a 67 and 
75% reduction in T1 respectively in the presence of the catalyst. Such rapid relaxation 
indicated nicotine 1 would be an unsuitable candidate for medical imaging on magnetic 
lifetime grounds alone. The fast relaxation in combination with relatively poor signal 
enhancement highlights their mutual relationship – a rapidly-relaxing nucleus would 
bleed away large amounts of signal before it could be observed, hence a poor signal 
enhancement measured. In theory, much more rapid relaxation in the presence of the 
catalyst implies more efficient polarisation of the substrate, as polarisation and relaxation 
both occur via the same scalar coupling network. However, magnetic lifetime will be the 
key parameter for any imaging application as highly efficient polarisation is pointless if 
none of it remains by the time the agent reaches the diagnostic site of interest. 
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Figure 44: (−)-nicotine 1 T1 relaxation times, both under unactivated and activated conditions 
 
Addition of a single deuterium substituent in 6-nicotine-d1 4 resulted in different T1 
relaxation times for the remaining proton resonances. In the unactivated studies, the 4-
pyridyl proton T1 remained unchanged from the equivalent in (−)-nicotine 1 at 8 seconds, 
the 5-pyridyl proton T1 increased by over sixty percent to 13 seconds and the 2-pyridyl 
proton T1 shortened slightly to 6 seconds. More promisingly, under activated conditions, 
all three resonances were slower relaxing than their equivalents in unlabelled nicotine 1, 
with the 5-pyridyl resonance having a T1 twice as long in 4 as in 1. The longest T1 was 
still only eight seconds, but reinforced the hypothesis that further deuteration would likely 
lead to increased relaxation time (Figure 45). 
 
 
 
Figure 45: 6-nicotine-d1 4 T1 relaxation times under unactivated and activated conditions 
 
The signal enhancement studies on 5,6-deuteronicotine 8 initially appeared to be 
somewhat disappointing as their T1 relaxation times under unactivated conditions were 
barely any better than those in singly-deuterated 4 (Figure 46). The 4-pyridyl proton was 
the slower relaxing of the two resonances at 14 seconds unactivated. However, under 
activated conditions the T1 times decreased by a relatively small proportion (~22-37%) 
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compared to (−)-nicotine 1 (~50-75%) and 6-nicotine-d1 4 (~37-50%). Therefore, 8 
exhibited the longest activated T1 relaxation times yet observed at 11 seconds for the 4-
pyridyl proton and 5 seconds for the 2-pyridyl proton. While this result represented a step 
in the right direction for increasing the T1 times, these values were still too short to be of 
much use in practical application of SABRE. 
 
 
 
Figure 46: 5,6-nicotine-d2 8 T1 relaxation times under unactivated and activated conditions 
 
By isolating the 5-pyridyl proton in 4,6-nicotine-d2 9 and thereby removing through-bond 
coupling as a relaxation pathway, it was hoped a greatly increased T1 relaxation time 
could be obtained. This hypothesis proved to be correct, with the unactivated conditions 
5-pyridyl T1 time measured at 31 seconds, more than double the next longest T1 observed 
in any of the isotopologues (Figure 47). Furthermore, the activated conditions T1 time for 
the 5-pyridyl proton was only slightly shorter at 27 seconds, which was nearly three times 
longer than the next best activated T1 and by far the smallest reduction in T1 between the 
unactivated and activated conditions observed for all substrates. It is likely that a direct 
5J interaction to the catalyst is the only through-bond coupling present, hence this 
relaxation pathway only exists in the brief time the substrate is bound to the catalyst and 
the impact on T1 is small (only around ~13% reduction for the 5-pyridyl proton). In 
contrast, the 2-pyridyl proton signal relaxed much more quickly, in a matter of a few 
seconds regardless of conditions. It could be that the 4-deutero substituent boosts 
interaction of the 2-pyridyl proton with the nearest aliphatic proton on the pyrrolidine 
ring, which is likely to relax quickly and thereby reducing the T1 of the 2-pyridyl proton. 
There is no observed coupling for the 2-pyridyl proton, suggesting interaction with the 
aliphatic proton is of 1 Hz or less. Tessari et al. have demonstrated that polarisation 
transfer via 4J and 5J coupling in SABRE is still possible despite typically small couplings 
of 1 Hz or less.62 Despite poor 2-pyridyl proton relaxation, 4,6-nicotine-d2 9 was 
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determined to have the most promise for further optimisation and study with the largest 
signal enhancement and longest proton T1 time of all substrates observed by far.  The 
superior performance of 9 again reinforced the relationship between long relaxation and 
high signal enhancement. 
 
 
  
 
Figure 47: 4,6-nicotine-d2 9 T1 relaxation times under unactivated and activated conditions in 
methanol-d4 and associated coupling mechanisms to explain T1 performance 
 
The relaxation performance of 2,6-nicotine-d2 10 was disappointing. The T1 times under 
unactivated conditions were on par with several other isotopologues (at 9 and 15 seconds 
for the 4-pyridyl and 5-pyridyl proton, respectively), but still markedly inferior to the best 
performing substrate, 4,6-nicotine-d2 9. Measurement of T1 relaxation times under 
activated conditions revealed extremely fast relaxation of less than two seconds for either 
pyridyl proton (Figure 48). Such rapid relaxation strongly suggested that 2,6-nicotine-d2 
10 would not be a suitable substrate for imaging application proton SABRE, even with 
optimisation. However, the rapid relaxation of the 4- and 5-pyridyl protons in the presence 
of catalyst reinforced the theory that a direct 5J coupling (both for polarisation and 
relaxation) was an important factor. 
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Figure 48: 2,6-nicotine-d2 10 T1 relaxation times under unactivated and activated conditions in 
methanol-d4 
 
With a view towards improving the biological compatibility and relevance of these 
studies, T1 magnetic lifetime experiments were performed in ethanol-d6 in place of 
methanol-d4. All other sample and experimental parameters were as for the methanol 
studies. Previous attempts by the group to use ethanol and ethanol/water mixtures gave 
much reduced activated T1 relaxation times compared to otherwise identical experiments 
conducted in methanol, but it was decided to test the nicotine isotopologues regardless in 
the substantially less toxic ethanol. Only the best substrate from the methanol studies, 
4,6-nicotine-d2 9, was selected for this further testing.  
 
It was found that 4,6-nicotine-d2 9 had superior T1 relaxation times under unactivated 
conditions in ethanol compared to those in methanol, the 5-pyridyl signal lasting for 37 
seconds. However, as observed in other compounds in ethanol in the group102, the 
magnetic lifetime of all resonances dropped to only a few seconds upon activation with 
catalyst and hydrogen (Figure 49). 
 
 
 
 
Figure 49: 4,6-nicotine-d2 9 T1 relaxation times under unactivated and activated conditions in 
ethanol-d6 
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The sharply reduced activated T1 relaxation times in ethanol-d6 prompted efforts to be 
focused elsewhere. However, rapid relaxation through the catalyst also implies rapid 
polarisation. Recent technique advances in biphasic SABRE to sequester the catalyst once 
polarisation is achieved (thereby slowing relaxation) indicate that further study with 
ethanol-d6, water or potentially a mixture of both is warranted.
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In conclusion, the variety of (−)-nicotine isotopologues prepared in Chapter 2 were 
successfully hyperpolarised using SABRE and their proton T1 relaxation times were 
shown to be altered significantly by the incorporation of deuterium substituents. High 
performance was apparently more dependent on the position/pattern of deuteration about 
the pyridyl ring than merely the number of deuterium substituents incorporated. 
Noticeable shortening of the T1 times were observed for substrates in the presence of the 
SABRE (pre)catalyst and hydrogen compared to substrate free in solution, with the 
magnitude of this shortening varying significantly with deuteration pattern. 4,6-nicotine-
d2 9 was identified as the most promising substrate, with greatly superior SABRE signal 
enhancement and T1 relaxation times measured.  
 
3.2 Only Para-hydrogen Spectroscopy (OPSY) 
 
There was concern that polarisation in (−)-nicotine 1 and its isotopologues might be being 
‘leaked’ through to the pyrrolidine ring protons, thereby reducing the detected signal 
enhancement of the pyridyl protons. A definite solution to this problem would be to 
selectively replace all the pyrrolidyl protons with deuterium, however, such a route would 
present a significant and time-consuming synthetic challenge. Instead, the potential for 
‘leaking’ was investigated by Only Para-hydrogen Spectroscopy (OPSY). OPSY is an 
NMR method that can remove signals derived from nuclei with thermally equilibrated 
spin state populations whilst leaving signals derived from para-hydrogen intact, thereby 
identifying which nuclei are directly affected by SABRE.61,104  
 
OPSY achieves distinction between thermal and hyperpolarised signals via pulsed field 
gradients (PFGs, an application of spatially-varied magnetic fields), also known as 
gradient pulses. PFGs interact differently with the distinct spin orders created in multi-
pulse experiments – this principle is also used in more common NMR experiments such 
as HSQC, where 12C isotopomer signals are removed and 13C signals remain. 
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Figure 50 shows the experimental protocol.61,104 The substrate is hyperpolarised in a 
‘shake-and-drop’ procedure and subjected to a 90˚ RF pulse, which creates Iz (single spin 
order term) and 2IzI2z (two spin order term) magnetic states. A subsequent PFG of set 
intensity and duration defocusses both magnetic states – the extra spin order term in the 
para-hydrogen-derived nuclei mean that this defocussing occurs twice as quickly. After 
a brief delay (~1.5 µs), a second 90˚ RF pulse is applied, followed immediately by a 
gradient pulse of double intensity and opposite polarity to the first PFG. 
 
Thermal nuclei = Iz  Para-hydrogen-derived nuclei = 2IzI2z 
 
As the para-hydrogen derived signals defocuss twice as fast as the thermal signals, they 
are refocussed by the second, double-intensity gradient pulse into a visible signal. The 
thermal signals remain unfocussed and hence, unobserved. This sequence is known as a 
double-quantum (DQ) coherence selection and an OPSY experiment using such a 
sequence is called OPSY-d. 
 
 
 
 
 
 
 
Figure 50: OPSY-d experimental protocol. The two rows represent the different pulse types 
employed, where RF/1H is the standard radio-frequency pulse and Gz is a pulsed field gradient (PFG) 
in the z-axis. The orientation of the two gradient pulses are reversed from one another 
 
There is a variant of OPSY called OPSY-z with a similar pulse sequence, known as zero-
quantum (ZQ, sometimes also called single-quantum, SQ) coherence selection. The 
OPSY-z pulse sequence is identical to that in OPSY-d except that there is no second pulse 
gradient. The absence of a specific refocussing pulse gradient means this method is 
susceptible to some thermal signals remaining observable. 
 
 (−)-Nicotine 1 was subjected to both OPSY-d and OPSY-z experiments to probe if 
polarisation transferred into the pyrrolidine ring from the pyridine component. In both 
experiments, signals for several of the pyrrolidinyl protons (in the region 3.2 – 1.6 ppm) 
RF 
pulses: 
 Gradient 
pulses: 
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were observed, indicating that polarisation in (−)-nicotine 1 does indeed ‘leak’ to protons 
on the pyrrolidine ring (Figure 51). Close comparison to the thermal 1H NMR spectrum 
of (−)-nicotine 1 revealed the signals corresponding to Hg (2.30 ppm) and N-methyl 
protons Hi (2.16 ppm) were not observed in the OPSY experiments, hence these protons 
were unaffected by hyperpolarisation (Figure 52). Although over half of the protons in 
the pyrrolidyl ring received some hyperpolarisation, the intensity of their signals was 
vastly reduced compared to the pyridyl proton signals, barely visible above the baseline. 
It was therefore concluded that polarisation transfer between the rings was relatively 
inefficient and the impact of the ‘leak’ for 1 was at most marginal. It should be 
emphasised that these spectra give antiphase peaks and are typically recorded in 
magnitude mode, hence the distortions in line shape observed. 
 
 
Figure 51: Thermal 1H NMR spectrum of (−)-nicotine 1 for direct comparison to OPSY spectra, 
focused on the pyrrolidyl proton signals at ~1.5-3.5 ppm 
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Figure 52: OPSY-d of (−)-nicotine 1. Peaks for some of the pyrrolidyl protons (Ha – Hf) were still 
observed although their magnitude was far less than that of the pyridyl protons at 7.5-8.5 ppm  
 
3.3 Optimisation overview 
 
Optimising SABRE catalysis is essential for imaging applications. This is in order to give 
maximum signal for the minimum amount of contrast agent - beneficial for both avoiding 
metabolic side-effects in the patient and unnecessary costs. Unfortunately, this is not as 
simple as it may sound. 
 
The performance of the SABRE technique is affected by a number of relatively well-
known variables.50,64,105 
 
1. Kinetics - the rates of exchange of hydrogen and substrate molecules on the 
catalyst and their relaxation 
2. Magnetic field – efficient polarisation transfer and the corresponding field (PTF) 
3. Mixing – the addition of components, their adequate mixing and interaction 
 
Several of these factors are interdependent on one another and are summarised in Figure 
53. 
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Figure 53: summary of the factors affecting SABRE 
 
The exchange of molecules on the iridium centre are reversible processes and so depend 
themselves on the ratio of catalyst to substrate, the temperature of the experiment and the 
pressure of hydrogen. Less well-known variables that have become apparent during this 
work and corroborated by others are the coupling/relaxation properties of the catalyst and 
substrate, their interdependencies and the effects they have on the above variables. 
Solvent can dramatically affect relaxation, exchange of molecules and the solubility of 
hydrogen – different solvents have not been investigated in detail because of this 
multitude of potential impacts. 
 
The initial substrate screening in Chapter 3.1 focused on testing a variety of nicotine 
isotopologues under a fixed set of conditions, evaluated by their signal enhancements and 
T1 relaxation times. Such studies reflected efforts to optimise the aforementioned 
coupling/relaxation properties by identifying the pattern of labelling that gave the best 
performance. The samples used involved standard solutions of 5 mM solution of 
IrCl(COD)(IMes) precatalyst 18 with 5 equivalents of the substrate in methanol-d4. All 
‘shake-and-drop’ SABRE experiments were performed at room temperature with 4 bar 
of para-hydrogen, shaking for 10 seconds in a 65 G polarisation transfer field adjacent to 
the spectrometer. T1 experiments always used 4 bar of hydrogen and methanol-d4 as the 
solvent (except a small number that used ethanol-d6 instead). 
 
4,6-nicotine-d2 9 was by far the best-performing substrate tested under these original 
conditions for both signal enhancement and T1 relaxation times. Hereafter, a series of 
experiments with varied conditions were run to optimise the performance of 9 further, 
with similar experiments performed on natural (−)-nicotine 1 for comparison.  
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3.4 Kinetics optimisation 
 
SABRE kinetics – primarily the exchange of molecules onto and from the catalyst – is 
one of the key factors in producing optimum signal enhancement. The scheme of SABRE 
depicted from III onwards in Chapter 1.3.2 is a gross simplification - the likely exchange 
mechanism is a series of equilibria shown in Figure 54.106 The first step is dissociation of 
a bound substrate molecule (A→B), followed by binding of a ‘fresh’ molecule of para-
hydrogen (B→C). Subsequent dissociation of the ‘old’ hydrogen molecule (C→D) and 
binding of a new substrate molecule from solution (D→E) complete the process. As a 
series of equilibria, these kinetic processes are affected by the relative abundances, 
environment and energy of the species involved, such as variations in concentration or 
temperature. 
 
 
 
Figure 54: substrate and hydrogen exchange mechanism for [Ir(H)2(IMes)(NIC)3] Cl (A) in 
methanol-d4. A is the active form of the IMes precatalyst 18, ‘NIC’ represents the nicotine substrate 
molecules bound via their pyridyl nitrogen. 
 
Increased overall exchange of substrate and para-hydrogen theoretically means more 
substrate molecules can be polarised in a given time, referred to as increased catalyst 
turnover. However, this also means that substrate and para-hydrogen molecules will 
spend less time bound to the catalyst and able to transfer polarisation between them, 
known as reduced catalyst lifetime.105,107  
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3.4.1 Alternative SABRE catalysts 
 
A family of SABRE precatalysts have been developed by the Duckett group that are 
similar to IrCl(COD)(IMes) 18, differing in their N-heterocyclic carbene component by 
sterics and electronics. Some give a different exchange rate of hydrogen/substrate 
molecules, some have decreased coupling interactions between catalyst and substrate and 
some have been designed to do both (Figure 55).  
 
 
Figure 55: alternative SABRE catalysts in order of increasing typical exchange rates 
 
Because exchange rates will vary between substrates, the catalyst must be tailored to the 
substrate in question for optimal performance. d22-IMes 19 was the first alternative 
precatalyst investigated, a deuterated analogue of IMes 18 that has shown excellent 
signal enhancement and T1 relaxation performance for other Duckett group 
members.65 Preliminary evaluation of the fast-exchanging IMes-derivative ICl 21 and 
slow-exchanging IMes-derivative ItBu 20 precatalysts was undertaken.  
  
A series of ‘shake-and-drop’ experiments were performed on 4,6-nicotine-d2 9 with fixed 
concentrations of precatalysts 19, 20 or 21 at 5 mM in methanol-d4 with 25 mM of 
substrate at 298 K (Figure 56).  
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Figure 56: signal enhancement vs. precatalyst for ‘shake-and-drop’ experiments on 4,6-nicotine-d2 9. 
Conditions and quantities are the standard 5 mM precatalyst, 25 mM substrate in methanol-d4 with 
4 bar p-H2 shaken in a ~65 G stray field for ten seconds  
 
It was observed that d22-IMes 19 offered noticeably (~25%) improved signal 
enhancement compared to the undeuterated IMes 18 for the same conditions, at over 900-
fold increase compared the thermal signal. Such a large increase was rationalised using 
similar logic to that applied in Chapter 3.1 – the deuteration of the catalyst carbene should 
reduce the number of relaxation pathways available through the catalyst, hence 
slowing the negative impact of relaxation on overall signal enhancement. The slightly 
increased steric bulk of the carbene relative to IMes 18 was also considered to potentially 
affect the SABRE process and was later investigated (see Chapter 4).   
  
In contrast, both ItBu 20 and ICl 21 gave noticeably poor performance compared to 
their IMes based equivalents, with neither precatalyst giving better than 400-fold signal 
enhancement. It was surmised that neither of these catalysts have ideal exchange rates at 
room temperature. Further study with varying temperatures would be needed to optimise 
their performance, but in the interests of time, it was decided to proceed with the excellent 
performance of d22-IMes 19. 
  
 
3.4.2 Variable-temperature SABRE studies 
 
In a typical complex, exchange of both hydrogen and substrate molecules increases with 
temperature. The balancing of catalyst turnover and catalyst lifetime combine to give an 
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optimum temperature for maximum signal enhancement for a given system. Another 
factor is hydrogen solubility – this is known to decrease in methanol with increasing 
temperature.92,108 
 
The slower exchange rates of nicotines relative to established high-performance SABRE 
substrates such as methyl nicotinate and pyridine suggested that slow exchange was 
limiting signal enhancement.64,109,110  A series of ‘shake-and-drop’ experiments were 
performed on (−)-nicotine 1 and 4,6-nicotine-d2 9 with increasing temperature to probe 
this theory (Figure 57). For safety reasons, temperatures above 313 K were not 
investigated – the NMR tubes currently employed are not rated beyond ~5 bar pressure. 
Stronger NMR tubes were available, but thicker walls and consequent reduction in tube 
volume were found to impede SABRE significantly, presumably through inferior mixing 
properties, reduction in para-hydrogen volume or a combination of the two. 
 
 
 
Figure 57: signal enhancement vs. temperature for (−)-nicotine 1 and 4,6-nicotine-d2 9. Samples were 
the ‘standard’ concentration of 5 mM IMes precatalyst 18 with 5 equivalents of substrates in 
methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with 4 bar para-hydrogen (absolute) a 
ten second shake in a 65 G field 
 
It was observed that the signal enhancement increased notably with temperature for (−)-
nicotine 1, giving credence to the theory that slow exchange had been a limiting factor 
thus far. The maximum signal enhancement of ~290-fold per proton was obtained at 308 
K – this represents a 36% increase in signal enhancement compared to at 298 K with 
otherwise identical conditions.  The signal enhancement started to fall above 308 K, 
0
100
200
300
400
500
600
700
800
298 300 302 304 306 308 310 312 314
S
ig
n
a
l 
e
n
h
a
n
c
e
m
e
n
t 
p
e
r 
p
ro
to
n
 
(r
e
la
ti
v
e
 t
o
 t
h
e
rm
a
l)
Temperature / K
4,6-nicotine-d2 (-)-nicotine
 99 
 
suggesting that the exchange rates had become too rapid for efficient polarisation. The 
decreasing solubility of hydrogen was likely also contributing to this decline in signal 
enhancement. 
 
However, initial hopes that noticeable increases in SABRE performance could be easily 
achieved with a simple small increase in temperature were tempered by results for 4,6-
nicotine-d2 9. As demonstrated in Chapter 3.1, 9 exhibited vastly superior signal 
enhancements (~250%) at 298 K compared to the undeuterated 1, but this superiority was 
rapidly eroded with even small increases in temperature. Indeed, at 308 K, 4,6-nicotine-
d2 9 only exhibited a 15% superiority in signal enhancements relative to undeuterated 
nicotine. Such a sharp decrease strongly suggested other factors being affected by the 
temperature increases. 
 
As relaxation in SABRE is known to also be affected by the kinetics of exchange, the T1 
relaxation times of (−)-nicotine 1 and 4,6-nicotine-d2 9 were measured with varying 
temperatures and otherwise identical conditions. Figure 58 shows the results for 4,6-
nicotine-d2 9. 
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Figure 58: activated conditions proton T1 relaxation time vs. temperature for 4,6-nicotine-d2 9 using 
precatalyst IMes 18. Samples were the ‘standard’ concentration of 5 mM IMes precatalyst 18 with 5 
equivalents of substrate in methanol-d4 activated with 4 bar (absolute) hydrogen 
 
It was observed that increases in temperature resulted in a dramatic shortening of the 
substrates’ T1 relaxation times - for example the T1 of 4,6-nicotine-d2 9 under the 
conditions tested fell by approximately 60% with only a 5 K increase in temperature. 
Such a decrease fits with the markedly reduced enhancements observed in Figure 57, 
where increased exchange of substrate and hydrogen with increased temperature was 
leading to faster relaxation (via through bond coupling etc.) and hence inferior SABRE 
performance. Therefore, it was concluded that room temperature (298 K) was the optimal 
temperature for further studies. 
 
3.4.3 Concentration of substrate vs. concentration of catalyst 
 
There are two aspects to how abundance of catalyst, substrate and the ratio between them 
affect the exchange process and/or SABRE as a whole. The first aspect is related to 
catalyst turnover. Theoretically, a low substrate abundance relative to catalyst (i.e. a high 
catalyst loading) would mean substrate molecules could experience multiple, mutually-
reinforcing polarisations in a given time, whereas increased substrate abundance would 
mean more molecules available to be polarised, although each molecule would be less 
likely to be repeatedly polarised.  
 
The second aspect relates to the competition between exchange of substrate and exchange 
of para-hydrogen. For example, the rate of change of intermediate B in Figure 54 is 
dependent on concentration of both substrate, affecting rate of conversion back to A (–
k1), and hydrogen, affecting rate of conversion to C (k2). The result is that increased 
substrate concentration will inevitably inhibit the exchange of para-hydrogen and 
therefore have a limiting effect on the NMR signal enhancement. Increased pressure of 
para-hydrogen should ameliorate the negative effects of increased substrate 
concentration on SABRE performance and this is discussed later in Chapter 3.4.4. 
Finding a ‘sweet-spot’ between these cases is paramount and every substrate is likely to 
be different. 
 
Given a tris-pyridyl catalyst-substrate complex (A in Figure 54), three bound substrate 
molecules will be on the activated catalyst. Such a complex imposes a practical lower 
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limit of four equivalents of substrate per catalyst molecule to ensure sufficient substrate 
free in solution and ready to bind upon bound substrate dissociation (Figure 54, A→E). 
In order to find a ‘sweet spot’ for sample concentration, a series of ‘shake-and-drop’ 
experiments were performed on (−)-nicotine 1 and 4,6-nicotine-d2 9 with fixed 
concentration of IMes precatalyst 18 and increasing substrate equivalents. The results 
were quantified by the signal enhancements (as in previous studies), by activated-
conditions 1H T1 relaxation times and also by the signal-to-noise ratio (SNR) for each 
concentration. SNR is, as the name describes, a measure of the absolute signal obtained 
from a sample compared to the background noise of the instrument and setup. Noise for 
a given setup is relatively constant, therefore SNR is an important parameter in assessing 
performance of a substrate.  
 
Figure 59: signal enhancement vs. substrate concentration @ 298 K for (−)-nicotine 1 and 4,6-
nicotine-d2 9 using precatalyst IMes 18. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM IMes 
precatalyst 18 in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with 4 bar para-
hydrogen (absolute) a ten second shake in a ~65 G stray field at 298 K 
 
It was observed that the signal enhancement was best at a low substrate concentration, 
decreasing as substrate abundance increased. However, the initially superior signal 
enhancement performance of 4,6-nicotine-d2 9 tails off with increasing substrate 
concentration far more quickly than (−)-nicotine 1, so much so that 9 has the same signal 
enhancement per proton at fifteen equivalents of substrate that 1 had at five. This can be 
further rationalised by the differing T1 relaxation networks found in each 
substrate/catalyst combination, essentially a reverse of the polarisation pathways 
described later in Chapter 3.5 and depicted in Figure 60.  
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Figure 60: potential through-bond couplings from substrate to catalyst as relaxation pathways for 
(−)-nicotine 1 and 4,6-nicotine-d2 9 
 
Another factor to consider is the limited supply of para-hydrogen in the sample tube. The 
sharp decrease in 4,6-nicotine-d2 9 performance with increasing substrate concentration 
can be explained by para-hydrogen becoming limiting. The effect is less pronounced for 
the less efficiently-polarised (−)-nicotine 1. 
 
These theories can be backed up empirically by measurement of 1H T1 times across a 
range of concentrations under the same conditions, the results of which are displayed in 
Figures 61 and 62. 
 
 
Figure 61: activated conditions proton T1 relaxation time vs. substrate concentration @ 298 K for 
(−)-nicotine 1 using precatalyst IMes 18. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM IMes 
precatalyst 18 in methanol-d4 activated with 4 bar (absolute) hydrogen at 298 K 
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The T1 relaxation times of (−)-nicotine 1 did indeed increase with increasing substrate 
concentration, reinforcing the theory that interactions with the catalyst are the dominant 
relaxation pathway for that substrate. Despite longest T1 time of only eight seconds, such 
an increasing trend suggested promise for imaging applications, where experiments are 
typically run with relatively high substrate equivalents. Sequestration of the catalyst after 
polarisation would likely improve this T1 further. 
 
 
Figure 62: activated conditions proton T1 relaxation time vs. substrate concentration @ 298 K for 
4,6-nicotine-d2 9 using precatalyst IMes 18. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM IMes 
precatalyst 18 in methanol-d4 activated with 4 bar (absolute) hydrogen at 298 K 
 
T1 relaxation times for 4,6-nicotine-d2 9 were noticeably shortened at four equivalents of 
substrate, where approximately three-quarters of all substrate molecules are bound at any 
given time and therefore can relax extensively through the catalyst regardless of 
relaxation pathways. However, the markedly reduced enhancement at five equivalents 
despite the significantly improved T1 relaxation times reinforces the notion that para-
hydrogen is limiting for 4,6-nicotine-d2 9. 
 
The SINO function in Bruker TopSpin was used to compare signal intensity to 
background noise to give the SNR (Figure 63). 
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Figure 63: signal-to-noise ratio vs. substrate concentration @ 298 K for (−)-nicotine 1 and 4,6-
nicotine-d2 9 using precatalyst 18. ‘Substrate equivalents’ refers to the concentration of substrate 
relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM IMes precatalyst 18 
in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with 4 bar para-hydrogen (absolute) 
a ten second shake in a ~65 G stray field at 298 K  
 
The signal-to-noise ratio for both substrates generally increases with in line with the 
quantity of substrate. This positive correlation fits with the theory that at higher substrate 
concentration, each individual molecule is polarised less (i.e. poor signal enhancement), 
but far more molecules are being polarised and a greater total signal results (increased 
SNR).  
 
The SNR of 4,6-nicotine-d2 9 is far superior to that of (−)-nicotine 1 at all concentrations 
tested, although it shows a trend of initially decreasing SNR with increasing substrate 
before increasing again above ~ 10 equivalents. This is likely related to the initially 
sharply decreasing signal enhancement that 9 exhibits as described previously. 
 
Overall, it was concluded that superior enhancements were obtained with very low 
substrate concentration, but the best absolute signal was obtained at higher substrate 
concentrations. Further tests at even higher substrate concentration would be ideal to 
further confirm this observation. Whichever of these factors is most important depends 
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on requirements, but absolute signal would be more desirable in a diagnostic imaging 
experiment such as MRI. 
 
Owing to the superior performance of 4,6-nicotine-d2 9 and the theorised reduction in 
relaxation pathways, it was decided to repeat the studies of varying substrate 
concentration with d22-IMes 19 (Figure 64).  
  
Figure 64: signal enhancement vs. substrate concentration @ 298 K for (−)-nicotine 1 and 4,6-
nicotine-d2 9 using precatalyst d22-IMes 19. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM d22-IMes 
precatalyst 19 in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with 4 bar para-
hydrogen (absolute) a ten second shake in a ~65 G stray field at 298 K 
 
The use of d22-IMes 19 as precatalyst afforded noticeably improved enhancement levels 
for all concentrations tested compared to the equivalent studies with IMes 18. In addition, 
4,6-nicotine-d2 9 displayed superior enhancements compared to (−)-nicotine 1 at all 
substrate concentrations tested with d22-IMes 19. Although this superiority is eroded 
somewhat between six and ten equivalents of substrate, the deuterated nicotine 9 has 
between 140 and 220% better signal enhancement than (−)-nicotine 1, in contrast to the 
IMes 18 concentration studies where the two substrates’ performance was nigh 
indistinguishable for fifteen equivalents of substrate.  
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Figure 65: Activated conditions proton T1 relaxation time vs. substrate concentration @ 298 K for 
(−)-nicotine 1 using precatalyst d22-IMes 19. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM d22-IMes 
precatalyst 19 in methanol-d4 activated with 4 bar (absolute) hydrogen at 298 K  
 
The trend of increasing T1 relaxation time with increasing substrate concentration 
observed for (−)-nicotine 1 with IMes 18 is also observed for d22-IMes 19, with the T1 
times increasing from around two-three seconds at 4-5 equivalents of substrate to over 
seven seconds at fifteen equivalents and higher. The T1 relaxation times observed were 
on average 67% improved upon their equivalents with IMes 18 at four equivalents, falling 
to on average 36% at fifteen equivalents (Figure 66). Deuteration on the catalyst clearly 
slows relaxation while bound, which in turn boosts the enhancement. 
 
Figure 66: activated-conditions proton T1 relaxation time vs. substrate concentration @ 298 K for 
4,6-nicotine-d2 9 using precatalyst d22-IMes 19. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM d22-IMes 
precatalyst 19 in methanol-d4 activated with 4 bar (absolute) hydrogen at 298 K 
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The effect on T1 relaxation times is far clearer when 4,6-nicotine-d2 9 with d22-IMes 19 
at higher substrate concentrations is considered. For a 15-equivalent loading, the high-
performing 5-proton activated conditions T1 time is a full thirteen seconds longer than 
with IMes, a 52% increase. Therefore, a combination of a deuterated catalyst and 
deuterated substrate is ideal.  
 
Signal-to-noise ratios observed with d22-IMes 19 were also consistently superior at almost 
all concentrations to the corresponding studies with IMes 18 for both substrates tested. 
4,6-nicotine-d2 9 reached an SNR of over 40,000 at higher substrate excesses with this 
precatalyst. At higher substrate excesses, the signal-to-noise ratio of 9 started to plateau. 
At even higher loadings, a fall in SNR was reported (Figure 67). This is due to the 
suppression of hydrogen exchange at higher substrate concentrations because of the 
competition for the same reaction intermediate. Furthermore, there will be an impact on 
the total amount of hydrogen present, which will lead to a further reduction in signal gain.  
 
 
Figure 67: signal-to-noise ratio vs. substrate concentration @ 298 K for (−)-nicotine 1 and 4,6-
nicotine-d2 9 using precatalyst d22-IMes 19. ‘Substrate equivalents’ refers to the concentration of 
substrate relative to the precatalyst. Samples were the ‘standard’ concentration of 5 mM IMes 
precatalyst 19 in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with 4 bar para-
hydrogen (absolute) a ten second shake in a ~65 G stray field at 298 K 
 
The apparent discrepancy that exists between the results for 4,6-nicotine-d2 9 with the 
two precatalysts at 4 equivalents of substrate is due to the effects of line width. The SINO 
function used to calculate SNR compares signal intensity of peaks with the intensity of a 
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designated ‘noise region’. However, this does not take peak signal integration into 
account – hence broader signals will give lower calculated SNR than sharper peaks even 
if their integrations and therefore the actual ‘size’ of the two are similar (Figure 68). 
‘Shake-and-drop’ experiments are run with the spectrometer deuterium lock turned off, 
which tends to give increasingly broad NMR spectrum peaks with repeated iterations. 
Therefore, a relatively large margin of error is inevitable in SNR data. Nonetheless, clear 
trends can still be observed. 
 
  
Figure 68: comparison of signal-to-noise ratio calculations using the SINO function for different 
iterations of the same ‘shake-and-drop’ experiment. 
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3.4.4 Variable-pressure SABRE studies 
 
As alluded to in Chapter 3.3, the SABRE exchange process involves a series of equilibria 
that will be affected by the concentration of reactants (hydrogen, substrate, catalyst) 
present. Increasing the concentration of substrate competitively and negatively affects the 
addition of ‘fresh’ para-hydrogen onto the catalyst (B→C in Figure 69), thereby limiting 
the rate at which substrate can be hyperpolarised and reducing signal enhancement. 
 
 
Figure 69 (repeat of Figure 54): substrate and hydrogen exchange mechanism for 
[Ir(H)2(IMes)(NIC)3] Cl (A) in methanol-d4. A is the active form of the IMes precatalyst 18, ‘NIC’ 
represents the nicotine substrate molecules bound via their pyridyl nitrogen 
 
To probe amelioration of this effect, a series of ‘shake-and-drop’ experiments were run 
on (−)-nicotine 1 and 4,6-nicotine-d2 9 where the para-hydrogen pressure was increased 
from the ‘standard’ 4 bar absolute up to 6 bar absolute (Figure 70). Higher pressures were 
not investigated for similar reasons to high temperatures in Chapter 3.4.2 – the standard 
NMR tubes available are only rated to 5 bar pressure relative to the environment (i.e. ~6 
bar absolute pressure).  
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Figure 70: signal enhancement vs. para-hydrogen pressure for (−)-nicotine 1 and 4,6-nicotine-d2 9. 
Samples were the ‘standard’ concentration of 5 mM IMes precatalyst 18 with 5 equivalents of 
substrates in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with a ten second shake in 
a ~65 G stray field at 298 K 
 
It was observed that the signal enhancement of (−)-nicotine 1 was substantially and 
disproportionately enhanced by increasing para-hydrogen pressure. The ~370-fold 
enhancement per proton observed for 1 at 6 bar para-hydrogen represented a 78% 
increase in enhancement for a 50% increase in hydrogen pressure. However, when the 
study was repeated with 4,6-nicotine-d2 9, only a marginal increase of up to ~7% was 
observed with increased pressure. Given the typical margin of error for ‘shake-and-drop’ 
experiments of 2-3%, the 7% performance boost obtained for 9 is not statistically 
significant. Hence, we can conclude in one case relaxation is limiting, while in the second 
para-hydrogen is limiting. This observation matches expectations based on efficiency of 
transfer. 
 
3.5 Polarisation transfer optimisation  
 
3.5.1 Varied PTF 
 
Polarisation transfer between the para-hydrogen (specifically the two derived hydrides 
on the iridium) and the substrate occurs via long-range 4J scalar coupling to a proton, 
specifically one situated ortho to the Ir-N bond.94,96,97 It had been previously shown that 
the magnitude of this 4J coupling is not the key factor in obtaining good polarisation 
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transfer. Instead, ideal polarisation transfer is achieved when the chemical shift difference 
between the hydrides and the substrate nuclei – hereafter referred to as ΔδHH – matches 
the 2J coupling between said hydrides.1 As chemical shift is dependent on magnetic field 
– the Zeeman effect – and scalar coupling is not, there will be an optimum field strength 
for optimum polarisation transfer. 
 
 Magnetic environments that are considered ‘high field’ are not appropriate for 
polarisation transfer, such as 94,000 G found inside a 400 MHz NMR spectrometer. At 
such a field, the ΔδHH of ~30 ppm typical of substrates produced in this project is 
equivalent to ~12,000 Hz, vastly different to the 5-10 Hz estimate of the 2JHH coupling it 
needs to match to facilitate efficient transfer of polarisation.19 ΔδHH is reduced to ~8 Hz 
at only 65 G, which is why such a PTF has been used as a standard in the project thus far.  
All substrate/catalyst combinations are different, however, and it was speculated that 
there may be a PTF different to 65 G that gives superior SABRE performance for nicotine 
isotopologues. To confirm whether this was or was not the case, a series of experiments 
were run on (−)-nicotine 1 and 4,6-nicotine-d2 9 using the automated flow setup detailed 
in Chapter 6, with standard concentration samples (5 mM IMes precatalyst, 25 mM 
substrate in methanol-d4). The results are shown in Figure 71 below. 
 
 
Figure 71: Signal enhancement vs. polarisation transfer field for (−)-nicotine 1 and 4,6-nicotine-d2 9 
using the automated flow setup. Samples were the ‘standard’ concentration of 5 mM IMes precatalyst 
18 and 25 mM substrate in methanol-d4, hyperpolarised by bubbling with 4 bar para-hydrogen 
(absolute) for ten seconds at 298 K  
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It was observed that 60-70 G was the best field strength for polarisation transfer under 
these conditions for both substrates tested, consistent with expectations from theory and 
literature.94,96,97 The maximum magnitude of the signal enhancement observed was 
different for both substrates compared to their ‘shake-and-drop’ equivalents. The peak 
enhancement for 4,6-nicotine-d2 9 was noticeably superior at ~930-fold enhancement per 
proton (versus ~750-fold for ‘shake-and-drop’) although the peak enhancement for (−)-
nicotine 1 was marginally worse at ~190-fold enhancement per proton (versus ~205-fold 
for ‘shake-and-drop’). The improvements observed for 9 were attributed to a more 
homogenous transfer field and more thorough and consistent mixing of the substrate, 
catalyst and hydrogen in the flow setup compared to that possible in a ‘shake-and-drop’ 
experiment. It was concluded that a lack of similar improvement for (−)-nicotine 1 with 
the flow setup was due to that substrate’s short T1 relaxation times suppressing any gains 
that might be made, as the transfer time into the spectrometer is longer than in a ‘shake-
and-drop’ (see Chapter 6 for experimental methods). 
 
Regarding the shape of the curves, whilst that of 4,6-nicotine-d2 9 showed a simple 
maximum at ~65 G, (−)-nicotine 1 had a more complicated relationship between PTF and 
enhancement. Three maxima are observed at ~25, ~65 and ~110 G. This observation can 
be rationalised with polarisation transfers to several protons on the pyridyl ring with 
different chemical shift, such as inequivalent ortho protons via 4J couplings or meta 
protons via 5J couplings, shown in Figure 72.111 As established previously, the magnitude 
of these couplings does not affect polarisation transfer, hence it is the varying ΔδHH that 
gives a different optimal PTF for each proton. The multiple maxima phenomenon was 
not seen for 4,6-nicotine-d2 9 as it only has a single ortho proton for 
4J coupling to the 
hydride. However, as 5J transfer to the meta proton was firmly established as viable, it is 
believed this coupling is also maximised at ~65 G given the single maximum observed. 
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Figure 72: Different possible polarisation transfers from catalyst hydrides to (-)-nicotine 1 and 4,6-
nicotine-d2 9. ‘IrL4’ represents the rest of an activated SABRE precatalyst of the IMes 18 form where 
the ligands ‘L’ are the other hydride, two other substrate molecules and the carbene. 
 
3.5.2 Varied shake/bubble time 
 
Hyperpolarisation of the substrate only occurs when unreacted para-hydrogen and 
substrate interact on and exchange with the iridium catalyst in the polarisation transfer 
field. The poor solubility of gaseous hydrogen in most applicable solvents means it 
requires vigorous physical mixing to maintain a supply of ‘fresh’ para-hydrogen and 
maintain the polarisation process.92,108 Mixing was achieved by shaking the reactants in 
an NMR tube in the case of ‘shake-and-drop’ experiments and by bubbling para-
hydrogen through the reaction vessel in the automated flow setup. 
 
The hyperpolarisation process can continue indefinitely until all available para-hydrogen 
is used up and only hydrogen remains – this difficult to probe using a ‘shake-and-drop’ 
setup on account of the limited tube volume, however the automated flow setup has an 
effectively unlimited supply of para-hydrogen to bubble. Overarching these factors is the 
inevitable relaxation of hyperpolarised material, meaning there should be a practical 
maximum for shake/bubble time after which no appreciable further increase in 
polarisation can be achieved.  
 
To this end, a series of SABRE experiments were run on (-)-nicotine 1 and 4,6-nicotine-
d2 9 using the automated flow setup with standard concentration samples (5 mM IMes 18 
precatalyst, 25 mM substrate in methanol-d4) and identical parameters save for varied 
bubble time. The results are shown in Figure 73. 
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Figure 73: Signal enhancement vs. bubble time for (-)-nicotine 1 and 4,6-nicotine-d2 9 using the 
automated flow setup. Samples were the ‘standard’ concentration of 5 mM IMes precatalyst 18 and 
25 mM substrate in methanol-d4, hyperpolarised by bubbling with 4 bar para-hydrogen (absolute) 
in a 65 G field at 298 K 
 
The overall relationship between bubble time and signal enhancement was not as clear as 
for the polarisation transfer field data. For (−)-nicotine 1, the bubble/shake time results 
rapidly plateau within experimental error. In contrast, the results with 4,6-nicotine-d2 9 
were superior at all bubbling times – there is an initial rapid rise in signal enhancement 
followed by a fall. 9 exhibited a far more definitive series of results, with a maximum 
signal enhancement per proton of ~1400x the thermal signal observed between just 4 and 
6 seconds bubbling time. This peak enhancement was a huge ~35% increase over the 
previously employed 10 second bubble/shake time, suggesting relaxation of the signal at 
longer bubble/shake times was more important for overall performance than the benefits 
of repeated polarisations were. This clearly also reflects the idea that para-hydrogen is 
no longer limiting. At longer bubbling times, the falloff is known and suggests para-
hydrogen has again become limiting.  
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3.6 Mixing optimisation 
 
The efficient transfer of polarisation from para-hydrogen in gaseous form to an 
appropriate substrate in solution via a catalyst necessitates that all these elements may 
interact and exchange with each other freely. Therefore, thorough mixing of such 
components is crucial for high-performance in SABRE. 
 
The standard ‘shake-and-drop’ experiments detailed thus far involved physically shaking 
a sealed Young’s tap NMR tube in a specific part of an NMR spectrometer’s stray 
magnetic field to mix the components and transfer polarisation between them. However, 
being forced to manually shake the tube meant consistent, thorough mixing was difficult 
and tiring to achieve, particularly with the constraint of needing to shake in the same place 
for a specific polarisation transfer field (PTF). The spectrometer stray field is by no means 
homogenous, with noticeable differences (20-30 G or higher) in field strength being 
observed by moving only a few centimetres in space. It was realised early in the project 
that it was very unlikely a shaken tube was experiencing the desired magnetic field 
throughout more than part of its shake. Results in Chapter 3.5.1 confirmed that varying 
PTF had a significant impact on SABRE performance, hence changes in field throughout 
the shake were highly undesirable. It was therefore concluded that a system with more 
vigorous shaking and a more consistent field strength would be needed for peak 
performance. 
 
The automated flow setup used in Chapter 3.5 has a much more homogenous magnetic 
field than that surrounding a spectrometer, but the setup was deemed too slow and 
awkward to use as an everyday tool for assessing SABRE performance of a wide variety 
of samples and conditions. In particular, the setup has almost no capacity for varying 
temperatures or gas pressures. Instead, a new piece of technology was perfected in the 
closing stages of the project – the magnetic shaker assembly (Figure 74). The assembly 
consists of a secure but easily-accessible housing for an NMR tube and spectrometer 
spinner, so that the contents can be removed quickly. The tube housing is surrounded by 
a stack of ring-shaped permanent magnets arranged to give a near-homogenous field of a 
specific strength – a range of shakers with different magnet arrangements give different 
desired fields. The assembly is used in the same manner as a conventional ‘shake and 
drop’ – the tube is shaken in the housing for the desired time, then removed and 
immediately placed in a spectrometer for measurement. A homogenous field strength 
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inside the shaker means there is no restriction on where it can be shaken, therefore there 
is no restriction on how vigorous the shaking is either, thereby eliminating two serious 
flaws with the original protocol. 
 
 
 
Figure 74: Schematic and photographic representation of the SABRE magnetic shaker. Individual 
rings are composed of (a) 4 or (b) 8 solid‐state magnets arranged at fixed distance r from the centre 
of the ring, oriented into a Halbach configuration to generate a homogeneous field along the x-axis 
in the centre. (c) shows rings combined with uniform spacing Δz to form a cylinder of length L with 
an outer diameter of D, shown photographically in (d). An NMR tube sitting in the centre of the 
cylinder will experience a net magnetic field Bx transverse to the long (z) axis of the cylinder. Adapted 
from Richardson et al., 2018112 
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A brief series of ‘shake-and-drop’ experiments were run on 4,6-nicotine-d2 9 to test the 
improved shaker setup (Figure 75). 
 
 
Figure 75: signal enhancement obtained in stray magnetic field versus with the magnetic shaker @ 
298 K for 4,6-nicotine-d2 9 using precatalyst IMes 18. Samples were the ‘standard’ concentration of 
5 mM IMes precatalyst 18 in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with 4 bar 
para-hydrogen (absolute) and a ten second shake at 298 K in either ~65 G stray field or in a 60 G 
shaker 
 
It was immediately obvious that the magnetic shaker produced vastly superior results to 
the original stray field protocol – 85% superior signal enhancement was obtained per 
proton with otherwise identical conditions. The new shaker assembly also demonstrated 
much more reliable and consistent results, significantly reducing the time taken to obtain 
a full set of at least three highly similar results. 
 
The arrival of the new magnetic shakers coincided with the variable para-hydrogen 
pressure studies detailed in Chapter 3.4.4. It was hypothesised that the marginal 
improvement with increasing pressure previously observed for 4,6-nicotine-d2 9 might be 
due to inefficient mixing wasting a greater available quantity of para-hydrogen. 
Therefore, another series of ‘shake-and-drops’ were performed on 4,6-nicotine-d2 9 with 
increasing para-hydrogen pressure but utilising the magnetic shaker assembly instead of 
the spectrometer stray field (Figure 76). 
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Figure 76: signal enhancement vs. para-hydrogen pressure for 4,6-nicotine-d2 9 with differing 
experimental mixing/PTF protocol. Samples were the ‘standard’ concentration of 5 mM IMes 
precatalyst 18 with 5 equivalents of substrates in methanol-d4, hyperpolarised in a ‘shake-and-drop’ 
protocol with a ten second shake in either a ~65 G stray field or a 60 G magnetic shaker assembly at 
298 K 
 
The magnetic shaker still offered vastly better performance than shaking in the stray field 
for a given set of conditions (approximately double the signal intensity), but such gains 
in performance were overshadowed by the continued minimal impact of increased 
hydrogen pressure. There was a small and tangible increase in hyperpolarisation of 4,6-
nicotine-d2 9 when increasing from 4 to 6 bar (absolute) of para-hydrogen, with signal 
enhancement boosted from ~1390-fold to ~1500-fold per proton. However, this increase 
represents only around a 9% increase in signal intensity for a 50% increase in hydrogen 
pressure (compared to ~7% observed with the same pressure increase shaken in the stray 
field). Therefore, the previously-theorised idea (see Chapter 3.4.4) that insufficient 
mixing was hampering increased-pressure SABRE performance gains of 9 was 
discounted. 
 
3.7 ‘Doping’ studies with fully-deuterated co-ligand 
 
It was considered that polarisation from para-hydrogen would be diluted between the 
multiple bound substrate ligands on the catalyst, similar to polarisation being diluted 
between protons on each substrate molecules themselves (Chapter 3.1.1).65 Extensive 
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catalyst redesign would be needed to eliminate multiple copies of the substrate on the 
iridium centre - it was theorised that a fully-deuterated co-ligand might achieve the same 
effect but much more quickly and easily. Such a co-ligand would bind competitively to 
the catalyst but without receiving polarisation, thereby reducing dilution of polarisation. 
This approach would effectively lower the substrate loading on the catalyst and more 
efficiently ‘funnel’ polarisation to the substrate (Figure 77) without the corresponding 
reduction in relaxation times previously observed with low substrate equivalents. 
 
 
Figure 77: use of a fully-deuterated co-ligand (Co-D) in conjunction with the desired substrate (Sub) 
to reduce dilution of polarisation between multiple bound substrate molecules. Ligand L is either Co-
D or Sub at any given time but is not considered relevant as the axial ligand receives minimal 
polarisation from para-hydrogen  
 
The deuterated co-ligand would ideally be a more highly deuterated analogue of the 
desired substrate to minimise undesired kinetic changes to the system – such as 
displacement of the substrate by preferential binding of the co-ligand. 2,4,5,6-
tetradeuteronicotine 22 was therefore selected as the desired co-ligand, although several 
attempts to synthesise it were unsuccessful. Given time constraints, it was decided to 
instead test the co-ligand approach with a sub-optimal but more readily-available 
alternative. Pyridine-d5 33 was selected given its similar structural and iridium-binding 
motifs to nicotines and easy acquisition as an NMR solvent. A series of ‘shake-and-drops’ 
were performed using nicotine 1 and 4,6-nicotine-d2 9 as substrates, IMes 18 and d22-
IMes 19 as precatalysts, pyridine-d5 as co-ligand and the magnetic shaker assembly 
detailed in Chapter 3.6. In order to directly assess any benefit of using the co-ligand, the 
samples prepared had 2.5 equivalents of substrate and 2.5 equivalents of co-ligand to 
match the 5 equivalents of substrate used as standard in previous testing. A comparison 
of these results is shown in Figure 78. 
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Figure 78: signal enhancement for various substrate, catalyst and co-ligand combinations. Samples 
were the ‘standard’ concentration of 5 mM IMes precatalyst X with either 5 equivalents of substrate 
or 2.5 equivalents each of substrate and co-ligand. Samples were in methanol-d4, hyperpolarised in a 
‘shake-and-drop’ protocol with 4 bar (absolute) of para-hydrogen and a ten second shake in a 60 G 
magnetic shaker assembly at 298 K 
 
The samples with co-ligand pyridine-d5 23 exhibited consistently and substantially 
improved signal enhancements compared to those with just the substrate. The mixture of 
deuterated nicotine 9, deuterated d22-IMes 19 precatalyst and deuterated pyridine-d5 23 
co-ligand combined to give a hitherto unprecedented signal enhancement of ~2700-fold 
per proton – equivalent to ~9% polarisation. Such a high level of hyperpolarisation is 
more than five times greater than using natural nicotine 1 alone with an undeuterated 
catalyst and serves to highlight explicitly the impact deuterium incorporations have to 
boost SABRE performance. To date, this is ~2700-fold enhancement is the single biggest 
polarisation achieved during the project. 
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However, as previously established, signal enhancements are not fully informative when 
assessing a system for MRI feasibility – the raw, bulk signal is more important, quantified 
by the signal-to-noise ratio (Figure 79). 
 
 
Figure 79: signal-to-noise ratio for various substrate, catalyst and co-ligand combinations. Samples 
were the ‘standard’ concentration of 5 mM IMes precatalyst X with either 5 equivalents of substrate 
or 2.5 equivalents each of substrate and co-ligand. Samples were in methanol-d4, hyperpolarised in a 
‘shake-and-drop’ protocol with 4 bar (absolute) of para-hydrogen and a ten second shake in a 60 G 
magnetic shaker assembly at 298 K 
 
Unfortunately, it was observed that the signal-to-noise ratio in those samples with co-
ligand was markedly inferior to their equivalents with substrate alone, indicating poor 
suitability for use in imaging applications. It was concluded that while each substrate 
molecule is substantially more efficiently polarised in the presence of the co-ligand, the 
reduced abundance of the substrate molecules ensures that the bulk signal observed is 
much smaller than in the absence of the co-ligand. It is also believed that using a more-
rapidly exchanging molecule (pyridine-d5 23) as the co-ligand may be adversely affecting 
the results, with the co-ligand effectively displacing the substrate from the catalyst and 
impeding the repeated polarisations desirable for strong bulk signal.  Results in the 
literature show that polarisation levels up to 45% per proton are possible with use of a 
more highly-deuterated analogue of a substrate as co-ligand and some optimisation of 
relative quantities.65 Therefore, it may yet be possible to improve on these mixed initial 
results for co-ligand use. 
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3.8 Imaging experiments 
 
Given the overall project aim to develop and refine agents for eventual use in imaging 
applications, it was considered prudent to probe the performance and signal lifetime of 
the nicotine substrates produced in some imaging experiments – even before optimisation 
of SABRE was complete. Such probing was achieved through a series of RARE (Rapid 
Acquisition with Relaxation Enhancement)113 and FISP (Fast Imaging with Steady-State 
Free Precession)114 experiments undertaken by colleague Alexandra Olaru. Both RARE 
and FISP are variants of the spin-echo experiment (Figure 80). 
 
Figure 80: the spin-echo experiment, the basis of most imaging techniques. Magnetisation in the z-
axis (A) is transferred into the (observable) xy-plane by a 90° RF pulse (B). The spins start to defocus 
about the xy-plane due to local field inhomogeneities (C, D). A second RF pulse of 180° is applied (E), 
flipping the defocusing spins in the xy-plane so that they start to refocus (F). When the spins refocus, 
an ‘echo’ signal is produced at the echo time TE (G), where TE is exactly twice the time interval the 
180˚ pulse was applied at. The simplified sequence described above ignores any quantum 
decoherence or imprecision in the RF pulses, which would realistically degrade the quality of the 
echo  
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The ‘echo’ signal produced in a spin-echo experiment is converted into spatial 
information about nuclei in the sample with pulsed field gradients (PFGs, spatially-varied 
magnetic fields as previously mentioned in Chapter 3.2). These PFGs are described as 
either phase-encoding or frequency-encoding, in which the applied gradients affect the 
phase or frequency (respectively) of the precession of each nucleus differently depending 
on their position in space. These differences are detected by the quadrature coils of the 
instrument and recorded mathematically in a grid known as k-space. k-space is not an 
image itself, but a deconstructed mathematical representation of the nuclear spatial 
frequencies in the sample. Each row (ky) in the grid is determined by the phase-encoding 
gradient(s) and is ‘filled’ (in kx) by data points from the application of frequency-encoding 
gradients (Figure 81). The rows are ‘filled’ one-by-one by application of different 
gradients on subsequent echoes - once the k-space grid is filled entirely, it can be 2D 
Fourier-transformed to produce the actual image.115,116 
 
 
 
Figure 81: the filling of k-space with data points using field gradients.116 Once filled, k-space can be 
2D Fourier-transformed to give the image 
 
Such a process could be analogised as light reflected off an object passing through a lens 
– all the light will be refracted but by different amounts dependent on where the light 
originated from and therefore where it hits the lens. The light after the lens does not show 
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an image of the object but contains information about its appearance (analogous to k-
space). A second lens (analogous to the 2D Fourier-transform) converts this data back 
into a recognisable image of the object (Figure 82).115 
  
 
Figure 82: lens analogy for the process of imaging from a spin-echo experiment. The lines represent 
echoes from the sample/object, which are turned into data points in k-space by the first ‘lens’ of field 
gradients, then converted back to an image by the second ‘lens’ of 2DFT to produce a 2D image of 
the object 
 
RARE is a technique focusing on providing high-intensity single-shot images of a 
compound, whereas FISP was instead focused on estimating the magnetic lifetime of the 
(hyperpolarised) signal in an imaging setting. Thus, RARE was considered somewhat 
analogous to measuring signal enhancements in conventional SABRE and FISP 
somewhat analogous to conventional measuring of T1 times. 
 
3.8.1 Rapid Acquistion with Relaxation Enhancement (RARE) studies 
 
In imaging applications, the absolute signal produced by a sample is key and was assessed 
by a series of RARE experiments. RARE is also known as a fast spin-echo experiment 
and was pioneered by Hennig et al. in 1986.113 It improves upon the conventional spin-
echo by employing a train of 180° RF pulses to generate multiple echoes from a single 
90° excitation pulse rather than just one (Figure 83). Each of these echoes has different 
phase-encoding gradients applied, thereby populating multiple rows of k-space within a 
single repetition time (TR, the time between excitations once relaxation to equilibrium is 
nominally complete). This echo train can be continued until the spins start to lose 
coherence by T2 relaxation – echo train length (ETL) is typically between 4 and 32 echoes 
for routine imaging.113,117 
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Figure 83: comparison of the RARE sequence to a conventional spin-echo. Multiple echoes can be 
recorded within the repetition time (TR) before relaxation is complete and another 90° excitation 
pulse is needed. Each echo is treated with different phase- and frequency-encoding field gradients to 
fill multiple lines of k-space within TR117,118 
 
The greatest advantage of recording multiple echoes per excitation is that the overall 
imaging process is dramatically sped up. It is so much faster than a conventional spin-
echo that extra time can be afforded recording more rows in k-space with extra phase-
encoding gradients to improve image resolution, or signal-to-noise can be improved via 
a lengthened TR to ensure full recovery of longitudinal magnetisation before the next 
excitation. Shorter imaging times also reduce the incidence of magnetic susceptibility 
effects, in which repeated exposure to gradient fields starts to magnetise the sample over 
time and significantly distort the produced image. 
 
A series of RARE experiments were combined with SABRE and the established ‘shake-
and-drop’ methodology (albeit shaking in a stray magnetic field) to assess the potential 
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of (−)-nicotine 1 and 4,6-nicotine-d2 9 for use in an imaging context. The results of these 
experiments are shown in Figure 84 and Table 2. 
 
 
 
Figure 84: One-shot 2D 1H MRI RARE results of  A  (−)-nicotine 1 with IMes 18 precatalyst (thermal),     
B  (−)-nicotine 1 with IMes 18 precatalyst (hyperpolarised),  C  (−)-nicotine 1 with d22-IMes 
precatalyst 19 (thermal),  D  (−)-nicotine 1 with d22-IMes precatalyst 19 (hyperpolarised),  E   4,6-
nicotine-d2 9 with IMes precatalyst 18 (thermal),  F  4,6-nicotine-d2 9 with IMes precatalyst 18 
(hyperpolarised),  G  4,6-nicotine-d2 9 with d22-IMes precatalyst 19 (thermal), and  H  4,6-nicotine-d2 
9 with d22-IMes precatalyst 19 (hyperpolarised). Samples were 5 mM precatalyst with 20 equivalents 
of substrate in methanol-d4, hyperpolarised in a ‘shake-and-drop’ protocol with a ten second shake 
in a ~65 G stray field at 298 K. The image acquisition parameters were: field of view (FOV) 1.5 x 1.5 
cm2, matrix 64 x 64, slice thickness 2 mm, TE/TEeff/TR = 4/4/600 ms. Raw data were zero-filled up to 
256 x 256 prior to the FFT and a sinebellsquared filter was applied to reduce the amount of white 
noise. The final resolution of the images obtained was 58 x 58 µm2 
 
Substrate Precatalyst 
SNR 
(thermal) 
SNR 
(hyperpolarised) 
SNR gain 
(SNRhyp/SNRth) 
(−)-nicotine 1 IMes 18 46 423 9.2 
(−)-nicotine 1 d22-IMes 19 44 962 21.9 
4,6-nicotine-d2 9 IMes 18 54 1138 21.1 
4,6-nicotine-d2 9 d22-IMes 19 41 1446 35.3 
 
Table 2: signal-to-noise ratios calculated for one-shot 2D 1H MRI rare results 
 
It was observed that the combination of 4,6-nicotine-d2 9 and d22-IMes 19 produced the 
most intense image by far, with a signal-to-noise ratio of nearly 1500. This result matched 
expectations given the established superiority of 9 and 19 in conventional SABRE 
studies. In contrast, the combination of non-deuterated (−)-nicotine 1 with non-deuterated 
IMes 18 produced an image barely one-quarter as intense. 
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3.8.2 Fast Imaging with Steady-state free Precession (FISP) studies 
 
There are many variations of the classical spin-echo experiment. Several of these 
variations rely on the concept of steady-state free precession (SSFP), a phenomenon 
observed when the repetition time (TR) of a classical spin-echo experiment is reduced to 
significantly less than T2 of the sample. Rapid repetition of the sequence means transverse 
magnetisation (Mxy) from the preceding excitation/echo is unable to fully relax to 
longitudinal magnetisation (Mz) before the next excitation pulse. When the next RF 
excitation is applied, this residual Mxy is flipped to Mz and vice-versa. Over several 
repetitions a constant/equilibrium Mxy (referred to as M’ss) component develops (Figure 
85). This equilibrium is manifested in the FID and echo signals merging after several 
repetitions (Figure 86).114,119 
 
 
Figure 85: establishment of a magnetic steady-state (M’ss), viewed in terms of magnetisation, from 
spin-echo experiments with short repetition times (TR<<T2). M0 is the maximum signal possible, 
where all spins are coherent and in the same plane at any given time 
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Figure 86: establishment of magnetic steady-state, viewed in terms of signal, from spin-echo 
experiments with short repetition times (TR<<T2). The FID signal from the second RF excitation 
overlaps with the echo from the first RF excitation – there is always some observable signal from 
then on 
 
The short TR of SSFP sequences means images can be acquired very quickly, sometimes 
even faster than in fast spin-echo sequences such as RARE. The degree of steady-state 
equilibrium increases with flip angle (i.e. the power of the RF excitation pulse from 0 to 
90°) with a flip angle of 50-80° typically yielding the best steady-state signals.114,117,120 A 
series of FISP experiments were performed on the same samples as in Chapter 3.8.1 with 
a mere 5° flip angle – although low flip angles give a poor SNR for the images, they allow 
TR to become extremely short. Therefore, decay of the hyperpolarised image could be 
observed multiple times over only a few seconds from polarisation. One such series is 
shown in Figure 87. 
 
Figure 87: One-shot 2D 1H hyperpolarised MRI FISP results of 4,6-nicotine-d2 9 in conjunction with the 
d22-IMes precatalyst 19 acquired after A 0.6 s, B 1.2 s, C 1.8 s, D 2.4 s, E 3.0 s, F 3.6 s, G 4.2 s and H 4.8 s 
from the polarisation transfer step. Time values calculated based on the intervals between each two 
consecutive scans and do not include the image acquisition times (~1 second). Image acquisition 
parameters were: field of view (FOV) 1.5 x 1.5 cm2, matrix 64 x 64, slice thickness 5 mm, TE/TR/TRscan = 
2/4/600 ms. Raw data were zero-filled up to 256 x 256 prior to the FFT and a sinebellsquared filter was 
applied to reduce the amount of white noise. The final resolution of the images obtained was 58 x 58 µm2 
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Visual inspection of the images shows the expected decay of signal intensity. The 
amplitude of the signal for each sample series was plotted as a function of time after 
normalisation to their respective maximum initial values (Figure 88). Given that the initial 
maximum signal is markedly different for each series, direct comparisons between series 
is ill-advised. 
 
Figure 88: 1H MRI signal decay expressed as a function of time as a fraction of the initial maximum 
signal, derived from low flip-angle FISP images of (−)-nicotine 1 with IMes 18 precatalyst (green 
diamonds), (−)-nicotine 1 with d22-IMes precatalyst 19 (blue squares), 4,6-nicotine-d2 9 with IMes 
precatalyst 18 (yellow triangles) and 4,6-nicotine-d2 9 with d22-IMes precatalyst 19 (dark green 
circles)  
 
By visual inspection alone, it was observed that (−)-nicotine 1 in conjunction with the 
IMes 18 catalyst polarises quite weakly, with the maximum signal intensity being only 
~70% higher than the value of the rapidly-reached signal at thermal equilibrium. Use of 
4,6-nicotine-d2 9 or the deuterated catalyst d22-IMes 19 significantly slowed the decay of 
this signal, with a combination of the two yielding the slowest decay of all. Such results 
fell in line with the trends established with earlier SABRE studies. 
 
A quantitative assessment of the performance of each sample can be obtained by 
calculating the decay rate for each signal versus time dependence using the Equation 2.  
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𝑦 = 𝑀0cos (𝜃)
t 3⁄ e−t T1⁄ + 𝑐 
 
Equation 2: T1 decay constant equation for MRI data – M0 is the maximum initial magnetisation, θ 
is the flip angle, t is time and c is the intercept 
 
Equation 2 was used in place of the standard T1 decay calculation, as the latter only applies 
to measurements made using an inversion-recovery or saturation-recovery experiment 
and hence is not suitable for MRI data. Signal decay constants were calculated for each 
sample and the results, together with the associated errors, are presented in Table 3.  These 
however cannot be taken as the true T1 times of the substrate signals, as the FISP method 
uses many excitation pulses during the experiment and residual signal in the xy-plane 
after such an excitation pulse can cause further dephasing and hence a reduction in signal. 
Therefore, the calculated decay constants are strongly suspected to be much smaller than 
the true T1 relaxation times of (−)-nicotine 1 and 4,6-nicotine-d2 9 under these 
conditions.121  
Ligand Catalyst precursor T1eff / s Error (±/ s) R
2 
(−)-nicotine 1 IMes 18 1.355 0.175 0.945 
(−)-nicotine 1 d22-IMes 19 3.014 0.054 0.999 
4,6-nicotine-d2 9 IMes 18 5.279 0.194 0.996 
4,6-nicotine-d2 9 d22-IMes 19 5.332 0.177 0.997 
 
Table 3: effective T1 relaxation times calculated 
 
3.9 Conclusions 
 
Study and optimisation of SABRE performance and magnetic lifetime for nicotine 
isotopologues 1, 4, 8, 9 and 10 has revealed significant complexity to the technique not 
previously fully recognised. Our evolving understanding has permitted a maximum 
polarisation of ~8.38 % and maximum activated T1 relaxation time of over 30 seconds 
compared to initial results of just ~0.64 % polarisation and ~ 8 seconds for the longest T1. 
The best performing substrate and conditions have been demonstrated as successful in 
preliminary imaging tests. It should be noted that there is still significant scope for further 
optimisation and better results may yet be possible. Refinement of the co-ligand protocol 
and new developments in biocompatible solvents and catalyst removal techniques should 
allow even greater performance to be achieved from this family of compounds. 
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4: SABRE exchange kinetics and modelling 
 
Chapter 3 demonstrated that the performance and longevity of the SABRE response is 
dramatically affected by the exchange rate of molecules between the iridium catalyst 
centre and the surrounding solution. The exchange processes are affected by 
concentration, temperature and catalyst, hence it was considered prudent to quantify the 
exchange rates for a range of conditions and thereby better focus further optimisation 
efforts.  
 
4.1 The nicotine-iridium complex and Exchange Spectroscopy 
(EXSY) 
 
4.1.1 Complex characterisation 
 
The active form of the substrate-catalyst complex for the nicotine isotopologues was 
initially assumed to have six ligands around iridium as is the case with pyridine.64 Three 
of those ligands bear pyridyl moieties, therefore this structure is hereafter referred to as a 
tris-pyridyl complex. Such an arrangement would typically have two equivalent 
equatorial pyridyl ligands (in this case, nicotine and derivatives bound through their 
pyridyl nitrogens) trans to equivalent hydrides, a distinct, inequivalent axial pyridyl 
ligand trans to the carbene ligand and a single hydride environment (Figure 90). However, 
two inequivalent, mutually-coupled and equal-intensity hydrides were consistently 
observed (Figure 89) in the nicotine-derived substrates, indicating there must be a 
different ligand arrangement.  
 
Figure 89: 1H NMR spectrum showing two distinct hydride signals when (−)-nicotine 1 and IMes 
precatalyst 18 react in methanol-d4 at 298 K with 4 bar of hydrogen. 
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Figure 90: the arrangement of substrate (NIC) molecules around the iridium centre in a typical 
SABRE catalyst. Colours correspond to a single magnetic environment  
 
 
It was also observed that there were consistently a multitude of new, distinct peaks 
produced when a nicotine substrate-precatalyst complex was converted to the active form 
by addition of hydrogen. These new peaks were considered too numerous to support a 
simple tris-pyridyl arrangement of substrate ligands, too numerous to be a complex 
containing a chloride or solvent ligand and too homogenous in their position and 
integration to be some sort of contaminant. COSY and NOESY NMR experiments 
revealed four distinct sets each of four pyridyl proton environments, all between 6.9 and 
8.6 ppm (Figures 91 and 92). These peaks correspond to three distinct pyridyl 
environments on the iridium centre and a fourth free in solution, consistent with an overall 
complex structure of a tris-pyridyl type, but with all ligands distinct from one another. 
The specific cause for this phenomenon was concluded as the bulky and chiral nature of 
the (−)-nicotine 1-based substrate ligands – by definition multiple chiral species binding 
to an achiral centre must be inequivalent, as there is no plane of symmetry in the resulting 
complex. 
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Figure 91: assignment of (−)-nicotine 1 1H NMR peaks at 243 K to specific resonances in specific 
binding sites on the IMes 18 iridium centre, assigned using COSY and NOESY experiments. The 
number above the peak corresponds to the pyridyl proton it is associated with, the colour indicates 
the ligand the proton is in  
 
 
Figure 92: COSY of (−)-nicotine 1 with IMes 18 at 243 K with colour labels matching Figure 91. 
Correlations between four distinct 5-pyridyl protons to their corresponding 4-pyridyl and 6-pyridyl 
environments are highlighted, helping confirm there are four different nicotine environments on and 
around the iridium centre. COSY details: DS =16, NS = 4, TD/size of FID = 2048/64 
 
The axial nicotine ligand has significantly different chemical shifts to those trans to the 
hydrides, hence it is not strongly polarised in a SABRE experiment (as mentioned 
previously in Chapter 2). In addition, similarly-positioned have previously exhibited very 
slow exchange processes owing to increased strength of the nitrogen-iridium bond.105 For 
these reasons, the specific behaviour of the axial nicotine ligand was not investigated. 
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4.1.2 Exchange Spectroscopy (EXSY) 
 
Having established that there were two equatorial ligand environments for the bound 
species which could exchange, their rates of exchange were quantified by Exchange Rate 
Spectroscopy (EXSY).122 In many other experiments, when a signal is excited, detection 
usually follows immediately. In EXSY, a single resonance is selectively excited and a 
short delay (referred to as mixing time, τmix) elapses before measurement. During this 
mixing time, the nuclei associated with the signal can move to a different site in the 
sample. In other words, a reaction has taken place or an exchange process has occurred. 
By varying the delay (τmix) in a series of experiments, the evolving abundance of excited 
nuclei at each site can be observed and the rate of exchange between them can be 
determined. This was achieved using the selnogp pulse sequence, in which selective 
excitation is achieved through the use of a shaped 180° RF pulse and the resulting 
magnetisation is refocused into observable signal by a series of 90° and 180° RF pulses 
(Figure 93).123-125  
 
-- 
Figure 93: The selnogp pulse sequence. I refers to operations on the RF coils, whereas Gz are 
operations to create pulsed field gradients (PFGs) in the z-axis. The ‘shaped’ RF pulse has its 
frequency offset to excite a specific resonance. τmix is the mixing time.123  
 
 
The initial work focused on determining observed rate constants for dissociation of 
substrate from the catalyst. Such rate constants were derived from fitting simulated data 
for abundance of the excited species against the real peak integration data via non-linear 
 135 
 
0
10
20
30
40
50
60
70
80
90
100
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5
%
 a
b
u
n
d
a
n
c
e
 b
y
 r
e
la
ti
v
e
 i
n
te
g
ra
ti
o
n
time / s
Free
Free (sim)
Bound1
Bound1 (sim)
Bound2
Bound2 (sim)
least-squares analysis. The simulated data was constructed from an initial kinetic model, 
hereafter referred to as Model 1, that considered two equatorial ligands (Bound 1 and 
Bound 2 in Figure 90) exchanging with ligands free in solution and with each other, with 
any intermediates ignored. It was considered from the onset that the exchanges rates of 
the two inequivalent ligands should be treated and calculated independently (although it 
was presumed that any differences due to the inequivalence would be minor). Therefore, 
data from excitation of both equatorial ligands was simultaneously fitted to the model 
data when deriving observed rate constants (Figure 94). As an example, the exchange of 
H5 in (−)-nicotine 1 from the Bound 1 position to the Bound 2 position and free-in-
solution is shown in Figure 94 in both real and simulated data – the observed rate 
constants kAB, kAC, kBA, kBC, kCA and kCB were altered until a satisfactory fit to the 
real data was obtained. The points (Free, Bound1, Bound2) represent the real, recorded 
data whereas the lines (Free (sim), Bound1 (sim), Bound2 (sim)) represent the 
corresponding simulated data – the abundance of excited ligands at the initial site 
decreases with time as they exchange into the Bound 2 site and to free in solution, 
approaching equilibrium by the end of observation at 0.5 seconds. 
 
  
 
 
 
 
 
 
 
 
b) 
 
Figure 94: a) Model 1, the initial kinetic model  b) raw real and simulated data for observed exchange of 
(−)-nicotine 1 molecules with precatalyst IMes 18 using Model 1, following selective excitation of the 
‘Bound 1’ resonance at 298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of 
substrate, activated with 4 bar of hydrogen.  
 136 
 
A selection of observed rate constants for each substrate/precatalyst combination at 298 
K is displayed for comparison below in Figure 95. The rate constants all increase greatly 
with temperature - full results for all temperatures are listed in Chapter 7. Very poor fits 
were observed for many of the entries, with minimum sum-of-least-squares well in excess 
of 100 frequently observed. Minimum sum-of-least-squares should not be used in direct 
quantitative comparison with one another, but large values still indicate a poor fit to 
reinforce the visually obvious. 
 
 
 
Figure 95: observed rate constants for dissociation of substrate molecules at 298 K using Model 1. 
Samples were 5 mM precatalyst in methanol-d4 with five equivalents of the substrate, activated with 
4 bar of hydrogen. Error bars shown are the standard deviation of all results (n=8). 
 
All combinations of precatalyst (IMes 18 and d22-IMes 19) and nicotine substrate ((−)-
nicotine 1 and 4,6-nicotine-d2 9) were determined to have dissociation rate constants 
between 3.3 and 3.8 s-1 at 298 K, with an average of 3.56 ± 0.16 s-1. This indicates far 
slower exchange processes than other substrates previously tested for SABRE in the 
group and that are known to hyperpolarise well, such as methyl nicotinate (~10 s-1 with 
IMes 18 at 298 K) and pyridine (~21 s-1 with IMes 18 at 298 K).102  
 
The noticeable differences by visual inspection and lack of an obvious trend between 
substrate and/or precatalyst deuteration and the observed rate constants suggested that 
Model 1 was flawed. Deuterium incorporation was expected to have a minimal effect on 
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the kinetics of SABRE, as no C-H bonds are broken during the exchange process and 
hence there should only small secondary kinetic isotope effects observed from deuterium 
substituents. Another potential cause for the deviation was T1 relaxation time variation 
for each of the bound equatorial ligands. The rate constants in EXSY are derived from 
the relevant abundances of each of the bound and free ligands as measured by NMR 
integration. However, these integrals will be affected by relaxation of all the species 
involved, which do not necessarily occur at the same rate. If an equatorial ligand had a 
shorter T1 than the free material, then its signal intensity would diminish more rapidly 
during the EXSY observation than that of the free material. Hence, the rate constants 
would be overestimated.  
 
It was also observed that the rate constants for Bound 1 and Bound 2 in each combination 
were very similar. However, in other cases (particularly between substrates) the 
difference is large enough to suggest statistical relevance and imply more complex 
interactions are taking place. It should be noted that standard deviation is a simplified 
assessment of the data, but hints at a wider problem as half of the eight entries were more 
than one standard deviation from the mean. As with variations between substrate/catalyst 
combinations, flaws in Model 1 and/or a lack of consideration of relaxation were 
suspected for the deviations. It should be emphasised that this was unexpected as such a 
model has been used widely. A more concrete and quantitative test of the variations 
between substrate/catalyst entries, such as analysis of variance (ANOVA), is questionable 
as there are insufficient data to produce a meaningful and reliable answer. Repeat 
experiments would be necessary to quantify the significance of such differences. 
 
Increasing the temperature of the experiments from 298 to just 303 K appeared to almost 
double the rate of substrate dissociation for all combinations of substrate and precatalyst 
tested. These observations empirically demonstrated the strong temperature dependence 
of the exchange processes in accordance with theory.64,105 
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Figure 96: observed rate constants for dissociation of substrate molecules at 303 K using Model 1. 
Samples were 5 mM precatalyst in methanol-d4 with five equivalents of the substrate, activated with 
4 bar of hydrogen 
 
The measuring of rate constants over a range of temperatures allowed construction of 
Eyring plots to determine the enthalpy and entropy of activation for the processes. A 
rearrangement of the Eyring equation (Equation 3) showed that a plot ln(k/T) versus 1/T 
would give a straight line with gradient equal to –ΔH‡/R and intercept of ln(kB/h) + ΔS‡/R.  
 
 
 
 
 
 
Equation 3: the Eyring equation and its rearrangement to derive enthalpy and entropy of activation. 
kB is Boltzmann’s constant, h is Planck’s constant and R is the universal gas constant 
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Figure 97: Enthalpies of activation for the dissociation of bound substrate molecules from iridium 
using data from Model 1. Error bars are the standard deviation of the mean (n=8) 
 
It was observed that every substrate/precatalyst combination gave roughly similar 
calculated enthalpies of activation, with an average of 87.19 ± 5.02 kJ mol-1. However, 
deviations were observed that were significant enough to cause concern at the viability of 
Model 1 – four out of eight combinations were more than one standard deviation from 
the mean. The same nitrogen-iridium bond is being broken in each case and so only 
secondary isotope effects from incorporated deuterium should have any impact on the 
strength of this bond. These secondary isotope effects are typically quite small, hence 
there should be near uniformity in the enthalpies of dissociation with an accurate model.  
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Figure 98: Entropies of activation for the dissociation of bound substrate molecules from iridium 
using Model 1 
 
Entropy of activation relates to the energy of the dissociation transition state. No obvious 
correlation was observed between deuteration of the catalyst and/or deuteration of the 
substrate and this parameter. However, when the calculated activation enthalpies and 
entropies of ligand dissociation were combined to calculate the Gibbs free energy of 
dissociation, strong uniformity was observed as expected by theory (Figure 99) at an 
average of 69.82 ± 0.13 kJ mol-1. All entries are within one standard deviation of the 
mean, except for two entries which are within 1.5 standard deviations of the mean. 
 
Figure 99: Gibbs free energies of activation for the dissociation of bound substrate molecules from 
iridium using Model 1 
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It was concluded overall that there were just too many unexplained and seemingly 
inconsistent deviations for Model 1 to be considered an accurate or reliable model of the 
SABRE exchange processes for (−)-nicotine isotopologues. Despite the relatively 
homogenous calculated free energies of activation being in line with theoretical 
expectations, it was decided a more thorough and considered model was required. 
  
4.2 Kinetic model improvements 
 
4.2.1 Models 2 and 3 
 
Model 1 was based on well-established existing model for ligand exchange in SABRE 
substrate-catalyst complexes with two equivalent equatorial ligand environments.105 It 
was not designed to take account of the increased complexity of two distinct equatorial 
environments that can both be individually excited/observed in EXSY and exchange 
ligands between one another. Hence, several distinct intermediates and increased number 
of species must also play a role, all of which are ignored by Model 1. Secondly, as 
outlined, the effects of relaxation on the kinetic data obtained are not incorporated into 
Model 1. Relaxation rates of bound and free ligands are known (see Chapter 3.1.2) to be 
different.  
 
To overcome the first of these limitations, a new model (Figure 100) was proposed that 
would consider as many species as possible, even those that cannot be observed directly. 
This model will hereafter be referred to as Model 2. It was considered prudent to tackle 
each of these substantial flaws sequentially rather than all at once, hence inclusion of the 
effects of relaxation will be discussed primarily in Chapter 4.2.2. 
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Figure 100: Model 2 – a kinetic model of the SABRE substrate exchange process for nicotines that 
considers intermediates and other species. Only those species marked with * have excited ligands and 
are therefore able to be directly observed by NMR 
 
As EXSY revolves around selectively exciting specific resonances/ligands, only those 
species that contain excited ligands can be observed. Species A and F are analogous to 
‘Bound 1’ and ‘Bound 2’ in the original model. Species H is derived from replacement 
of the excited ligand in either A or F with an unexcited ligand present in solution – the 
resulting lack of excited ligands means H is unobservable. G is an important species that 
cannot be directly observed, as NMR signals for each of its excited ligands will overlap 
completely with the excited ligand in A and in F. This means that signals observed 
ostensibly for A or F are instead representative of A + G/2 and F + G/2, respectively, and 
must be taken into account in the model. Species B and C are the (presumed) trigonal 
bipyrimidal intermediates, whereas D and E represent substrate ligands free in solution, 
unexcited and excited respectively. 
 
In order to further improve on Model 1, a series of constraints were placed upon Model 2 
to ensure that the rate constants produced were sensible. Initially, the only constraints 
were that all chemically-identical processes must have equal rates, e.g. dissociation of a 
ligand from the iridium centre from a specific binding site must occur at the same rate 
same regardless of whether that ligand has been NMR-excited or  not.  
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Lastly, the real and simulated abundance of each of the species was expressed as a 
percentage of the whole, measured by NMR integration. The initial results of applying 
the new model and its constraints to existing data can be seen in Figures 6 and 7 below. 
 
 
Figure 101: raw real and simulated data for observed exchange of (−)-nicotine 1 molecules with 
precatalyst IMes 18 using Model 2, following selective excitation of Bound 1 (species A) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen.  
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Figure 102: raw real and simulated data for observed exchange of (−)-nicotine 1 molecules with 
precatalyst IMes 18 using Model 2, following selective excitation of Bound 1 (species F) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen  
 
Visual inspection of the plots was sufficient to determine Model 2 was producing a very 
poor fit, especially with the initial fit of free excited ligand E and the exchange between 
species A and F at higher mixing times. In addition, the rate constants produced by this 
model were also obviously nonsensical – this is shown in Table 4. It should be noted for 
comparison that the rate constants kAB and kAC in this model are equivalent to the 
dissociation rate constants from ‘Bound 1’ and ‘Bound 2’ in Model 1, respectively.  
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-20.674 2.826 2.749 0 15.099 0 0 0 A 
1.921 -27.375 0 0 0 2.065 0 23.391 B 
2.065 0 -27.375 0 0 1.921 23.391 0 C 
8.244 0 0 -9.262 0 1.019 0 0 D 
10.978 0 0 0 -21.959 10.979 0.002 0 E 
0 2.749 2.826 0 14.670 -20.244 0 0 F 
0 0 0 0 21.274 0 -21.274 0 G 
0 0 0 0 0 0 0 0 H 
A B C D E F G H  
 
Table 4: (observed) rate constants generated by Model 2 for (−)-nicotine 1 molecules with precatalyst 
IMes 18 at 298 K. kXY = XY (i.e. kAB is row A, column B). Only rates marked in green are actual rates, 
those in grey correspond to processes that do not exist. Rates marked in bold are equivalent to the 
‘Bound 1’ and ‘Bound 2’ dissociations in Model 1. 
 
The calculated rate constants for dissociation from the Bound 1 (kAB) and Bound 2 (kAC) 
sites broadly matched their equivalents derived from Model 1 at ~ 3 s-1. However, the 
rates of production of intermediates B and C did not equal their rates of consumption, a 
theoretical impossibility. Furthermore, many rates were set to zero by the data solver in 
an attempt to fit the simulated EXSY data to the real data. For example, the dissociat ion 
of species A to form equal amounts of intermediate C and unexcited free ligand D cannot 
have two different rates and yet Model 2 calculated kAC and kAD as 2.749 s
-1 and 0 s-1, 
respectively. It was obvious from these results that Model 2 was possibly even more 
flawed than Model 1 was and would require serious changes and refinements. 
 
A major flaw in Model 2 was made apparent when all the rate constants were deliberately 
set to 2.5 s-1 to ‘reset’ the model for further improvement and fitting. It was observed that 
the fit by visual inspection was more reasonable and that the least-squares error (i.e. the 
deviation of the fitted data from the real data) for species D (unexcited ligand free in 
solution) and species H (complex with two unexcited equatorial ligands) made up more 
than 99% of the entire sum of least squares error for all species (Table 5, Figure 103). 
While it was accepted that the rate constants could not actually all be 2.5 s-1, it was still 
concluded from the errors generated that species D and (to a lesser extent) H must be 
severely affecting the results as the solver attempted to reduce them to zero. Bias 
introduced by modelling of D and H was understandable, as they are the only two non-
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intermediate species in the model that cannot be directly observed by NMR and therefore 
have no real data as backup or correction to the simulated data. 
 
B C D E H A+G/2 F+G/2 sum time (s) 
- - - - - - - - 0 
0.048 0.040 96.067 0.043 0.116 0.052 0.089 96.455 0.05 
0.063 0.037 87.259 0.140 0.588 0.221 0.075 88.383 0.1 
0.073 0.032 80.191 0.189 1.265 0.353 0.034 82.136 0.15 
0.082 0.027 74.686 0.177 2.011 0.379 0.010 77.372 0.2 
0.090 0.024 70.377 0.146 2.745 0.326 0.003 73.711 0.25 
0.096 0.022 66.980 0.103 3.421 0.325 0.001 70.948 0.3 
0.102 0.020 64.284 0.080 4.020 0.235 0.007 68.747 0.35 
0.107 0.018 62.128 0.044 4.536 0.222 0.015 67.070 0.4 
0.111 0.017 60.391 0.018 4.972 0.197 0.035 65.740 0.45 
0.114 0.016 58.979 0.003 5.335 0.174 0.042 64.664 0.5 
         
      Total: 755.226  
 
Table 5: EXSY fitting least squares errors using Model 2 for (−)-nicotine 1 molecules with precatalyst 
IMes 18 at 298 K with all rate constants artificially set to 2.5 s-1. The columns highlighted in green 
are the errors for species D and H and the sum of errors for all species – D and H make up more than 
99% of the total error at each time interval and in total  
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Figure 103: raw real and simulated data for observed exchange of (−)-nicotine 1 molecules with 
precatalyst IMes 18 using Model 2, following selective excitation of Bound 1 (species F) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen  
 
Model 2 was incrementally improved with the following changes: 
 
 Unobservable species D and H were removed from consideration in the fitting 
process instead of attempting to use assumptions with no factual backup 
 The percentage relative abundance of species by NMR integration was changed 
to an actual concentration as half of the species (B, C, D and H) present cannot 
be observed by NMR 
 Further constraints were added to ensure negative or zero rate constants were 
forbidden, dissociative processes (e.g. A → C + D) must have the same rate for 
formation of each product (i.e. kAC = kAD) and the rate of production of 
intermediates B and C must equal the rates at which they are consumed 
 A series of EXSY experiments exciting ligand free in solution (E) for each 
substrate/catalyst combination to provide a greater proportion of real data – 
these data are now simultaneously fit in an expanded model 
 The inclusion of data points from free ligand (E) excitation means there are now 
nine sets of data being used to fit eight (A-H) variables whereas before there 
were only six sets of data. Eberhardt et al. show that at least N-1 experiments are 
needed to robustly determine causal relationships between N variables – this 
condition is now satisfied by the extra data126 
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These cumulative improvements to the model, hereafter referred to as Model 3, are shown 
in Figures 104-106.  
 
Figure 104: raw real and simulated data for observed exchange of (−)-nicotine 1 molecules with 
precatalyst IMes 18 using Model 3, following selective excitation of Bound 1 (species A) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen  
 
Figure 105: raw real and simulated data for observed exchange of (−)-nicotine 1 molecules with 
precatalyst IMes 18 using Model 3, following selective excitation of Bound 1 (species F) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen 
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Figure 106: raw real and simulated data for observed exchange of (−)-nicotine 1 molecules with 
precatalyst IMes 18 using Model 2, following selective excitation of ligand ‘free’ in solution (species 
E) resonance at 298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of 
substrate, activated with 4 bar of hydrogen.  
 
It was observed that although the fit for Model 3 was much improved compared to Model 
2, there was significant deviation between the real data and simulated data at higher time 
intervals. The deviation was particularly acute in excitation of ligand free in solution 
(Figure 106), where the observed concentration of excited free ligand dropped off far 
more quickly than predicted. This discrepancy was again attributed to relaxation of the 
NMR signal not yet being considered in the model. Model 3 was subsequently applied to 
a range of catalyst-substrate combinations across a range of temperatures (Figure 107). 
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Figure 107: observed rate constants for dissociation of substrate molecules at 298 K using Model 3. 
Samples were 5 mM precatalyst in methanol-d4 with five equivalents of the substrate, activated with 
4 bar of hydrogen 
 
The observed rates of dissociation of each bound form in a catalyst-substrate combination 
are much more homogenous than those obtained originally using Model 1 (see Figure 4). 
Furthermore, while Model 1 had no obvious correlation between rates and deuteration of 
catalyst and/or substrate, the results from Model 3 were more promising. There appeared 
to be a relationship between deuteration of the substrate and rate of dissociation, with 
both entries for 4,6-nicotine-d2 9 calculated as dissociating ~0.8 s
-1 slower than their 
equivalents with (−)-nicotine 1.  This contrasted with the previous theory that deuterated 
substrates should not differ much from their undeuterated counterparts – as secondary 
kinetic isotope effects on molecules this size should be relatively small. However, it was 
yet again suspected that unaccounted relaxation differences were the culprit for the varied 
dissociation rates, as it was already well-established (Chapter 3) that 4,6-nicotine-d2 9 
relaxes much more slowly than (−)-nicotine 1. Relatively rapid relaxation of the signal 
for (−)-nicotine 1 would artificially inflate the rate at which substrate was dissociating 
compared to any similar effect on 4,6-nicotine-d2 9, consistent with Model 3 observations 
above. 
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4.2.2 Model 4 
 
Errors and fits observed with Models 2 and 3 showed it was paramount to properly 
account for relaxation effects when trying to model SABRE exchange. The solution 
proposed was relatively simple - a relaxation term was added to the end of calculations 
of simulated concentration of each species (Equation 4). This term approximated 
relaxation by removing a small amount of signal/apparent concentration (proportional to 
the relaxation time T1) with each entry in the simulated series to help match the observed 
reduction of signal in the real data. Therefore, the data solver was not creating errors 
trying to fit two essentially different datasets as if they represented the same process. 
 
… − (
1
𝑇1
) [𝑋]𝑝𝑟𝑒𝑣(∆𝑡) 
Equation 4: simulated relaxation term for kinetic modelling. [X]prev refers to the concentration of 
‘species X’ in the previous iteration and Δt is the time elapsed since that previous iteration 
 
As T1 relaxation times are known to change dramatically between substrate free in 
solution and substrate bound to the catalyst, the value of T1 used in Equation 4 was 
changed between the free and bound values as appropriate for the species it was applied 
to. It was also acknowledged that the values of T1 used may not be entirely representative 
of the true T1 times, for example, the T1 values used for ‘bound’ ligand were actually the 
T1 values of the ligand free in solution but in the presence of the activated catalyst (i.e. 
activated conditions as described in Chapter 3.1.2). This is a weighted average of the 
bound and free ligand T1 values and is used because the rapid exchange of molecules at 
ambient temperatures makes measuring the ‘true’ bound ligand T1 impractical. Therefore, 
the T1 values inputted were constrained by a sensible range and allowed to be varied by 
the model to ensure a good fit. 
 
It was also realised that rigidly defining the initial concentrations of the various species 
was likely causing bias in the fit. Every measured data point in each series varied by some 
margin of error (due to inherent experimental error, etc.) and so it was considered prudent 
to treat the starting point with some flexibility to compensate. Therefore, the initial 
concentration of each species was defined as a (limited) range about the theoretical value. 
 
 152 
 
The cumulative improvements featured in Model 4 were applied to the EXSY spectra 
various combinations of precatalyst, substrate and temperature. As a sample, the results 
for 4,6-nicotine-d2 9 with IMes 18 at 298 K are shown below in Figures 108-110. Full 
results are listed in Chapter 7. Visually, the fits were much improved, with minimum 
sum-of-least-squares in single figures. 
 
 
Figure 108: raw real and simulated data for observed exchange of 4,6-nicotine-d2 9 molecules with 
precatalyst IMes 18 using Model 4, following selective excitation of Bound 1 (species A) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen 
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Figure 109: raw real and simulated data for observed exchange of 4,6-nicotine-d2 9 molecules with 
precatalyst IMes 18 using Model 4, following selective excitation of Bound 2 (species F) resonance at 
298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of substrate, activated 
with 4 bar of hydrogen 
 
 
Figure 110: raw real and simulated data for observed exchange of 4,6-nicotine-d2 9 molecules with 
precatalyst IMes 18 using Model 4, following selective excitation of ligand ‘free’ in solution (species 
E) resonance at 298 K. Samples were 5 mM precatalyst in methanol-d4 with five equivalents of 
substrate, activated with 4 bar of hydrogen 
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The results obtained using Model 4 indicated a significant improvement over previous 
models, with sum-of-least-squares values no greater than 5 indicating an excellent fit. In 
addition, the rate constants derived from this fit generally appear to be sensible (Table 6). 
The rate of dissociation of ligands from species A and F into their constituent species is 
consistently around 3 s-1 and the consumption of intermediates B, C, D and E are all 
approximately the same as each other. 
 
-11.712 3.058 2.798 2.798 3.058 0 0 0 A 
23.950 -50.273 0 0 0 23.249 0 3.075 B 
23.249 0 -50.273 0 0 23.950 3.075 0 C 
23.249 0 0 -50.273 0 23.950 0 3.075 D 
23.950 0 0 0 -50.273 23.249 3.075 0 E 
0 2.798 3.058 3.058 2.798 -11.712 0 0 F 
0 0 44.417 0 44.417 0 -88.835 0 G 
0 44.417 0 44.417 0 0 0 -88.835 H 
A B C D E F G H  
 
Table 6: (observed) rate constants generated by Model 4 for 4,6-nicotine-d2 9 and IMes 18 at 298 K. 
kXY = XY (i.e. kAB is row A, column B). Only rates marked in green are actual rates, those in grey 
correspond to processes that do not exist. Rates marked in bold are equivalent to the ‘Bound 1’ and 
‘Bound 2’ dissociations in Model 1 
 
Model 4 was subsequently applied to all combinations of substrate and precatalyst across 
a range of temperatures (Figure 111). The calculated dissociative rate constants appeared 
relatively homogenous as expected with theoretical predictions, at an average of 3.08 ± 
0.07 s-1 for all combinations. Deviation between the bound forms and between 
substrate/precatalyst combinations was minimal, with all entries bar one within a single 
standard deviation of the mean. It should be noted that although the exchange rates appear 
more uniform in Model 4, the more important distinction is that the average dissociation 
rate is a full 15% lower than it was for the equivalent data analysed by Model 1. Given 
how crucial optimum exchange rates are for SABRE efficiency, this is a significant 
discovery. 
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Figure 111: observed rate constants for dissociation of substrate molecules at 298 K using Model 4. 
Samples were 5 mM precatalyst in methanol-d4 with five equivalents of the substrate, activated with 
4 bar of hydrogen. Error bars are the standard deviation of all results (n=8) 
 
Once more, the measuring of rate constants over a range of temperatures using Equation 
3 allowed construction of Eyring plots to determine the enthalpy (Figure 112) and entropy 
(Figure 113) of activation for dissociation of ligands for each combination of substrate 
and precatalyst. 
  
Figure 112: enthalpies of activation for ligand dissociation for a range of substrate/precatalyst 
combinations using Model 4. Error bars are the standard deviation of all results (n=8) 
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It was observed that every substrate/precatalyst combination gave very similar enthalpies 
of activation, at an average of 88.2 ± 4.8 kJ mol-1. Some variations were still observed 
but less than those in the original Model 1 – five out of eight entries are within one 
standard deviation of the mean and all are within 1.5 standard deviations of the mean. 
The same nitrogen-iridium bond is being broken in each case – it can be concluded from 
the similarity in enthalpy that secondary isotope effects from incorporated deuterium have 
little effect on the strength of this bond. 
 
  
Figure 113: entropies of activation for ligand dissociation for a range of substrate/precatalyst 
combinations. Error bars are the standard deviation of all results (n=8) 
 
Entropy of activation relates to the energy of the dissociation transition state. No obvious 
correlation was observed between deuteration of the catalyst and/or deuteration of the 
substrate and this parameter. Given the relative homogeneity of exchange rates at a given 
temperature and the enthalpies of activation, it can be concluded that variations in entropy 
of activation are not a key determining factor for the exchange processes.  
 
As with Model 1, the activation enthalpies and entropies of dissociation were used to 
calculate the Gibbs free energies of dissociation for Model 4. 
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Figure 114: Gibbs free energies of activation for the dissociation of bound substrate molecules from 
iridium using Model 4 
 
Strong uniformity in the results was observed, with an average of 70.10 ± 0.13 kJ mol-1 
for every combination of catalyst and substrate tested. Only one entry lay outside one 
standard deviation of the mean giving good confidence in the reliability of the result. 
 
4.3 Summary/Conclusions 
 
Chirality is not a parameter considered previously in the analysis of SABRE. Once the 
unusual property of chemically-distinct ligands on the catalyst was noticed, it became 
apparent that reliably calculating exchange rates of chiral ligands was significantly more 
complex and many parameters were being ignored. The use of the existing simple model 
gave somewhat varied results with no obvious correlation – these variations were difficult 
to rationalise with the confident theory that deuterium-labelling makes minimal changes 
to the masses of the substrate and catalyst and secondary kinetic/remote isotope effects 
are typically small. 
 
More thorough assessment considering intermediate and unobservable species led to 
Model 3, where a significantly lower, yet consistent dissociation rate was calculated for 
entries with deuterated substrate ligands versus their non-deuterated equivalents. This 
confirmed suspicions that relaxation of the signal, as-yet unmodelled, was artificially 
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boosting the calculated exchange rates of more rapidly-relaxing ligands (i.e. non-
deuterated nicotine ligands) and artificially reducing the calculated rates for more slowly-
relaxing ligands (i.e. deuterated nicotines). It is fortunate that the calculated exchange 
rates for nicotines are relatively slow, as other well-documented systems likely exchange 
too rapidly for the effects of relaxation on EXSY to be readily noticed. 
 
Model 4 incorporated a term to help account for differing relaxation rates of various 
species. It calculated plausible observed rate constants for defined species and 
intermediates with reduced deviation observed in dissociation rate, activation enthalpies 
and free energies for varyingly deuterated substrates and precatalysts. The quality of fit 
was also noticeably improved upon all previous models. While it may appear by some 
measures that Model 4 is only a marginal improvement upon Model 1 for this system, it 
is important to recognise that Model 4 assesses considerably more variables and 
incorporates over 50% more raw data through the inclusion of free ligand excitation 
EXSY and relaxation data. Hence, the results produced can be more confidently 
expressed as accurate.  
 
The key result for Model 4 is a significantly lower calculated average dissociation rate at 
3.079 s-1 at 298 K versus 3.562 s-1 calculated using Model 1, a full 16% reduction. Similar 
reductions between 8 and 19% were observed for Model 4 versus Model 1 at the other 
temperatures tested (for full data, see the appendix in Chapter 7). As Model 1 is essentially 
the model by which the majority of literature SABRE exchange data has been calculated, 
it could be concluded that existing literature will have significantly overestimated 
exchange rates. 
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5: Future work 
 
As a complex and multidisciplinary project, there is a wide scope for future work. Firstly, 
there is the potential for testing new nicotine-based SABRE substrates. Such substrates 
could have alternative deuteration patterns on the pyridine ring not covered by the 
Comins-derived methodology used thus far. Alternatively, deuteration of the pyrrolidine 
ring may yield improved results by reducing the small quantiy of hyperpolarisation 
‘leakage’ into that ring observed by OPSY. Thirdly, isotopic labelling and SABRE studies 
could be readily extended to similar/related compounds such as isonicotine and 
nornicotine. 
 
Continuation of SABRE studies on the nicotine isotopologues in this project is another 
option for further study. Optimisation of solvent was only briefly covered in the project, 
selection and refinement with a more biocompatible solvent would greatly lead in 
progressing the initial imaging studies undertaken so far into full in vivo MRI. 
Alternatively, SABRE-RELAY offers another promising route to testing nicotine 
isotopologues for in vivo use. 
 
Lastly, the results from Model 4 suggest existing literature exchange rates are likely 
overestimates. Therefore, applying Model 4 to another chiral SABRE system to allow 
further refinement, or adapting the model to assess the more common achiral substrates 
should prove insightful. Chiral amines, particularly amino acids, are of great interest as 
potential SABRE substrates and initial efforts could focus there. 
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6: Experimental 
 
6.1 Standard/general methods 
 
All non-aqueous reactions were carried out under oxygen free Ar using flame-dried 
glassware. THF was freshly distilled from benzophenone, diethyl ether was freshly 
distilled over sodium. Alkyllithiums were titrated against N-benzylbenzamide before 
use.37 (-)-Nicotine 1, n-hexane and methanol were each distilled over CaH2 before use. 
Brine refers to a saturated solution. Water is distilled water. 
 
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-
440 mesh). Thin layer chromatography was carried out using commercially available 
Merck F254 aluminium backed silica plates. Proton (400 MHz) and carbon (100.6 MHz) 
NMR spectra were recorded on a JEOL ECX-400 or Bruker Avance III instrument using 
5mm inverse gradient probes and internal deuterium locks. For samples recorded in 
CHCl3, chemical shifts are quoted in parts per million relative to CHCl3 (δH 7.25) and 
CDCl3 (δC 77.0, central line of triplet). Carbon NMR spectra were recorded with broad 
band proton decoupling and assigned using DEPT experiments. Coupling constants (J) 
are quoted in Hertz. Infrared spectra were recorded on a Perkin Elmer Spectrum Two FT-
IR spectrometer with UATR attachment. Electrospray high and low resonance mass 
spectra were recorded at room temperature on a Bruker Daltronics microTOF 
spectrometer. Buffered LC-MS experiments were conducted at room temperature on a 
Thermo Scientific Dionex UltiMate 3000 with a 2.7 µm x 4.6 mm x 50 mm reversed-
phase column, 0.6 mL min-1 flow rate and an 8 min continuous gradient from 10 mM 
ammonium formate(aq) to acetonitrile, connected to a Bruker amaZon SL ion trap 
spectrometer. 
 
4 Bar of hydrogen/para-hydrogen refers to the absolute pressure in the sample vessel. 
The gauge pressure displayed on an MKS Baratron® capacitance manometer indicates 
pressure relative to ambient atmospheric conditions. 3 Bar on these gauges therefore 
correspond to approximately 4 bar of absolute pressure.  
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6.2 Specialised approaches 
 
Preparation of para-hydrogen 
 
Para-hydrogen was produced by cooling hydrogen gas to 25 K over iron (III) oxide in a 
para-hydrogen generator supplied by Bruker. 99% para-hydrogen produced in this 
manner was used throughout the project. 
 
Standard sample preparation and activation (Method 1) 
 
A specified substrate, a precatalyst and solvent were placed in an NMR tube fitted with a 
Young’s tap. The standard concentrations of reagents was 25 mM substrate, 5 mM 
catalyst in 0.6 mL methanol-d4 unless otherwise stated.  This concentration was chosen 
because it leads to an active catalyst of form [Ir(H)2(NHC)(substrate)3]Cl and a 2-fold 
excess of substrate in solution. 
 
The sample was degassed under vacuum at −78 ºC, the warmed to rt, charged with 4 bar 
of hydrogen gas and shaken vigorously for ~10 s. This process allows catalyst activation 
to occur. Catalyst activation was viewed by following appearance of peaks in the hydride 
region (~22-23 ppm) of a thermal 1H NMR spectrum. Complete activation had occurred 
when these peaks no longer increased in size. 
 
Achieving SABRE (shake-and-drops in stray field) (Method 2) 
 
A sample was prepared according to Method 1. The NMR tube was recharged with 4 bar 
of para-hydrogen and shaken vigorously in an up-down motion by hand for 10 s in the 
stray magnetic field of an NMR spectrometer at 65 G (unless otherwise stated), then 
immediately placed in the spectrometer for measurement with a one-scan 1H NMR 
experiment.  
 
The NMR tube was removed from the spectrometer and vented of remaining para-
hydrogen before being recharged. The process was repeated to allow for error in the 
individual experiments. 
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Achieving SABRE (shake-and-drops with magnetic shaker) (Method 3) 
 
A sample was prepared according to Method 1. The NMR tube was recharged with 4 bar 
of para-hydrogen, placed in the magnetic shaker assembly and sealed. The assembly was 
shaken vigorously in an up-down motion by hand for 10 s after which the NMR tube was 
removed and immediately placed in the spectrometer for measurement with a one-scan 
1H NMR experiment.  
 
The NMR tube was removed from the spectrometer and vented of remaining para-
hydrogen before being recharged. The process was repeated to allow for error in the 
individual experiments. 
 
Calculation of signal enhancement 
 
The 1H NMR signal enhancement was calculated by direct comparison of integrals in the 
spectrum of a hyperpolarised sample to those in a reference spectrum of the same sample 
when completely relaxed and polarised thermally. Experimentally, the reference and 
hyperpolarised spectra were collected using the same NMR spectrometer with identical 
acquisition parameters (in particular the receiver gain). The raw integrals were compared 
using Equation 5, where E is the enhancement, Shyp is the signal of the hyperpolarised 
sample measured by integral and Stherm is the signal of the thermally polarised sample 
measured by integral: 
𝐸 =
𝑆ℎ𝑦𝑝
𝑆𝑡ℎ𝑒𝑟𝑚
 
 
Equation 5: equation for calculation of signal enhancement 
 
Flow methodology (Method 4) 
 
In a different approach, hyperpolarisation was achieved through use of an automated 
polariser setup. The volume of the cell was increased relative to that of an NMR tube, 
hence the new standard volume was 3 mL of solvent with the same standard 25 mM 
substrate and 5 mM precatalyst concentrations as for Method 1. 
 
The full 3 mL sample was injected into the mixing chamber. Hydrogen at 4 bar was 
bubbled through the sample for activation, which was then shuttled via a transfer line into 
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the 125 µL cell of a p-H2-modified Bruker TXI inverse gradient flow probe in the NMR 
spectrometer. A thermal 1H spectrum was recorded for reference signal intensity as in 
Method 2. 
 
After return of the sample to the mixing chamber, hyperpolarisation was achieved by 
para-hydrogen bubbling at 4 bar in a polarisation transfer field generated by the 
chamber’s coil. Standard bubbling time was 10 seconds with 65 G transfer field unless 
otherwise specified. This mimicks the shaking action performed in Method 2. 
Subsequent, immediate shuttling to the spectrometer occured, followed by recording of a 
one-scan 1H NMR spectrum. 
 
The benefits of this approach are that the field and bubbling time can both be rigorously 
controlled. Potential problems are solvent evaporation with repeated shuttling and a ~5 s 
delay between polarisation and measurement. This compares to ~2s delay for the shake-
and-drops. 
 
 
 
Figure 115: Depiction of automated flow setup for SABRE 
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1H T1 relaxation time measurement via inversion-recovery (Method 5) 
 
A sample was prepared according to Method 1. The NMR tube was recharged with 4 bar 
of hydrogen and shaken vigorously in an up-down motion by hand. Catalyst activation 
was determined by thermal 1H NMR.  
 
Derivation of the substrate’s 1H T1 relaxation times was achieved through the inversion-
recovery pulse sequence depicted in Figure 116. An initial 180° pulse flips longitudinal 
magnetisation Mz into the –z axis. A subsequent 90° pulse after time delay τ moves 
magnetisation into the observable xy plane, where it is observed over time t. As the 
magnitude of magnetisation in –z gradually decreases with time, delay τ between the two 
pulses will give decreased observable signal intensity. Multiple iterations with variation 
of τ allows the decay/relaxation of the NMR signal to be observed and quantified. 
 
 
Figure 116: inversion-recovery pulse sequence to derive T1 relaxation times 
 
1H T1 relaxation time measurement via saturation-recovery (Method 6) 
 
A sample was prepared according to Method 1. The NMR tube was recharged with 4 bar 
of hydrogen and shaken vigorously in an up-down motion by hand. Catalyst activation 
was determined by thermal 1H NMR. Derivation of the substrate’s 1H T1 relaxation times 
was achieved through the saturation recovery pulse sequence depicted in Figure 117. A 
train of rapidly-repeated 90˚ RF pulses (sometimes called a ‘pulse comb’) completely 
dephases longitudinal magnetisation Mz. Mz recovers over time delay τ and a subsequent 
90° pulse moves recovered magnetisation into the observable xy-plane, where it is 
observed over time t. As the recovery of magnetisation in the z-axis gradually increases 
with time, increased delay τ between the two pulses will give increased observable signal 
intensity. Multiple iterations with variation of τ allows the decay/relaxation of the NMR 
signal to be observed and quantified. 
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Figure 117: saturation-recovery pulse sequence to derive T1 relaxation times. Note that the ‘pulse 
comb’ of repeated 90˚ pulses does not necessarily contain four pulses, this is merely a simplification 
 
 
Exchange Spectroscopy (EXSY) (Method 7) 
 
A sample was prepared according to Method 1. The NMR tube was recharged with 4 bar 
of hydrogen and shaken vigorously in an up-down motion by hand. Catalyst activation 
was determined by thermal 1H NMR. When a signal is excited, detection usually follows 
immediately. If a signal is selectively excited and a short period elapses before measuring, 
then the nuclei associated with the signal can move to a different site in the molecule. In 
other words, a reaction has taken place or an exchange process has occurred. By varying 
the delay, the rate of this change can be determined. 
 
This was achieved using the selnogp pulse sequence (described in Chapter 4.1.2). selnogp 
selectively excites a specific proton resonance in each catalyst form of the substrate in a 
series of experiments with varying mixing time. Observed rate constants for dissociation 
of substrate from the catalyst were determined via non-linear least-squares analysis of the 
results against simulated data. Repetitions of the process at different temperatures allowed 
construction of an Eyring plot to determine the activation entropy and enthalpy of this 
process. 
 
 
 
 
 
 
 
 
 167 
 
Error calculation 
 
Errors given throughout this project are the standard error (i.e. standard deviation of the 
mean) unless otherwise specified. Standard errors are calculated according to Equation 6 
below. 
 
𝑆. 𝐸 =
𝜎
√𝑛
 
Equation 6: equation for standard error (S.E.), where σ is the standard deviation and n is the number 
of entries in the data series 
 
 
6.3 Synthetic results 
 
 (R)-6-Chloro-5-(1-methylpyrrolidin-2-yl)pyridine 2 (6-chloronicotine) and (R)-2-
chloro-5-(1-methylpyrrolidin-2-yl)pyridine 3 (2-chloronicotine) 
 
 
n-Butyllithium (13.00 mL of a 2.5 M solution in hexanes, 32.4 mmol, 5.4 eq.) was added 
dropwise to a stirred solution of 2-(dimethylamino)ethanol (0.90 mL, 18.0 mmol, 3.0 eq.) 
in n-hexane (10 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 30 
min and then cooled to −20 °C. Then, (−)-nicotine 1 (0.95 mL, 6.0 mmol, 1.0 eq.) was 
added dropwise. The resulting solution was stirred at −20 °C for 1 h and then cooled to 
−78 °C. A solution of hexachloroethane (5.68 g, 24.0 mmol, 4.0 eq.) in toluene (15 mL) 
was added and the solution was stirred at −78 °C for 1 h. Saturated NaHCO3(aq) (20 mL) 
was added and the two layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc as eluent gave an 80:20 mixture (by 1H NMR 
spectroscopy) of 2-chloronicotine 3 and 6-chloronicotine 2 (309 mg, 26%) as a pale 
yellow oil, RF (EtOAc) 0.26; 
1H NMR (400 MHz, CDCl3) diagnostic peaks for 2-
chloronicotine 3: 8.25 (dd, J = 4.5, 2.0 Hz, 1H, 6-py), 7.94 (dd, J = 7.5, 2.0 Hz, 1H, 4-py) 
and 6-chloronicotine 2 (592 mg, 51%) as a pale yellow oil, RF (EtOAc) 0.14; [α]D20  −121 
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(c 1.0 in CH2Cl2) (lit.,
38 –154 (c. 1.0 in MeCN)); IR (ATR): 2965, 2779, 1552, 1448, 
1357, 1215, 1108, 880 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.28 (d, J = 2.0 Hz, 1H, 2-
py), 7.66 (dd, J = 8.0, 2.0 Hz, 1H, 4-py), 7.27 (d, J = 8.0 Hz, 1H, 5-py), 3.21 (ddd, J = 
9.5, 8.0, 2.0 Hz, 1H, NCH), 3.07 (dd, J = 8.5, 8.5 Hz, 1H, NCH), 2.29 (ddd, J = 9.5, 8.5, 
8.5 Hz, 1H, NCH), 2.23-2.15 (m, 1H, CH), 2.14 (s, 3H, NMe), 1.98-1.88 (m, 1H, CH), 
1.85-1.76 (m, 1H, CH), 1.71-1.60 (m, 1H, CH); 13C NMR (100.6 MHz): δ 150.1 (C, 6-
py), 149.2 (CH, 2-py), 138.0 (C, 3-py), 137.8 (CH, 4-py), 124.3 (CH, 5-py), 64.9 (NCH), 
56.8 (NCH2), 40.6 (NMe), 33.4 (CH2), 22.8 (CH2); MS (ESI) m/z 199 [(M (
37Cl) + H)+, 
31], 197 [(M (35Cl) + H)+, 100] ; HRMS m/z calculated for C10H13
35ClN2 (M + H)
+ 
197.0840, found 197.0846 (−1.9 ppm error). Spectroscopic data consistent with those 
reported in the literature.38 
 
Lab book number: WHD/1/11/1 
 
n-Butyllithium (3.80 mL of a 1.43 M solution in hexanes, 5.4 mmol, 5.4 eq.) was added 
dropwise to a stirred solution of 2-(dimethylamino)ethanol (0.30 mL, 3.0 mmol, 3.0 eq.) 
in n-hexane (2 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 30 min 
and then cooled to −20 °C. Then, (−)-nicotine 1 (0.16 mL, 1.0 mmol, 1.0 eq.) was added 
dropwise. The resulting solution was stirred at −20 °C for 1 h and then cooled to −78 °C. 
A solution of hexachloroethane (946 mg, 4.0 mmol, 4.0 eq.) in n-hexane (3 mL) was 
added and the solution was stirred at −78 °C for 1 h. Saturated NaHCO3(aq) (5 mL) was 
added and the two layers were separated. The aqueous layer was extracted with CH2Cl2 
(3 × 10 mL). The combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column chromatography 
on silica with EtOAc as eluent gave 2-chloronicotine 3 as a pale yellow oil (12 mg, 6%), 
6-chloronicotine 2 as a pale yellow oil (101 mg, 51%) and a 40:60 mixture (by 1H NMR 
spectroscopy) of 2-chloronicotine 3 and 6-chloronicotine 2 as a yellow oil (10 mg, 5%).  
 
Lab book number: WHD/1/1/1 
 
n-Butyllithium (11.30 mL of a 1.43 M solution in hexanes, 16.2 mmol, 5.4 eq.) was added 
dropwise to a stirred solution of 2-(dimethylamino)ethanol (0.80 mL, 9.0 mmol, 3.0 eq.) 
in n-hexane (5 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 30 min 
and then cooled to −20 °C. Then, (−)-nicotine 1 (0.48 mL, 3.0 mmol, 1.0 eq.) was added 
dropwise. The resulting solution was stirred at −20 °C for 1 h and then cooled to −78 °C. 
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A solution of hexachloroethane (2.84 g, 12.0 mmol, 4.0 eq.) in n-hexane (10 mL) was 
added and the solution was stirred at −78 °C for 1 h. Saturated NaHCO3(aq) (10 mL) was 
added and the two layers were separated. The aqueous layer was extracted with CH2Cl2 
(3 × 10 mL). The combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column chromatography 
on silica with EtOAc as eluent gave 6-chloronicotine 2 as a pale yellow oil (117 mg, 20%) 
and recovered (−)-nicotine 1 (216 mg, 44%). 1H NMR spectrum of the crude product 
indicated trace quantities of 2-chloronicotine 3, but this was not isolated.  
 
Lab book number: WHD/1/5/1 
 
(R)-5,6-Dichloro-5-(1-methylpyrrolidin-2-yl)pyridine 5 (5,6-dichloronicotine)  
 
 
 
n-Butyllithium (0.50 mL of a 2.5 M solution in hexanes, 1.1 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of 2,2,6,6-tetramethylpiperidine (0.20 mL, 1.1 mmol, 1.1 
eq.) in THF (2 mL) at −78 °C under Ar. The resulting solution was stirred at −78 °C for 
1 h. Then, a solution of 6-chloronicotine 2 (200 mg, 1.0 mmol, 1.0 eq.) in THF (1 mL) 
was added dropwise and the resulting solution was stirred at −78 °C for 1 h. A solution 
of hexachloroethane (290 mg, 1.2 mmol, 1.2 eq.) in THF (1 mL) was added and the 
solution was stirred at −78 °C for 1 h. Saturated NaHCO3 (aq) (2 mL) was added and the 
two layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 10 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
EtOAc as eluent gave 5,6-dichloronicotine 5 (136 mg, 59%) as a dark yellow oil, RF 
(EtOAc) 0.55; [α]D20 −138 (c 1.0 in CH2Cl2)(lit.,18 [α]D24 – 134 (c 0.55 in CH2Cl2)); IR 
(ATR): 2968, 2781, 1547, 1420, 1392, 1329, 1149, 1042 cm-1; 1H NMR (400 MHz, 
CDCl3): δ 8.19 (d, J = 2.5 Hz, 1H, 2-py), 7.80 (d, J = 2.5 Hz, 1H, 4-py), 3.22 (ddd, J = 
9.0, 7.0, 2.0 Hz, 1H, NCH), 3.10 (dd, J = 8.5, 8.5 Hz, 1H, NCH), 2.31 (ddd, J = 9.5, 9.0, 
9.0 Hz, 1H, NCH), 2.24-2.18 (m, 1H, CH), 2.16 (s, 3H, NMe), 1.99-1.88 (m, 1H, CH), 
1.86-1.76 (m, 1H, CH), 1.70-1.59 (m, 1H, CH) ; 13C NMR (100.6 MHz): δ 147.7 (C, 6-
py), 146.8 (CH, 2-py), 140.4 (C, 5-py), 137.9 (CH, 4-py), 130.8 (C, 3-py), 67.5 (NCH), 
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57.1 (NCH2), 40.6 (NMe), 35.8 (CH2), 22.8 (CH2); MS (ESI) m/z 233 [(M (
35Cl37Cl) + 
H)+, 64], 231 [(M (35Cl2) + H)
+, 100]; HRMS m/z calculated for C10H12
35Cl2N2 (M + H)
+ 
231.0450, found 231.0458 (−2.8 ppm error). Spectroscopic data consistent with those 
reported in the literature.18 
 
Lab book number: WHD/1/9/4 
 
 
(R)-4,6-Dichloro-5-(1-methylpyrrolidin-2-yl)pyridine 6 (4,6-dichloronicotine)  
 
 
n-Butyllithium (0.88 mL of a 2.5 M solution in hexanes, 2.2 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of 6-chloronicotine 2 (394 mg, 2.0 mmol, 1.0 eq.) in THF 
(3 mL) at −78 °C under Ar. The resulting solution was stirred at −78 °C for 1 h. A solution 
of hexachloroethane (520 mg, 2.2 mmol, 1.1 eq.) in THF (2 mL) was added and the 
solution was stirred at −78 °C for 1 h. Saturated NaHCO3 (aq) (10 mL) was added and the 
two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
EtOAc as eluent gave 4,6-dichloronicotine 6 (349 mg, 76%) as a colourless oil, RF 
(EtOAc) 0.57; [α]D20 − 141 (c 1.0 in CH2Cl2)(lit.,18 [α]D27 – 182 (c 0.55 in CH2Cl2)); IR 
(ATR): 2955, 2778, 1556, 1450, 1357, 1215, 1108, 876 cm-1; 1H NMR (400 MHz, CDCl-
3): δ 8.55 (s, 1H, 2-py), 7.31 (s, 1H, 5-py), 3.54 (dd, J = 8.0, 8.0 Hz, 1H, NCH), 3.23 (ddd, 
J = 9.5, 7.5, 2.0 Hz, 1H, NCH), 2.45-2.30 (m, 2H, NCH + CH), 2.23 (s, 3H, NMe), 1.94-
1.76 (m, 2H, CH), 1.58-1.47 (m, 1H, CH); 13C NMR (100.6 MHz): δ 149.7 (CH, 2-py), 
149.6 (C, 6-py), 145.1 (C, 4-py), 136.2 (C, 3-py), 124.0 (CH, 5-py), 64.9 (NCH), 56.8 
(NCH2), 40.6 (NMe), 33.4 (CH2), 22.8 (CH2); MS (ESI) m/z 233 [(M (
35Cl37Cl) + H)+, 
65], 231 [(M (35Cl2) + H)
+, 100]; HRMS m/z calculated for C10H12
35Cl2N2 (M + H)
+ 
231.0450, found 231.0458 (−2.9 ppm error). Spectroscopic data consistent with those 
reported in the literature.18 
 
Lab book number: WHD/1/21/3  
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(R)-2,6-Dichloro-5-(1-methylpyrrolidin-2-yl)pyridine 7 (2,6-dichloronicotine) 
 
 
 
n-Butyllithium (3.20 mL of a 2.2 M solution in hexanes, 7.10 mmol, 5.4 eq.) was added 
dropwise to a stirred solution of 2-(dimethylamino)-ethanol (0.38 mL, 3.74 mmol, 3.0 
eq.) in n-hexane (5 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 
30 min and then cooled to −20 °C. Then, a solution of 6-chloronicotine 2 (245 mg, 1.25 
mmol, 1.0 eq.) in n-hexane (1 mL) was added dropwise. The resulting solution was stirred 
at −20 °C for 1 h and then cooled to −78 °C. A solution of hexachloroethane (1.28 g, 5.39 
mmol, 4.3 eq.) in toluene (5 mL) was added and the solution was stirred at −78 °C for 1 
h. Saturated NaHCO3(aq) (5 mL) was added and the two layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with EtOAc as eluent gave 2,6-
chloronicotine 7 (148 mg, 51%) as a mid-yellow oil, RF (EtOAc) 0.38; [α]D20 −156 (c 1.0 
in CH2Cl2) (lit.,
18 [α]D26 – 191 (c 2.45 in CH2Cl2)); IR (ATR): 2936, 1547, 1452, 1424, 
1322, 1138, 831, 781 cm-1; 1H NMR (400 MHz, CDCl3): δ 7.92 (d, J = 8.0 Hz, 1H, 4-py), 
7.27 (d, J = 8.0 Hz, 1H, 5-py), 3.51 (dd, J = 8.0, 8.0 Hz, 1H, NCH), 3.21 (ddd, J = 9.5, 
7.5, 2.5 Hz, 1H, NCH), 2.45-2.32 (m, 2H, NCH + CH), 2.20 (s, 3H, NMe), 1.90-1.77 (m, 
2H, CH), 1.54-1.42 (m, 1H, CH); 13C NMR (100.6 MHz): δ 149.4 (C, 6-py), 148.0 (C, 2-
py), 139.4 (C, 3-py), 137.4 (CH, 4-py), 123.5 (CH, 5-py), 65.8 (NCH), 56.8 (NCH2), 40.6 
(NMe), 33.4 (CH), 22.9 (CH); MS (ESI) m/z 233 [(M (35Cl37Cl) + H)+, 64], 231 [(M 
(35Cl2) + H)
+, 100]; HRMS m/z calculated for C10H12
35Cl2N2 (M + H)
+ 231.0450, found 
231.0458 (−3.4 ppm error). Spectroscopic data consistent with those reported in the 
literature.18 
 
Lab book number: WHD/1/28/10 
 
 
n-Butyllithium (4.39 mL of a 2.5 M solution in hexanes, 10.98 mmol, 5.4 eq.) was added 
dropwise to a stirred solution of 2-(dimethylamino)-ethanol (0.61 mL, 6.09 mmol, 3.0 
eq.) in toluene (10 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 30 
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min and then cooled to −20 °C. Then, a solution of an 80:20 mixture of chloronicotines 2 
and 3 (400 mg, 2.03 mmol, 1.0 eq.) in toluene (2 mL) was added dropwise. The resulting 
solution was stirred at −20 °C for 1 h and then cooled to −78 °C. A solution of 
hexachloroethane (1.44 g, 6.09 mmol, 3.0 eq.) in toluene (10 mL) was added and the 
solution was stirred at −78 °C for 1 h. Saturated NaHCO3(aq) (10 mL) was added and the 
two layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 10 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
EtOAc as eluent gave 2,6-chloronicotine 7 (388 mg, 83%) as a mid-yellow oil. 
 
Lab book number: WHD/1/85/10 
 
 
(R)-4-Bromo-6-chloro-5-(1-methylpyrrolidin-2-yl)pyridine 14 (4-bromo-6-
chloronicotine)  
 
 
 
n-Butyllithium (0.45 mL of a 2.5 M solution in hexanes,  1.1 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of 6-chloronicotine 2 (235 mg, 1.20 mmol, 1.0 eq.) in THF 
(2 mL) at −78 °C under  Ar. The resulting solution was stirred at −78 °C for 1 h. A solution 
of N-bromosuccinimide (235 mg, 1.32 mmol, 1.1 eq.) in THF (1 mL) was added and the 
solution was stirred at −78 °C for 1 h. Saturated NaHCO3(aq) (10 mL) was added and the 
two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product (116 mg) as a brown oil, which contained a 60:40 mixture of 4-
bromo-6-chloronicotine 14 and 6-chloronicotine 2 (by 1H NMR spectroscopy), RF 
(EtOAc) 0.52; 1H NMR (400 MHz, CDCl3) diagnostic peaks for 4-bromo-6-
chloronicotine 14: δ 8.51 (s, 1H, 2-py), 7.50 (s, 1H, 5-py). After storing in a freezer at 
−20 °C for 48 h, the product turned pink and had decomposed as shown by 1H NMR 
spectroscopy and TLC. 
 
Lab book number: WHD/1/18/8  
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(R)-4-Iodo-6-chloro-5-(1-methylpyrrolidin-2-yl)pyridine 15 (4-iodo-6-
chloronicotine) 
 
 
 
n-Butyllithium (0.45 mL of a 2.5 M solution in hexanes, 1.1 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of 6-chloronicotine 2 (201 mg, 1.0 mmol, 1.0 eq.) in THF 
(2 mL) at −78 °C under  Ar. The resulting solution was stirred at −78 °C for 1 h. A solution 
of iodine (279 mg, 1.1 mmol, 1.1 eq.) in THF (1 mL) was added and the solution was 
stirred at −78 °C for 1 h. Saturated NaHCO3(aq) (5 mL) was added and the two layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined 
organic layers were washed with 10% Na2S2O3(aq) (10 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc as eluent gave 4-iodo-6-chloronicotine 15 (113 mg, 
35%) as a white solid, mp 97-99 °C (lit.,18 100-101 °C); RF (EtOAc) 0.50; [α]D20 −150 (c 
1.0 in CH2Cl2) (lit.,
18 [α]D27 −141 (c 3.45 in CH2Cl2); IR (ATR): 2936, 2804, 2759, 1552, 
1530, 1437, 1360, 1215, 1110, 857 cm-1; 1H NMR (400 MHz, CDCl3): δ 8.38 (s, 1H, 2-
py), 7.75 (s, 1H, 5-py), 3.35 (dd, J = 8.0, 8.0 Hz, 1H, NCH), 3.25 (ddd, J = 9.5, 7.5, 2.0 
Hz, 1H, NCH), 2.45-2.30 (m, 2H, NCH + CH), 2.22 (s, 3H, NMe), 1.94-1.76 (m, 2H, 
CH), 1.53-1.40 (m, 1H, CH); 13C NMR (100.6 MHz): δ 149.6 (C, 6-py), 149.0 (CH, 2-
py), 140.8 (C, 3-py), 133.7 (CH, 5-py), 112.3 (C, 4-py), 71.6 (NCH), 56.9 (NCH2), 40.6 
(NMe), 33.8 (CH2), 22.8 (CH2); MS (ESI) m/z 323 [(M (
35Cl) + H)+, 100]; HRMS m/z 
calculated for C10H12I
35ClN2 (M + H)
+ 322.9806, found 322.9802 (+1.2 ppm error). 
Spectroscopic data consistent with those in the literature.18 
 
Lab book number: WHD/1/22/9  
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(R)-6-Deutero-5-(1-methylpyrrolidin-2-yl)pyridine 4 (6-nicotine-d1) 
 
 
 
6-Chloronicotine 2 (222 mg, 1.13 mmol, 1.0 eq.), 5% palladium on activated charcoal (22 
mg, 10% by weight, 10.3 μmol Pd), potassium carbonate (312 mg, 2.26 mmol, 2.0 eq.) 
and CH3CH2OD (10 mL) were place6d in a Parr reactor vessel. The Parr reactor was then 
sealed, purged with nitrogen and pressurised with deuterium gas to 8 bar. The reactor 
contents were stirred at room temperature for 18 h, when analysis by buffered LC-MS 
indicated that conversion to the product was complete. The Parr reactor was vented of 
remaining deuterium and the solids were removed by filtration through Celite. The filtrate 
was evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 90:10 CH2Cl2-MeOH as eluent gave 6-nicotine-
d1 4 (88 mg, 48%) as a very pale yellow oil, RF (90:10 CH2Cl2:MeOH) 0.16; [α]D20 −124 
(c 1.0 in CH2Cl2); IR (ATR): 2941, 2773 (C-D), 1567, 1459, 1395, 1330, 1205, 1043, 
1021, 896, 863 cm-1; 1H NMR (400 MHz, CDCl3): δ 8.48 (br s, 1H, 2-py), 7.65 (dd, J = 
8.0, 2.0 Hz, 1H, 4-py), 7.21 (d, J = 8.0 Hz, 1H, 5-py), 3.20 (ddd, J = 9.0, 7.5, 2.0 Hz, 1H, 
NCH), 3.04 (dd, J = 8.5, 8.5 Hz, 1H, NCH), 2.25 (ddd, J = 9.0, 9.0, 8.5 Hz, 1H, NCH), 
2.21-2.13 (m, 1H, CH), 2.12 (s, 3H, NMe), 1.99-1.86 (m, 1H, CH), 1.86-1.74 (m, 1H, 
CH), 1.73-1.64 (m, 1H, CH); 13C NMR (100.6 MHz): δ 149.5 (CH, 2-py), 148.2 (CD, 
1:1:1 triplet, J = 27.0 Hz, 6-py), 138.6 (C, 3-py), 134.8 (CH, 4-py), 123.4 (CH, 5-py), 
68.8 (NCH), 56.9 (NCH2), 40.3 (NMe), 35.1 (CH2), 22.5 (CH2); MS (ESI) m/z 164 [(M 
+ H)+, 100]; HRMS m/z calculated for C10H13DN2 (M + H)
+ 164.1293, found 164.1290 
(+2.2 ppm error).  
 
Lab book number: WHD/1/13/5 
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(R)-5,6-Dideutero-5-(1-methylpyrrolidin-2-yl)pyridine 8 (5,6-nicotine-d2) 
 
 
 
5,6-Dichloronicotine 5 (330 mg, 1.43 mmol, 1.0 eq.), 5% palladium on activated charcoal 
(33 mg, 10% by weight, 15.5 μmol Pd), potassium carbonate (395 mg, 2.86 mmol, 2.0 
eq.) and CH3CH2OD (10 mL) were placed in a Parr reactor vessel. The Parr reactor was 
then sealed, purged with nitrogen and pressurised with deuterium gas to 8 bar. The reactor 
contents were stirred at room temperature for 24 h, when analysis by buffered LC-MS 
indicated conversion to the product was ca. 50 % complete. The reactor was repressurised 
with deuterium to 8 bar and stirred for another 72 h, when analysis by buffered LC-MS 
indicated conversion to product was complete. The Parr reactor was vented of remaining 
deuterium and the solids were removed by filtration through Celite. The filtrate was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 90:10 EtOAc-MeOH as eluent gave 5,6-nicotine-d2 8 (101 
mg, 43%) as a pale yellow oil, RF (EtOAc) 0.12; [α]D20 −119 (c 1.0 in CH2Cl2); IR (ATR): 
2955, 2515 (C-D), 1659, 1559, 1394, 1196, 928 cm-1; 1H NMR (400 MHz, CDCl3): δ 
8.51 (s, 1H, 2-py), 7.68 (s, 1H, 4-py), 3.23 (ddd, J = 9.5, 8.5, 1.5 Hz, 1H, NCH), 3.06 (dd, 
J = 8.0, 8.0 Hz, 1H, NCH), 2.25 (ddd, J = 9.5, 9.0, 9.0 Hz, 1H, NCH), 2.24-2.16 (m, 1H, 
CH), 2.15 (s, 3H, NMe), 1.99-1.89 (m, 1H, CH), 1.86-1.77 (m, 1H, CH), 1.74-1.64 (m, 
1H, CH); 13C NMR (100.6 MHz): δ 149.5 (CH, 2-py), 138.7 (C, 3-py), 134.7 (CH, 4-py), 
68.9 (NCH), 57.0 (NCH2), 40.4 (NMe), 35.1 (CH2), 22.6 (CH2) (2 x C-D resonances not 
resolved); MS (ESI) m/z 165 [(M + H)+, 100]; HRMS m/z calculated for C10H12D2N2 (M 
+ H)+ 165.1355, found 165.1361.0846 (−3.2 ppm error).  
 
Lab book number: WHD/1/17/7 
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(R)-4,6-Dideutero-5-(1-methylpyrrolidin-2-yl)pyridine 9 (4,6-nicotine-d2) 
 
 
 
4,6-Dichloronicotine 6 (231 mg, 1.0 mmol, 1.0 eq.), 5% palladium on activated charcoal 
(46 mg, 20% by weight, 21.6 μmol Pd), potassium carbonate (274 mg, 2.0 mmol, 2.0 eq.) 
and CH3CH2OD (10 mL) were placed in a Parr reactor vessel. The Parr reactor was then 
sealed, purged with nitrogen and pressurised with deuterium gas to 8 bar. The reactor 
contents were stirred at room temperature for 2 h, when analysis by buffered LC-MS 
indicated conversion to the product was complete. The Parr reactor was vented of 
remaining deuterium and the reactor contents were filtered through Celite and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc as eluent gave 4,6-nicotine-d2 9 (75 mg, 45%) as a 
very pale yellow oil, RF (EtOAc) 0.11; [α]D20 −124 (c 1.0 in CH2Cl2); IR (ATR): 2945, 
2777 (C-D), 1552, 1455, 1310, 1216, 1041, 901. 603 cm-1; 1H NMR (400 MHz, CDCl3): 
δ 8.52 (s, 1H, 2-py), 7.25 (s, 1H, 5-py), 3.24 (ddd, J = 9.5, 8.5, 1.5 Hz, 1H, NCH), 3.09 
(dd, J = 8.5, 8.5 Hz, 1H, NCH), 2.30 (ddd, J = 9.5, 9.0, 9.0 Hz, 1H, NCH), 2.25-2.17 (m, 
1H, CH), 2.15 (s, 3H, NMe), 2.01-1.90 (m, 1H, CH), 1.87-1.78 (m, 1H, CH), 1.77-1.67 
(m, 1H, CH); 13C NMR (100.6 MHz): δ 149.4 (CH, 2-py), 138.5 (C, 3-py), 123.4 (CH, 5-
py), 68.9 (NCH), 60.0 (NCH2), 40.3 (NMe), 35.1 (CH2), 22.5 (CH2), 2x C-D resonances 
not resolved; MS (ESI) m/z 165 [(M + H)+, 100]; HRMS m/z calculated for C10H12D2N2 
(M + H)+ 165.1355, found 165.1364 (−4.7 ppm error). 
 
Lab book number: WHD/1/27/6 
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(R)-2,6-Dideutero-5-(1-methylpyrrolidin-2-yl)pyridine 10 (2,6-nicotine-d2) 
 
 
 
2,6-Dichloronicotine 7 (139 mg, 0.6 mmol, 1.0 eq.), 5% palladium on activated charcoal 
(28 mg, 20% by weight, 13.2 μmol Pd), potassium carbonate (166 mg, 2.0 mmol, 2.0 eq.) 
and CH3CH2OD (10 mL) were placed in a Parr reactor vessel. The Parr reactor was then 
sealed, purged with nitrogen and pressurised with deuterium gas to 8 bar. The reactor 
contents were stirred at room temperature for 2 h, when analysis by buffered LC-MS 
indicated conversion to the product was complete. The Parr reactor was vented of 
remaining deuterium and the solids were removed by filtration through Celite. The filtrate 
was evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with EtOAc as eluent gave 2,6-dideuteronicotine 10 
(31 mg, 31%) as a very pale yellow oil, RF (EtOAc) 0.10; [α]D20 −127 (c 1.0 in CH2Cl2); 
IR (ATR): 2923, 1979, 1264, 1034, 734 cm-1; 1H NMR (400 MHz, CDCl3): δ 7.67 (d, J 
= 8.0 Hz 1H, 4-py), 7.23 (d, J = 8.0 Hz, 1H, 5-py), 3.22 (ddd, J = 9.5, 7.5, 2.0 Hz, 1H, 
NCH), 3.06 (dd, J = 8.5, 8.5 Hz, 1H, NCH), 2.28 (ddd, J = 9.5, 9.0, 9.0 Hz, 1H, NCH), 
2.22-2.16 (m, 1H, CH), 2.14 (s, 3H, NMe), 2.01-1.88 (m, 1H, CH), 1.85-1.76 (m, 1H, 
CH), 1.74-1.65 (m, 1H, CH); 13C NMR (100.6 MHz): δ 149.1 (CD, 1:1:1 triplet, J = 28.0 
Hz, 2-py), 148.3 (CD, 1:1:1 triplet, J = 27.0 Hz, 6-py) , 138.5 (C, 3-py), 134.8 (CH, 4-
py), 123.4 (CH, 5-py), 68.8 (NCH), 57.0 (NCH2), 40.3 (NMe), 35.1 (CH2), 22.5 (CH2); 
MS (ESI) m/z 165 [(M + H)+, 100]; HRMS m/z calculated for C10H12D2N2 (M + H)
+ 
165.1350, found 165.1355 (+3.1 ppm error).  
 
Lab book number: WHD/1/29/11 
 
 
 
 
 
 
 
 
 
 
 
 178 
 
6.4 SABRE and other NMR results 
 
6.4.1 Varied substrate concentration – enhancements 
 
Samples were prepared according to Method 1, although with varying concentration of 
the substrate. ‘Equivalents’ refers to substrate equivalents, where one equivalent is 5 mM 
concentration, the same as the standard precatalyst concentration. Therefore, four 
equivalents of substrate is 20 mM, etc. ‘SNR’ is signal-to-noise ratio. Polarisation was 
achieved via Method 2, i.e. with samples shaken in a stray field of 65 G. 
 
(−)-nicotine 1, IMes 18 
 
Lab book/raw file reference: WHD/A/1/1, WHD/A/7/7 
 
Equivalents 
Signal enhancement (relative to thermal) 
SNR 2-proton 6-proton 4-proton 5-proton Avg. per proton 
4 303 (±14) 337 (±21) 320 (±10) 42 (±17) 251 (±15) 5296 
5 237 (±9) 320 (±5) 215 (±11) 50 (±31) 206 (±14) 15254 
6 237 (±18) 256 (±20) 233 (±18) 70 (±5) 199 (±15) 12176 
8 228 (±12) 254 (±12) 218 (±11) 87 (±18) 197 (±13) 8289 
10 217 (±2) 237 (±3) 200 (±4) 95 (±5) 187 (±3) 9339 
15 166 (±12) 178 (±11) 147 (±11) 66 (±7) 139 (±10) 12278 
 
4,6-nicotine-d2 9, IMes 18 
  
Lab book/raw file reference: WHD/A/1/1, WHD/A/9/9 
 
 
Equivalents 
Signal enhancement (relative to thermal) 
SNR 
2-proton 5-proton Avg. per proton 
4 759 (±9) 947 (±11) 853 (±10) 24371 
5 485 (±17) 1010 (±14) 748 (±16) 24892 
6 639 (±17) 711 (±14) 675 (±16) 26300 
10 261 (±14) 297 (±19) 279 (±17) 25413 
15 204 (±9) 231 (±11) 217 (±10) 26773 
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(−)-nicotine 1, d22-IMes 19  
 
Lab book/raw file reference: WHD/A/12/12 
 
Equivalents 
Signal enhancement (relative to thermal) 
SNR 
2-proton 6-proton 4-proton 5-proton Avg. per proton 
4 363 (±1) 427 (±8) 362 (±9) 14 (±7) 291 (±6) 4509 
6 447 (±7) 441 (±11) 337 (±13) 24 (±0) 312 (±8) 16936 
8 325 (±4) 373 (±6) 268 (±1) 46 (±13) 253 (±6) 24614 
10 225 (±10) 225 (±7) 246 (±4) 48 (±5) 186 (±6) 24788 
15 149 (±3) 119 (±3) 85 (±2) 25 (±6) 94 (±4) 22302 
 
4,6-nicotine-d2 9, d22-IMes 19 
  
Lab book/raw file reference: WHD/A/10/10 
Equivalents 
Signal enhancement (relative to thermal) 
SNR 
2-proton 5-proton Avg. per proton 
4 761 (±35) 1092 (±30) 926 (±32) 25528 
6 793 (±43) 1088 (±27) 940 (±35) 32961 
8 616 (±36) 731 (±2) 673 (±19) 38318 
10 430 (±6) 485 (±13) 457 (±10) 35125 
15 275 (±7) 304 (±9) 290 (±8) 40826 
 
6.4.2 Varied substrate concentration studies – T1 
 
Samples were prepared according to Method 1, although with varying concentration of 
the substrate. ‘Equivalents’ refers to substrate equivalents, where one equivalent is 5 mM 
concentration, the same as the standard precatalyst concentration. Therefore, four 
equivalents of substrate is 20 mM, etc. T1 relaxation times in this series were recorded 
using Method 5 (inversion-recovery). 
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(−)-nicotine 1, IMes 18 
 
Lab book/raw file reference: WHD/A/8/8  
Equivalents 
T1 relaxation time (activated conditions) / s 
2-proton 6-proton 4-proton 5-proton 
4 1.63 1.63 2.09 2.71 
5 2.97 3.11 3.15 3.87 
7 2.96 3.13 3.79 3.94 
15 3.98 4.60 4.69 4.54 
25 6.02 7.63 6.13 6.25 
 
4,6-nicotine-d2 9, Imes 18 
 
Lab book/raw file reference: WHD/A/8/8  
Equivalents 
T1 relaxation time (activated conditions) / s 
2-proton 5-proton 
4 3.05 16.84 
5 4.79 26.50 
15 4.46 23.80 
25 3.78 19.35 
 
(−)-nicotine 1, d22-Imes 19 
 
Lab book/raw file reference: WHD/A/11/11  
Equivalents 
T1 relaxation time (activated conditions) / s 
2-proton 6-proton 4-proton 5-proton 
4 2.76 2.92 3.14 4.58 
5 2.27 2.09 2.72 3.30 
15 5.63 6.94 5.85 5.77 
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4,6-nicotine-d2 9, d22-IMes 19 
 
Lab book/raw file reference: WHD/A/11/11  
Substrate equivalents 
T1 relaxation time (activated conditions)/ s 
2-proton 5-proton 
4 3.02 18.93 
5 3.24 19.17 
15 5.65 37.63 
 
6.4.2 Variable temperature SABRE – enhancements 
 
Samples were prepared according to Method 1. Results were obtained using Method 2.  
 
(−)-nicotine 1, IMes 18 
 
Lab book/raw file reference: WHD/A/18/18. 
 
Temperature / K 
Signal enhancements (relative to activated thermal) 
2-proton 6-proton 4-proton 5-proton Avg. per proton 
298 237 ±9 320 ±5 215 ±11 50 ±31 212 ±14 
303 332 ±24 315 ±49 297 ±15 6 ±2 259 ±3 
308 525 ±18 221 ±4 399 ±5 8 ±1 295 ±4 
313 384 ±23 275 ±16 331 ±11 13 ±1 264 ±4 
 
4,6-nicotine-d2 9, IMes 18 
 
Lab book/raw file reference: WHD/A/18/18 
 
Temperature / K 
Signal enhancements (relative to activated thermal) 
2-proton 5-proton Avg. per proton 
298 485 ±17 1010 ±14 748 ±16 
303 317 ±13 273 ±9 295 ±11 
308 273 ±4 391 ±8 332 ±6 
313 260 ±7 358 ±6 309 ±7 
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6.4.3 Variable pressure SABRE 
 
Samples were prepared according to Method 1. Results were obtained using Method 2 or 
Method 3 as specified. Lab book/raw file reference: WHD/A/23/23 
(−)-nicotine 1, IMes 18, shaken in stray field 
 
Absolute p-H2 pressure / bar 
Signal enhancements (relative to activated thermal) 
2-proton 6-proton 4-proton 5-proton Avg. per proton 
4 237 ±9 320 ±5 215 ±11 50 ±31 212 ±14 
5 304 ±2 406 ±7 363 ±8 24 ±4 274 ±5 
6 556 ±20 450 ±8 440 ±11 21 ±4 366 ±11 
 
4,6-nicotine-d2 9, IMes 18, shaken in stray field 
 
Absolute p-H2 pressure / bar 
Signal enhancements (relative to activated thermal) 
2-proton 5-proton Avg. per proton 
4 485 ±17 1010 ±14 748 ±16 
5 657 ±28 933 ±25 795 ±27 
6 556 ±20 21 ±4 288 ±12 
 
4,6-nicotine-d2 9, IMes 18, shaken with 60 G magnetic shaker 
 
Absolute p-H2 pressure / bar 
Signal enhancements (relative to activated thermal) 
2-proton 5-proton Avg. per proton 
4 1064 ±23 1713 ±26 1389 ±24 
5 1145 ±28 1782 ±36 1464 ±32 
6 1212 ±19 1807 ±1 1510 ±10 
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6.4.4 Flow experiments 
 
Results were obtained using Method 3. Lab book/raw file reference: WHD/A/14/14 
 
(−)-nicotine 1, with varying polarisation transfer field 
 
 
PTF/G 
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
Avg. per 
proton 
0 42.8 72.6 72.3 138.0 81.4 
10 57.6 85.2 78.2 103.7 81.2 
20 125.0 180.6 168.0 131.1 151.2 
30 147.2 200.1 182.8 73.8 151.0 
40 124.4 154.5 146.7 19.1 111.2 
50 193.9 197.5 190.3 46.3 157.0 
60 216.3 224.2 226.7 103.7 192.7 
70 206.7 218.7 222.9 107.8 189.0 
80 166.0 175.2 187.5 89.1 154.4 
90 123.1 120.8 141.6 92.4 119.5 
100 80.1 74.7 85.0 89.3 82.3 
110 94.9 86.5 86.0 93.7 90.3 
120 68.1 72.8 68.6 27.8 59.3 
130 58.1 65.4 60.9 5.5 47.5 
140 55.2 68.7 64.8 28.2 54.2 
 
(−)-nicotine 1 with varying bubbling time 
 
 
Bubbling time / s 
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton Avg. per proton 
0 0.7 0.7 0.6 0.6 0.7 
2 157.6 160.4 180.8 84.5 145.8 
4 168.9 174.4 197.5 95.1 159.0 
6 156.8 164.9 184.0 84.5 147.6 
8 182.7 187.6 211.9 97.0 169.8 
10 198.0 201.1 227.6 101.7 182.1 
12 175.4 178.7 202.3 92.5 162.2 
14 195.3 202.5 232.8 108.5 184.8 
16 202.9 204.8 235.8 104.7 187.1 
18 180.9 179.9 207.6 93.3 165.4 
20 199.4 213.0 244.9 113.9 192.8 
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4,6-nicotine-d2 9 with varying polarisation transfer field 
 
  
PTF/G 
Signal enhancement (relative to thermal) 
2-proton 5-proton Avg. per proton 
0 977.3 436.7 707.0 
10 763.1 680.8 721.9 
20 756.1 717.5 736.8 
30 654.9 867.8 761.3 
40 629.4 981.6 805.5 
50 659.9 1091.5 875.7 
60 680.5 1165.1 922.8 
70 659.8 1136.8 898.3 
80 688.3 1015.6 852.0 
90 662.4 937.8 800.1 
100 630.5 942.5 786.5 
110 696.3 829.0 762.7 
120 676.4 849.2 762.8 
130 656.3 830.3 743.3 
140 592.0 887.3 739.6 
 
 
4,6-nicotine-d2 9 with varying bubbling time 
 
 
Bubbling time / s 
Signal enhancement 
2-proton 5-proton Avg. per proton 
0 0 0 0.0 
2 750.3 1143.3 946.8 
4 1101.0 1712.9 1407.0 
6 1059.7 1808.9 1434.3 
8 931.0 1550.5 1240.7 
10 806.5 1291.2 1048.8 
12 668.6 1105.6 887.1 
14 641.0 1041.0 841.0 
16 599.6 957.5 778.5 
18 530.2 800.6 665.4 
20 445.2 694.9 570.1 
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6.4.5 Mixing studies results 
 
(−)-nicotine 1, IMes 18 shaken in 60 G shaker assembly 
 
Lab book/raw file reference: WHD/A/28/28 
 
Signal enhancements (relative to activated thermal) 
2-proton 6-proton 4-proton 5-proton Avg. per proton SNR 
637 ±30 596 ±54 642 ±13 289 ±18 541 ±29 11382 
 
 
6.5 EXSY results 
 
Results were obtained using Method 5. Lab book/raw file reference: WHD/A/16/16. 
EXSY traces, Eyring plots and errors are included in Chapter 7. 
 
(−)-nicotine 1, IMes 18 
 
T / K 
kobs/ s
-1 
Bound1->Free Bound2->Free 
288 0.797 1.040 
293 1.460 1.666 
298 3.092 3.181 
303 5.303 6.465 
   
  Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 90.947 86.330 
∆S‡ / JK-1mol-1 69.169 54.870 
∆G300‡ / kJmol-1 
 
70.196 69.869 
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(−)-nicotine 1, d22-IMes 19 
 
T / K 
kobs/ s
-1 
Bound1->Free Bound2->Free 
288 0.778 1.000 
293 1.502 1.647 
298 3.026 3.105 
303 5.998 5.529 
   
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 94.460 82.480 
∆S‡ / JK-1mol-1 80.917 41.351 
∆G300‡ / kJmol-1 70.185 70.075 
 
4,6-nicotine-d2 9, IMes 18 
 
T / K 
kobs/ s
-1 
Bound1->Free Bound2->Free 
288 0.790 0.759 
293 1.847 1.468 
298 3.058 2.998 
303 5.637 5.261 
   
  Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 90.280 92.519 
∆S‡ / JK-1mol-1 67.490 74.349 
∆G300‡ / kJmol-1 70.033 70.214 
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4,6-nicotine-d2 9, d22-IMes 19 
 
T / K 
kobs/ s-1 
Bound1->Free Bound2->Free 
288 0.991 0.847 
293 1.847 1.468 
298 3.152 3.019 
303 5.604 5.259 
   
  Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 80.716 87.497 
∆S‡ / JK-1mol-1 35.647 57.563 
∆G300‡ / kJmol-1 70.022 70.228 
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7: Appendices 
 
 
7.1 Model 1 EXSY plots and rate constant tables 
 
7.1.1 Model 1 (−)-nicotine 1, IMes 18 
 
 
288 K 
 
Figure 118: ‘Bound 1’ (A+G/2) excitation @ 288 K 
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Figure 119: ‘Bound 2’ (F+G/2) excitation @ 288 K 
 
 Free Bound1 Bound2 
Free -0.354 0.220 0.134 
Bound1 0.894 -1.332 0.438 
Bound2 1.093 0.383 -1.477 
 
Table 7: Model 1 observed rate constants for (−)-nicotine 1, IMes 18 @ 288 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 16.857 
Bound 2 3.932 
Total 20.788 
 
Table 8: sum of least squares for each plot 
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293 K 
 
Figure 120: ‘Bound 1’ (A+G/2) excitation @ 293 K 
 
 
Figure 121: ‘Bound 2’ (F+G/2) excitation @ 293 K 
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 Free Bound1 Bound2 
Free -1.249 0.733 0.516 
Bound1 1.608 -2.698 1.090 
Bound2 2.044 0.760 -2.804 
 
Table 9: Model 1 observed rate constants for (−)-nicotine 1, IMes 18 @ 293 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 17.735 
Bound 2 2.756 
Total 20.490 
 
Table 10: sum of least squares for each plot 
 
298 K 
 
 
Figure 122: ‘Bound 1’ (A+G/2) excitation @ 298 K 
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Figure 123: ‘Bound 2’ (A+G/2) excitation @ 298 K 
 
 Free Bound1 Bound2 
Free -2.270 1.228 1.043 
Bound1 3.362 -5.136 1.775 
Bound2 3.546 1.455 -5.001 
 
Table 11: Model 1 observed rate constants for (−)-nicotine 1, IMes 18 @ 298 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 21.405 
Bound 2 19.876 
Total 41.281 
 
Table 12: sum of least squares for each plot 
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303 K 
 
  
 
Figure 124: ‘Bound 1’ (A+G/2) excitation @ 303 K 
 
 
Figure 125: ‘Bound 2’ (F+G/2) excitation @ 303 K 
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 Free Bound1 Bound2 
Free -4.667 2.616 2.051 
Bound1 5.494 -8.356 2.861 
Bound2 6.673 1.752 -8.424 
 
Table 13: Model 1 observed rate constants for (−)-nicotine 1, IMes 18 @ 303 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 38.871 
Bound 2 46.442 
Total 85.313 
 
 Table 14: sum of least squares for each plot 
 
Eyring plots 
 
 
Figure 126: Eyring plot of Bound 1 for (−)-nicotine 1, IMes 18 
y = -10500x + 30.678
R² = 0.9952
-7
-6
-5
-4
-3
-2
-1
0
0.00325 0.0033 0.00335 0.0034 0.00345 0.0035
ln
(k
/T
)
1/T / K-1
 196 
 
 
Figure 127: Eyring plot of Bound 2 for (−)-nicotine 1, IMes 18 
 
Kinetic parameters 
 
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 86.713 83.972 
∆S‡ / JK-1mol-1 55.483 47.661 
∆G300‡ / kJmol-1 70.066 69.672 
 
Table 15: kinetic parameters for (−)-nicotine 1, IMes 18 
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7.1.2 Model 1 (−)-nicotine 1, d22-IMes 19 
 
288 K 
 
 
Figure 128: ‘Bound 1’ (A+G/2) excitation @ 288 K 
 
 
Figure 129: ‘Bound 2’ (F+G/2) excitation @ 288 K 
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 Free Bound1 Bound2 
Free -0.655 0.499 0.156 
Bound1 0.855 -1.294 0.439 
Bound2 1.065 0.315 -1.380 
 
Table 16: Model 1 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 288 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 8.388 
Bound 2 2.188 
Total 10.576 
 
Table 17: sum of least squares for each plot 
293 K 
 
 
Figure 130: ‘Bound 1’ (A+G/2) excitation @ 293 K 
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Figure 131: ‘Bound 2’ (F+G/2) excitation @ 293 K 
  
 Free Bound1 Bound2 
Free -1.631 0.676 0.956 
Bound1 1.781 -2.473 0.692 
Bound2 1.950 0.817 -2.767 
 
Table 18: Model 1 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 293 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 2.056 
Bound 2 3.004 
Total 5.060 
 
Table 19: sum of least squares for each plot 
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298 K 
  
 
Figure 132: ‘Bound 1’ (A+G/2) excitation @ 298 K 
 
 
Figure 133: ‘Bound 2’ (F+G/2) excitation @ 298 K 
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 Free Bound1 Bound2 
Free -3.249 1.389 1.861 
Bound1 3.524 -4.668 1.144 
Bound2 3.732 1.564 -5.296 
 
Table 20: Model 1 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 298 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 11.895 
Bound 2 13.752 
Total 25.647 
 
Table 21: sum of least squares for each plot 
 
303 K 
  
 
Figure 134: ‘Bound 1’ (A+G/2) excitation @ 303 K 
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Figure 135: ‘Bound 2’ (F+G/2) excitation @ 303 K 
  
 Free Bound1 Bound2 
Free -6.049 2.883 3.167 
Bound1 6.559 -8.558 1.998 
Bound2 5.779 2.541 -8.320 
 
Table 22: Model 1 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 303 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
 
Excitation Sum of least squares 
Bound 1 180.024 
Bound 2 267.283 
Total 447.307 
 
Table 23: sum of least squares for each plot 
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Eyring plots 
 
 
Figure 136: Eyring plot of Bound 1 for (−)-nicotine 1, d22-IMes 19 
 
 
Figure 137: Eyring plot of Bound 2 for (−)-nicotine 1, d22-IMes 19 
 
Kinetic parameters 
 
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 96.191 80.642 
∆S‡ / JK-1mol-1 88.201 36.081 
∆G300‡ / kJmol-1 69.733 69.819 
 
Figure 138: kinetic parameters for (−)-nicotine 1, d22-IMes 19 
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7.1.3 Model 1 4,6-nicotine-d2 9, IMes 18 
 
288 K 
 
 
Figure 139: ‘Bound 1’ (A+G/2) excitation @ 288 K 
 
 
Figure 140: ‘Bound 2’ (F+G/2) excitation @ 288 K 
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 Free Bound1 Bound2 
Free -1.366 0.698 0.668 
Bound1 0.981 -1.190 0.209 
Bound2 0.939 0.152 -1.091 
 
Table 24: Model 1 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 288 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 16.881 
Bound 2 21.742 
Total 38.623 
 
Table 25: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
 
293 K 
 
 
Figure 141: ‘Bound 1’ (A+G/2) excitation @ 293 K 
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Figure 142: ‘Bound 2’ (F+G/2) excitation @ 293 K 
 
 Free Bound1 Bound2 
Free -2.158 0.985 1.173 
Bound1 2.332 -2.658 0.327 
Bound2 1.877 0.539 -2.416 
 
Table 26: Model 1 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 293 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 23.041 
Bound 2 28.383 
Total 51.424 
 
Table 27: sum of least squares for each plot 
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298 K 
 
 
Figure 143: ‘Bound 1’ (A+G/2) excitation @ 298 K 
 
 
Figure 144: ‘Bound 2’ (F+G/2) excitation @ 298 K 
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 Free Bound1 Bound2 
Free -3.892 1.867 2.025 
Bound1 3.612 -4.527 0.915 
Bound2 3.543 1.152 -4.694 
 
Table 28: Model 1 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 298 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 17.252 
Bound 2 13.744 
Total 30.995 
 
Table 29: sum of least squares for each plot 
303 K 
 
 
Figure 145: ‘Bound 1’ (A+G/2) excitation @ 303 K 
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Figure 146: ‘Bound 2’ (F+G/2) excitation @ 303 K 
  
 Free Bound1 Bound2 
Free -7.716 4.505 3.210 
Bound1 5.910 -8.106 2.196 
Bound2 6.015 1.479 -7.495 
 
Table 30: Model 1 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 303 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 25.419 
Bound 2 33.471 
Total 58.890 
 
Table 31: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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Eyring plots 
 
 
Figure 147: Eyring plot of Bound 1 for 4,6-nicotine-d2 9, IMes 18 
 
 
Figure 148: Eyring plot of Bound 2 for 4,6-nicotine-d2 9, IMes 18 
 
Kinetic parameters 
 
  Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 82.227 87.663 
∆S‡ / JK-1mol-1 41.617 59.459 
∆G‡300 / kJmol-1 69.742 69.825 
 
Figure 149: kinetic parameters for 4,6-nicotine-d2 9, IMes 18 
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7.1.4 Model 1 4,6-nicotine-d2 9, d22-IMes 19 
 
288 K 
 
Figure 150: ‘Bound 1’ (A+G/2) excitation @ 288 K 
 
Figure 151: ‘Bound 2’ (F+G/2) excitation @ 288 K 
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 Free Bound1 Bound2 
Free -0.570 0.516 0.054 
Bound1 0.911 -1.193 0.283 
Bound2 0.808 0.179 -0.987 
 
Table 32: Model 1 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 288 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 12.975 
Bound 2 15.029 
Total 28.005 
 
Table 33: sum of least squares for each plot 
293 K 
 
Figure 152: ‘Bound 1’ (A+G/2) excitation @ 293 K 
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Figure 153: ‘Bound 2’ (F+G/2) excitation @ 293 K 
 
 Free Bound1 Bound2 
Free -2.117 1.277 0.840 
Bound1 2.005 -2.439 0.434 
Bound2 1.726 0.454 -2.180 
 
Table 34: Model 1 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 293 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 37.010 
Bound 2 33.872 
Total 70.882 
 
Table 35: sum of least squares for each plot  
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298 K 
 
Figure 154: ‘Bound 1’ (A+G/2) excitation @ 298 K 
 
Figure 155: ‘Bound 2’ (F+G/2) excitation @ 298 K 
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 Free Bound1 Bound2 
Free -4.714 1.994 2.721 
Bound1 3.446 -4.047 0.601 
Bound2 3.554 1.192 -4.746 
 
Table 36: Model 1 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 298 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 44.441 
Bound 2 45.773 
Total 90.214 
 
Table 37: sum of least squares for each plot 
 
303 K 
 
Figure 156: ‘Bound 1’ (A+G/2) excitation @ 303 K 
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Figure 157: ‘Bound 2’ (F+G/2) excitation @ 303 K 
 
kY   Y=XY Free Bound1 Bound2 
Free -6.972 3.935 3.037 
Bound1 6.105 -7.549 1.445 
Bound2 5.771 1.417 -7.188 
 
Table 38: Model 1 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 303 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
Bound 1 42.067 
Bound 2 71.859 
Total 113.926 
 
Table 39: sum of least squares for each plot 
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Eyring plots 
 
 
Figure 158: Eyring plot of Bound 1 for 4,6-nicotine-d2 9, d22-IMes 19 
 
 
Figure 159: Eyring plot of Bound 2 for 4,6-nicotine-d2 9, d22-IMes 19 
 
Kinetic parameters 
 
  Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 90.515 89.592 
∆S‡ / JK-1mol-1 69.236 65.303 
∆G300‡ / kJmol-1 69.744 70.001 
 
Figure 160: kinetic parameters for 4,6-nicotine-d2 9, d22-IMes 19 
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7.2 Model 4 EXSY plots and rate constant tables 
 
7.2.1 Model 4 (−)-nicotine 1, IMes 18 
 
288 K 
 
Figure 161: ‘Bound 1’ (A+G/2) excitation @ 288 K 
 
  
Figure 162: ‘Bound 2’ (F+G/2) excitation @ 288 K 
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Figure 163: ‘Free’ (E) excitation @ 288 K 
 
-3.876 0.897 1.041 1.041 0.897 0 0 0 A 
4.699 -12.864 0 0 0 5.083 0 3.082 B 
5.083 0 -12.864 0 0 4.699 3.082 0 C 
5.083 0 0 -12.864 0 4.699 0 3.082 D 
4.699 0 0 0 -12.864 5.083 3.082 0 E 
0 1.041 0.897 0.897 1.041 -3.876 0 0 F 
0 0 11.026 0 11.026 0 -22.053 0 G 
0 11.026 0 11.026 0 0 0 -22.053 H 
A B C D E F G H  
 
Table 40: Model 4 observed rate constants for (−)-nicotine 1, IMes 18 @ 288 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
 Excitation Sum of least squares   Relax Bound Relax Free Relax Inter. 
Bound 1 
0.233 
 1.021 10.000 1.021 
Bound 2 
0.399 
    
Free 
1.667 
    
Total 
2.299 
    
 
Table 41: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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293 K 
 
Figure 164: ‘Bound 1’ (A+G/2) excitation @ 293 K 
 
Figure 165: ‘Bound 2’ (F+G/2) excitation @ 293 K 
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Figure 166: ‘Free’ (E) excitation @ 293 K 
 
-6.253 1.460 1.666 1.666 1.460 0 0 0 A 
7.968 -18.972 0 0 0 7.934 0 3.070 B 
7.934 0 -18.972 0 0 7.968 3.070 0 C 
7.934 0 0 -18.972 0 7.968 0 3.070 D 
7.968 0 0 0 -18.972 7.934 3.070 0 E 
0 1.666 1.460 1.460 1.666 -6.253 0 0 F 
0 0 15.646 0 15.646 0 -31.291 0 G 
0 15.646 0 15.646 0 0 0 -31.291 H 
A B C D E F G H  
 
Table 42: Model 4 observed rate constants for (−)-nicotine 1, IMes 18 @ 293 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.380  1.155 10.000 1.155 
Bound 2 0.067     
Free 2.918     
Total 3.365     
 
Table 43: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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298 K 
 
  
Figure 167: ‘Bound 1’ (A+G/2) excitation @ 298 K 
  
Figure 168: ‘Bound 2’ (A+G/2) excitation @ 298 K 
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Figure 169: ‘Free’ (E) excitation @ 298 K 
 
-12.547 3.092 3.182 3.182 3.092 0 0 0 A 
24.844 -52.084 0 0 0 24.169 0 3.071 B 
24.169 0 -52.084 0 0 24.844 3.071 0 C 
24.169 0 0 -52.084 0 24.844 0 3.071 D 
24.844 0 0 0 -52.084 24.169 3.071 0 E 
0 3.182 3.092 3.092 3.182 -12.547 0 0 F 
0 0 45.548 0 45.548 0 -91.097 0 G 
0 45.548 0 45.548 0 0 0 -91.097 H 
A B C D E F G H  
 
 
Table 44: Model 4 observed rate constants for (−)-nicotine 1, IMes 18 @ 298 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
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Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.208  0.984 10.000 0.984 
Bound 2 0.245     
Free 1.960     
Total 2.413     
 
Table 45: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
303 K 
 
  
Figure 170: ‘Bound 1’ (A+G/2) excitation @ 303 K 
  
Figure 171: ‘Bound 2’ (F+G/2) excitation @ 303 K 
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Figure 172: ‘Free’ (E) excitation @ 303 K 
 
-21.850 5.303 5.622 5.622 5.303 0 0 0 A 
27.634 -55.320 0 0 0 24.612 0 3.075 B 
24.612 0 -55.320 0 0 27.634 3.075 0 C 
24.612 0 0 -55.320 0 27.634 0 3.075 D 
27.634 0 0 0 -55.320 24.612 3.075 0 E 
0 5.622 5.303 5.303 5.622 -21.850 0 0 F 
0 0 43.552 0 43.552 0 -87.105 0 G 
0 43.552 0 43.552 0 0 0 -87.105 H 
A B C D E F G H  
 
Table 46: Model 4 observed rate constants for (−)-nicotine 1, IMes 18 @ 303 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
 
 
 
 
 
 
 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
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Bound 1 1.044  1.151 12.000 1.151 
Bound 2 1.220     
Free 1.537     
Total 3.801     
 
 Table 47: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
 
Eyring plots 
 
 
Figure 173: Eyring plot of Bound 1 for (−)-nicotine 1, IMes 18 
 
Figure 174: Eyring plot of Bound 2 for (−)-nicotine 1, IMes 18 
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Kinetic parameters 
 
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 90.947 86.330 
∆S‡ / JK-1mol-1 69.169 54.870 
∆G300‡ / kJmol-1 70.196 69.869 
 
Table 48: kinetic parameters for (−)-nicotine 1, IMes 18 
 
7.2.2 Model 4 (−)-nicotine 1, d22-IMes 19 
 
288 K 
 
Figure 175: ‘Bound 1’ (A+G/2) excitation @ 288 K 
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Figure 176: ‘Bound 2’ (F+G/2) excitation @ 288 K 
 
Figure 177: ‘Free’ (E) excitation @ 288 K 
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-3.556 0.778 1.000 1.000 0.778 0 0 0 A 
6.008 -15.658 0 0 0 6.574 0 3.075 B 
6.574 0 -15.658 0 0 6.008 3.075 0 C 
6.574 0 0 -15.658 0 6.008 0 3.075 D 
6.008 0 0 0 -15.658 6.574 3.075 0 E 
0 1.000 0.778 0.778 1.000 -3.556 0 0 F 
0 0 13.880 0 13.880 0 -27.759 0 G 
0 13.880 0 13.880 0 0 0 -27.759 H 
A B C D E F G H  
 
Table 49: Model 4 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 288 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares 
 
 Relax Bound Relax Free Relax Inter. 
Bound 1 0.258 
 
 7.389 10.628 7.389 
Bound 2 0.173 
 
    
Free 0.647 
 
    
Total 1.077 
 
    
 
Table 50: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
293 K 
 
Figure 178: ‘Bound 1’ (A+G/2) excitation @ 293 K 
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Figure 179: ‘Bound 2’ (F+G/2) excitation @ 293 K 
  
Figure 180: ‘Free’ (E) excitation @ 293 K 
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-6.297 1.502 1.647 1.647 1.502 0 0 0 A 
5.727 -15.062 0 0 0 6.260 0 3.075 B 
6.260 0 -15.062 0 0 5.727 3.075 0 C 
6.260 0 0 -15.062 0 5.727 0 3.075 D 
5.727 0 0 0 -15.062 6.260 3.075 0 E 
0 1.647 1.502 1.502 1.647 -6.297 0 0 F 
0 0 11.914 0 11.914 0 -23.827 0 G 
0 11.914 0 11.914 0 0 0 -23.827 H 
A B C D E F G H  
 
Table 51: Model 4 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 293 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.732  2.030 20.000 2.030 
Bound 2 0.826     
Free 1.504     
Total 3.061     
 
Table 52: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
298 K 
  
Figure 181: ‘Bound 1’ (A+G/2) excitation @ 298 K 
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Figure 182: ‘Bound 2’ (F+G/2) excitation @ 298 K 
  
Figure 183: ‘Free’ (E) excitation @ 298 K 
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-12.232 3.011 3.105 3.105 3.011 0 0 0 A 
21.534 -44.807 0 0 0 20.185 0 3.088 B 
20.185 0 -44.807 0 0 21.534 3.088 0 C 
20.185 0 0 -44.807 0 21.534 0 3.088 D 
21.534 0 0 0 -44.807 20.185 3.088 0 E 
0 3.105 3.011 3.011 3.105 -12.232 0 0 F 
0 0 38.429 0 38.429 0 -76.858 0 G 
0 38.429 0 38.429 0 0 0 -76.858 H 
A B C D E F G H  
 
Table 53: Model 4 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 298 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.336  0.813 20.000 0.813 
Bound 2 0.408     
Free 0.723     
Total 1.467     
 
Table 54: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
303 K 
  
Figure 184: ‘Bound 1’ (A+G/2) excitation @ 303 K 
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Figure 185: ‘Bound 2’ (F+G/2) excitation @ 303 K 
  
Figure 186: ‘Free’ (E) excitation @ 303 K 
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-22.497 5.710 5.538 5.538 5.710 0 0 0 A 
327.13 -64.622 0 0 0 28.818 0 3.091 B 
28.818 0 -64.622 0 0 32.713 3.091 0 C 
28.818 0 0 -64.622 0 32.713 0 3.091 D 
32.713 0 0 0 -64.622 28.818 3.091 0 E 
0 5.538 5.710 5.710 5.538 -22.497 0 0 F 
0 0 53.284 0 53.284 0 -106.568 0 G 
0 53.284 0 53.284 0 0 0 -106.568 H 
A B C D E F G H  
 
Table 55: Model 4 observed rate constants for (−)-nicotine 1, d22-IMes 19 @ 303 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 1.195  1.269 20.000 1.269 
Bound 2 1.571     
Free 1.677     
Total 4.444     
 
Table 56: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
 
Eyring plots 
 
 
Figure 187: Eyring plot of Bound 1 for (−)-nicotine 1, d22-IMes 19 
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Figure 188: Eyring plot of Bound 2 for (−)-nicotine 1, d22-IMes 19 
 
Kinetic parameters 
 
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 94.460 82.480 
∆S‡ / JK-1mol-1 80.917 41.351 
∆G300‡ / kJmol-1 70.185 70.075 
 
Figure 189: kinetic parameters for (−)-nicotine 1, d22-IMes 19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.2.3 Model 4 4,6-nicotine-d2 9, IMes 18 
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288 K 
  
Figure 190: ‘Bound 1’ (A+G/2) excitation @ 288 K 
  
Figure 191: ‘Bound 2’ (F+G/2) excitation @ 288 K 
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Figure 192: ‘Free’ (E) excitation @ 288 K 
 
-3.098 0.790 0.759 0.759 0.790 0 0 0 A 
9.782 -21.385 0 0 0 8.528 0 3.075 B 
8.528 0 -21.385 0 0 9.782 3.075 0 C 
8.528 0 0 -21.385 0 9.782 0 3.075 D 
9.782 0 0 0 -21.385 8.528 3.075 0 E 
0 0.759 0.790 0.790 0.759 -3.098 0 0 F 
0 0 19.836 0 19.836 0 -39.671 0 G 
0 19.836 0 19.836 0 0 0 -39.671 H 
A B C D E F G H  
 
Table 57: Model 4 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 288 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.243  25.156 41.501 25.156 
Bound 2 0.236     
Free 0.394     
Total 0.874     
 
Table 58: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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293 K 
  
Figure 193: ‘Bound 1’ (A+G/2) excitation @ 293 K 
  
Figure 194: ‘Bound 2’ (F+G/2) excitation @ 293 K 
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Figure 195: ‘Free’ (E) excitation @ 293 K 
 
-6.630 1.847 1.468 1.468 1.847 0 0 0 A 
8.589 -19.066 0 0 0 7.402 0 3.075 B 
7.402 0 -19.066 0 0 8.589 3.075 0 C 
7.402 0 0 -19.066 0 8.589 0 3.075 D 
8.589 0 0 0 -19.066 7.402 3.075 0 E 
0 1.468 1.847 1.847 1.468 -6.630 0 0 F 
0 0 15.751 0 15.751 0 -31.502 0 G 
0 15.751 0 15.751 0 0 0 -31.502 H 
A B C D E F G H  
 
Table 59: Model 4 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 293 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.478  22.000 41.000 22.000 
Bound 2 0.375     
Free 0.915     
Total 1.768     
 
Table 60: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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298 K 
  
Figure 196: ‘Bound 1’ (A+G/2) excitation @ 298 K 
  
Figure 197: ‘Bound 2’ (F+G/2) excitation @ 298 K 
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Figure 198: ‘Free’ (E) excitation @ 298 K 
 
-11.712 3.058 2.998 2.998 3.058 0 0 0 A 
23.950 -50.273 0 0 0 23.249 0 3.075 B 
23.249 0 -50.273 0 0 23.950 3.075 0 C 
23.249 0 0 -50.273 0 23.950 0 3.075 D 
23.950 0 0 0 -50.273 23.249 3.075 0 E 
0 2.998 3.058 3.058 2.998 -11.712 0 0 F 
0 0 44.417 0 44.417 0 -88.835 0 G 
0 44.417 0 44.417 0 0 0 -88.835 H 
A B C D E F G H  
 
Table 61: Model 4 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 298 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.315  22.000 40.600 22.000 
Bound 2 0.250     
Free 1.095     
Total 1.661     
 
Table 62: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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303 K 
  
Figure 199: ‘Bound 1’ (A+G/2) excitation @ 303 K 
  
Figure 200: ‘Bound 2’ (F+G/2) excitation @ 303 K 
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Figure 201: ‘Free’ (E) excitation @ 303 K 
 
-21.797 5.637 5.261 5.261 5.637 0 0 0 A 
231.688 -437.563 0 0 0 202.722 0 3.153 B 
202.722 0 -437.563 0 0 231.688 3.153 0 C 
202.722 0 0 -437.563 0 231.688 0 3.153 D 
231.688 0 0 0 -437.563 202.722 3.153 0 E 
0 5.261 5.637 5.637 5.261 -21.797 0 0 F 
0 0 426.665 0 426.665 0 -853.330 0 G 
0 426.665 0 426.665 0 0 0 -853.330 H 
A B C D E F G H  
 
Table 63: Model 4 observed rate constants for 4,6-nicotine-d2 9, IMes 18 @ 303 K. Rate constants are 
read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 1.231  10.7 15.0 10.7 
Bound 2 0.490     
Free 1.577     
Total 3.298     
 
Table 64: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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Eyring plots 
 
 
Figure 202: Eyring plot of Bound 1 for 4,6-nicotine-d2 9, IMes 18 
 
 
Figure 203: Eyring plot of Bound 2 for 4,6-nicotine-d2 9, IMes 18 
 
Kinetic parameters 
 
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 90.280 92.519 
∆S‡ / JK-1mol-1 67.490 74.349 
∆G‡300 / kJmol-1 70.033 70.214 
 
Figure 204: kinetic parameters for 4,6-nicotine-d2 9, IMes 18 
y = -10859x + 31.877
R² = 0.9898
-7
-6
-5
-4
-3
-2
-1
0
0.00325 0.0033 0.00335 0.0034 0.00345 0.0035
ln
(k
/T
)
1/T / K-1
y = -11128x + 32.702
R² = 0.9987
-7
-6
-5
-4
-3
-2
-1
0
0.00325 0.0033 0.00335 0.0034 0.00345 0.0035
ln
(k
/T
)
1/T / K-1
 246 
 
7.2.4 Model 4 4,6-nicotine-d2 9, d22-IMes 19 
 
288 K 
 
Figure 205: ‘Bound 1’ (A+G/2) excitation @ 288 K 
 
Figure 206: ‘Bound 2’ (F+G/2) excitation @ 288 K 
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Figure 207: ‘Free’ (E) excitation @ 288 K 
 
-3.676 0.991 0.847 0.847 0.991 0 0 0 A 
9.789 -20.931 0 0 0 8.089 0 3.053 B 
8.089 0 -20.931 0 0 9.789 3.053 0 C 
8.089 0 0 -20.931 0 9.789 0 3.053 D 
9.789 0 0 0 -20.931 8.089 3.053 0 E 
0 0.847 0.991 0.991 0.847 -3.676 0 0 F 
0 0 19.093 0 19.093 0 -38.187 0 G 
0 19.093 0 19.093 0 0 0 -38.187 H 
A B C D E F G H  
 
Table 65: Model 4 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 288 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.632  30.0 41.5 30.0 
Bound 2 0.587     
Free 2.471     
Total 3.690     
 
Table 66: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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293 K 
 
Figure 208: ‘Bound 1’ (A+G/2) excitation @ 293 K 
 
Figure 209: ‘Bound 2’ (F+G/2) excitation @ 293 K 
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Figure 210: ‘Free’ (E) excitation @ 293 K 
 
-6.630 1.847 1.468 1.468 1.847 0 0 0 A 
8.589 -19.066 0 0 0 7.402 0 3.075 B 
7.402 0 -19.066 0 0 8.589 3.075 0 C 
7.402 0 0 -19.066 0 8.589 0 3.075 D 
8.589 0 0 0 -19.066 7.402 3.075 0 E 
0 1.468 1.847 1.847 1.468 -6.630 0 0 F 
0 0 15.751 0 15.751 0 -31.502 0 G 
0 15.751 0 15.751 0 0 0 -31.502 H 
A B C D E F G H  
 
Table 67: Model 4 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 293 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.47826  22 41 22 
Bound 2 0.37528     
Free 0.91485     
Total 1.76839     
 
Table 68: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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298 K 
 
Figure 211: ‘Bound 1’ (A+G/2) excitation @ 298 K 
 
Figure 212: ‘Bound 2’ (F+G/2) excitation @ 298 K 
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Figure 213: ‘Free’ (E) excitation @ 298 K 
 
-12.422 3.152 3.019 3.019 3.152 0 0 0 A 
26.727 -51.062 0 0 0 21.257 0 3.079 B 
21.257 0 -51.062 0 0 26.727 3.079 0 C 
21.257 0 0 -51.062 0 26.727 0 3.079 D 
26.727 0 0 0 -51.062 21.257 3.079 0 E 
0 3.019 3.152 3.152 3.019 -12.422 0 0 F 
0 0 44.851 0 44.851 0 -89.702 0 G 
0 44.851 0 44.851 0 0 0 -89.702 H 
A B C D E F G H  
 
Table 69: Model 4 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 298 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 0.704  32.0 40.6 32.0 
Bound 2 0.482     
Free 3.405     
Total 4.591     
 
Table 70: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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303 K 
 
Figure 214: ‘Bound 1’ (A+G/2) excitation @ 303 K 
 
Figure 215: ‘Bound 2’ (F+G/2) excitation @ 303 K 
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Figure 216: ‘Free’ (E) excitation @ 303 K 
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5.259 -21.726 0 0 F 
0 0 427.359 0 
 
427.359 0 
-
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0 G 
0 427.359 0 427.359 
 
0 0 0 
-
854.718 H 
A B C D  E F G H  
 
Table 71: Model 4 observed rate constants for 4,6-nicotine-d2 9, d22-IMes 19 @ 303 K. Rate constants 
are read as kXY, i.e. kAB is row A, column B 
Excitation Sum of least squares  Relax Bound Relax Free Relax Inter. 
Bound 1 1.48835  30 20 30 
Bound 2 0.67089     
Free 1.70689     
Total 3.86613     
 
Table 72: sum of least squares for each plot and the modelled T1 relaxation parameters (in seconds) 
used 
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Eyring plots 
 
 
Figure 217: Eyring plot of Bound 1 for 4,6-nicotine-d2 9, d22-IMes 19 
 
 
Figure 218: Eyring plot of Bound 2 for 4,6-nicotine-d2 9, d22-IMes 19 
 
Kinetic parameters 
 Bound 1 -> Free Bound 2 -> Free 
∆H‡ / kJmol-1 80.716 87.497 
∆S‡ / JK-1mol-1 35.647 57.563 
∆G300‡ / kJmol-1 70.022 70.228 
 
Figure 219: kinetic parameters for 4,6-nicotine-d2 9, d22-IMes 19 
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7.3 EXSY Eyring error estimates 
 
7.3.1 Model 1 errors 
 
T
 /
 K
 
kobs/ s-1   
(-)-nicotine, 
IMes 
(-)-nicotine, d22-
IMes 
4,6-nicotine-d2, 
IMes 
4,6-nicotine-d2, d22-
IMes   
B
o
u
n
d
1
 
B
o
u
n
d
2
 
B
o
u
n
d
1
 
B
o
u
n
d
2
 
B
o
u
n
d
1
 
B
o
u
n
d
2
 
B
o
u
n
d
1
 
B
o
u
n
d
2
 
A
v
g
. 
S
. 
D
ev
 
288 0.894 1.093 0.855 1.065 0.981 0.939 0.911 0.808 0.943 0.099 
293 1.608 2.044 1.781 1.950 2.332 1.877 2.005 1.726 1.915 0.223 
298 3.362 3.546 3.524 3.912 3.612 3.543 3.446 3.554 3.562 0.161 
303 5.594 6.673 6.559 5.779 5.910 6.015 6.105 5.771 6.051 0.384 
∆H‡  86.710 83.970 96.193 80.643 82.227 87.663 90.515 89.592 87.189 5.017 
∆S‡ 55.480 47.660 88.200 36.080 41.617 59.459 69.236 65.303 57.879 16.715 
∆G300‡  70.034 69.672 69.733 69.819 69.742 69.825 69.744 70.001 69.821 0.131 
 
Table 73: Model 1 EXSY data combined, with standard deviation errors. ∆H‡ is in kJmol-1, ∆S‡ is in 
JK-1mol-1 and ∆G300‡ is in kJmol-1 
 
7.3.2 Model 4 errors 
 
T
 /
 K
 
kobs/ s
-1   
(-)-nicotine, 
IMes 
(-)-nicotine, d22-
IMes 
4,6-nicotine-d2, 
IMes 
4,6-nicotine-d2, 
d22-IMes   
B
o
u
n
d
1
 
B
o
u
n
d
2
 
B
o
u
n
d
1
 
B
o
u
n
d
2
 
B
o
u
n
d
1
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o
u
n
d
2
 
B
o
u
n
d
1
 
B
o
u
n
d
2
 
A
v
g
. 
S
. 
D
ev
 
288 0.797 
1.040 0.778 1.000 0.790 0.759 0.991 0.847 0.875 0.115 
293 
1.460 1.666 1.502 1.647 1.847 1.468 1.847 1.468 1.613 0.165 
298 
3.092 3.181 3.026 3.105 3.058 2.998 3.152 3.019 3.079 0.065 
303 
5.303 6.465 5.959 5.480 5.637 5.261 5.604 5.259 5.621 0.415 
∆H‡  
90.947 86.330 94.460 82.480 90.280 92.519 80.716 87.497 88.154 4.817 
∆S‡ 
69.169 54.870 80.917 41.351 74.660 74.349 35.647 57.563 61.066 16.503 
∆G300‡  
70.196 69.869 70.185 70.075 70.033 70.214 70.022 70.228 70.103 0.126 
 
Table 74: Model 4 EXSY data combined, with standard deviation errors. ∆H‡ is in kJmol-1, ∆S‡ is in 
JK-1mol-1 and ∆G300‡ is in kJmol-1 
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7.3.3 Comparison 
 
T / K 
Avg dissociation rate / s
-1
  
Model 1 S. dev. Model 4 S. dev. % change 
288 0.943 0.099 0.875 0.115 -7.79% 
293 1.915 0.223 1.613 0.165 -18.74% 
298 3.562 0.161 3.079 0.065 -15.70% 
303 6.051 0.384 5.621 0.415 -7.65% 
      
Average ∆H‡ / kJmol-1   
Model 1 S. dev. Model 4 S. dev. % change  
87.189 5.017 88.154 4.817 1.09%  
      
Average ∆S‡ / JK-1mol-1   
Model 1 S. dev. Model 4 S. dev. % change  
57.879 16.715 61.066 16.503 5.22%  
      
Average ∆G300
‡
 / kJmol
-1
   
Model 1 S. dev. Model 4 S. dev. % change  
69.821 0.131 70.103 0.126 0.40%  
 
Table 75: comparison of data from Models 1 and 4, with errors 
 
7.4 SABRE error estimates 
 
7.4.1 Varied substrate concentration 
 
(−)-nicotine 1, IMes 18 
 
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 301.113 370.758 338.895 74.331 
2 279.931 342.551 304.695 35.087 
3 327.298 299.124 316.039 18.041 
Mean 302.781 337.478 319.876 42.486 
SD 23.728 36.086 17.420 28.865 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 13.699 20.834 10.058 16.665 
Standard error as % of mean 4.524 6.173 3.144 39.225 
 
Table 76: ‘shake and drop’ errors for 4 equivalents (−)-nicotine 1 with IMes 18, shaken in stray field. 
Lab book reference no. WHD/A/7/7 A 
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Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 238.726 311.437 208.035 36.954 
2 251.515 328.240 236.929 109.909 
3 221.026 321.634 199.330 3.176 
Mean 237.089 320.437 214.765 50.013 
SD 15.311 8.465 19.682 54.552 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 8.840 4.888 11.363 31.495 
Standard error as % of mean 3.728 1.525 5.291 62.975 
 
Table 77: ‘shake and drop’ errors for 5 equivalents (−)-nicotine 1 with IMes 18, shaken in stray field. 
Lab book reference no. WHD/A/1/1 A 
 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 222.279 252.861 224.533 74.207 
2 273.112 292.850 266.680 75.249 
3 216.842 222.722 206.652 61.065 
Mean 237.411 256.145 232.622 70.174 
SD 31.037 35.179 30.820 7.906 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 17.919 20.311 17.794 4.564 
Standard error as % of mean 7.548 7.929 7.649 6.504 
 
Table 78: ‘shake and drop’ errors for 6 equivalents (−)-nicotine 1 with IMes 18, shaken in stray field. 
Lab book reference no. WHD/A/7/7 B 
 
 
 
 
 
 
 
 
 
 
 
 258 
 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 214.285 234.144 195.974 91.750 
2 221.078 243.101 207.362 104.656 
3 215.793 234.979 196.629 88.178 
Mean 217.052 237.408 199.988 94.861 
SD 3.567 4.948 6.394 8.668 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 2.060 2.857 3.692 5.005 
Standard error as % of mean 0.949 1.203 1.846 5.276 
 
Table 79: ‘shake and drop’ errors for 10 equivalents (−)-nicotine 1 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/7/7 D 
 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 177.115 190.163 158.731 71.952 
2 177.483 188.775 157.969 72.341 
3 142.408 156.233 125.658 52.609 
Mean 165.669 178.390 147.453 65.634 
SD 20.145 19.202 18.879 11.282 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 11.631 11.086 10.900 6.514 
Standard error as % of mean 7.021 6.214 7.392 9.924 
 
Table 80: ‘shake and drop’ errors for 15 equivalents (−)-nicotine 1 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/7/7 E 
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(−)-nicotine 1, d22-IMes 19 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 361.592 435.371 370.286 6.395 
2 364.573 419.076 352.768 21.373 
       
Mean 363.082 427.224 361.527 13.884 
SD 2.107 11.523 12.387 10.591 
No. of data points (n) 2 2 2 2 
Root n 1.41421 1.41421 1.41421 1.41421 
Standard error 1.4901 8.1477 8.75915 7.489 
Standard error as % of mean 0.4104 1.90713 2.42282 53.9398 
 
Table 81: ‘shake and drop’ errors for 4 equivalents (−)-nicotine 1 with d22-IMes 19, shaken in stray 
field. Lab book reference no. WHD/A/12/12 A2 
 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 453.596 452.449 349.426 24.430 
2 440.185 430.167 324.032 23.686 
       
Mean 446.890 441.308 336.729 24.058 
SD 9.483 15.756 17.956 0.526 
No. of data points (n) 2 2 2 2 
Root n 1.414 1.414 1.414 1.414 
Standard error 6.705 11.141 12.697 0.372 
Standard error as % of mean 1.500 2.525 3.771 1.545 
 
Table 82: ‘shake and drop’ errors for 6 equivalents (−)-nicotine 1 with d22-IMes 19, shaken in stray 
field.  Lab book reference no. WHD/A/12/12 B2 
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Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 331.926 383.994 269.026 68.011 
2 325.827 363.146 265.861 22.398 
3 316.746 372.855 269.282 47.477 
Mean 324.833 373.332 268.056 45.962 
SD 7.638 10.432 1.906 22.844 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 4.410 6.023 1.100 13.189 
Standard error as % of mean 1.358 1.613 0.410 28.696 
 
Table 83: ‘shake and drop’ errors for 8 equivalents (−)-nicotine 1 with d22-IMes 19, shaken in stray 
field.  Lab book reference no. WHD/A/12/12 C2 
 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 240.780 257.477 165.317 58.529 
2 225.413 245.378 163.441 40.854 
3 207.414 234.526 151.423 48.399 
Mean 224.536 245.793 160.060 49.261 
SD 16.700 11.481 7.539 8.869 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 9.642 6.629 4.352 5.121 
Standard error as % of mean 4.294 2.697 2.719 10.395 
 
Table 84: ‘shake and drop’ errors for 10 equivalents (−)-nicotine 1 with d22-IMes 19, shaken in stray 
field. Lab book reference no. WHD/A/12/12 D2 
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2-proton 6-proton 4-proton 5-proton 
1 144.386 119.847 88.779 12.693 
2 155.132 123.528 83.687 28.231 
3 146.706 113.517 82.284 33.669 
Mean 148.741 118.964 84.916 24.864 
SD 5.654 5.063 3.418 10.886 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 3.265 2.923 1.973 6.285 
Standard error as % of mean 2.195 2.457 2.324 25.277 
 
Table 85: ‘shake and drop’ errors for 15 equivalents (−)-nicotine 1 with d22-IMes 19, shaken in stray 
field.  Lab book reference no. WHD/A/12/12 E2 
 
 
4,6-nicotine-d2 9, IMes 18 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 773.628 929.595 
2 762.009 967.118 
3 742.312 943.710 
Mean 759.316 946.808 
SD 15.831 18.952 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 9.140 10.942 
Standard error as % of mean 1.204 1.156 
 
Table 86: ‘shake and drop’ errors for 4 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/9/9 A 
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Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 468.113 974.633 
2 490.522 1021.289 
3 497.003 1034.782 
Mean 485.213 1010.235 
SD 30.259 23.578 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 17.470 13.613 
Standard error as % of mean 3.601 1.347 
 
Table 87: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/1/1 E 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 666.062 737.943 
2 606.188 692.801 
3 643.759 703.563 
Mean 638.670 711.436 
SD 30.259 23.578 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 17.470 13.613 
Standard error as % of mean 2.735 1.913 
 
Table 88: ‘shake and drop’ errors for 6 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/9/9 B 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 288.735 334.530 
2 249.941 281.919 
3 243.303 274.231 
Mean 260.659 296.893 
SD 24.539 32.820 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 14.168 18.949 
Standard error as % of mean 5.435 6.382 
 
Table 89: ‘shake and drop’ errors for 10 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/9/9 D 
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Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 195.296 219.779 
2 212.347 241.908 
      
Mean 203.822 230.843 
SD 12.056 15.647 
No. of data points (n) 2 2 
Root n 1.414 1.414 
Standard error 8.525 11.064 
Standard error as % of mean 4.183 4.793 
 
Table 90: ‘shake and drop’ errors for 15 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/9/9 E 
 
4,6-nicotine-d2 9, d22-IMes 19 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 824.355 1137.279 
2 703.320 1035.748 
3 754.069 1103.929 
Mean 760.581 1092.319 
SD 60.780 51.752 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 35.091 29.879 
Standard error as % of mean 4.614 2.735 
 
Table 91: ‘shake and drop’ errors for 4 equivalents 4,6-nicotine-d2 9 with d22-IMes 19, shaken in stray 
field. Lab book reference no. WHD/A/10/10 A2 
 
 
 
 
 
 
 
 
 
 264 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 811.081 1142.324 
2 711.883 1049.495 
3 856.175 1087.511 
Mean 793.046 1093.110 
SD 73.817 46.667 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 42.618 26.943 
Standard error as % of mean 5.374 2.465 
 
Table 92: ‘shake and drop’ errors for 6 equivalents 4,6-nicotine-d2 9 with d22-IMes 19, shaken in stray 
field. Lab book reference no. WHD/A/10/10 B2 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 580.199 732.476 
2 652.263 728.973 
     
Mean 616.231 730.724 
SD 50.957 2.477 
No. of data points (n) 2 2 
Root n 1.414 1.414 
Standard error 36.032 1.752 
Standard error as % of mean 5.847 0.240 
 
Table 93: ‘shake and drop’ errors for 8 equivalents 4,6-nicotine-d2 9 with d22-IMes 19, shaken in stray 
field. Lab book reference no. WHD/A/10/10 C2 
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Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 434.221 525.580 
2 418.039 486.906 
3 438.101 484.545 
Mean 430.120 499.010 
SD 10.641 23.040 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 6.143 13.302 
Standard error as % of mean 1.428 2.666 
 
Table 94: ‘shake and drop’ errors for 10 equivalents 4,6-nicotine-d2 9 with d22-IMes 19, shaken in 
stray field. Lab book reference no. WHD/A/10/10 D2 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 289.830 323.748 
2 260.698 289.764 
3 276.598 298.271 
4 273.938 305.409 
Mean 367.022 405.731 
SD 14.587 17.684 
No. of data points (n) 4 4 
Root n 2 2 
Standard error 7.293 8.842 
Standard error as % of mean 1.987 2.179 
 
Table 95: ‘shake and drop’ errors for 15 equivalents 4,6-nicotine-d2 9 with d22-IMes 19, shaken in 
stray field. Lab book reference no. WHD/A/10/10 E2 
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7.4.2 Substrate screen 
 
6-nicotine-d1 4, IMes 18 
  
Signal enhancement (relative to thermal) 
2-proton 4-proton 5-proton 
1 427.121 391.142 35.307 
2 416.886 362.634 10.286 
3 399.986 328.694 40.016 
Mean 414.664 360.823 28.536 
SD 13.703 31.263 15.980 
No. of data points (n) 3 3 3 
Root n 1.732 1.732 1.732 
Standard error 7.912 18.050 9.226 
Standard error as % of mean 1.908 5.002 32.330 
 
Table 96: ‘shake and drop’ errors for 5 equivalents 6-nicotine-d1 4 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/1/1 C 
 
5,6-nicotine-d2 8, IMes 18 
  
Signal enhancement (relative to thermal) 
2-proton 4-proton 
1 294.465 283.890 
2 239.337 230.198 
3 232.696 218.726 
Mean 255.499 244.271 
SD 33.908 34.787 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 19.577 20.084 
Standard error as % of mean 7.662 8.222 
 
Table 97: ‘shake and drop’ errors for 5 equivalents 5,6-nicotine-d2 8 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/1/1 D 
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2,6-nicotine-d2 10, IMes 18 
  
Signal enhancement (relative to thermal) 
4-proton 5-proton 
1 336.907 232.446 
2 296.303 179.767 
3 329.884 189.382 
Mean 321.031 200.531 
SD 21.701 28.054 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 12.529 16.197 
Standard error as % of mean 3.903 8.077 
 
Table 98: ‘shake and drop’ errors for 5 equivalents 2,6-nicotine-d2 10 with IMes 18, shaken in stray 
field. Lab book reference no. WHD/A/13/13 A 
 
 
7.4.3 Alternative catalysts 
 
4,6-nicotine-d2 9, ItBu 20 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 386.105 413.923 
2 381.214 409.448 
3 384.631 403.148 
Mean 383.983 408.840 
SD 2.509 5.413 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 1.449 3.125 
Standard error as % of mean 0.377 0.764 
 
Table 99: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 9 with ItBu 20, shaken in stray 
field. Lab book reference no. WHD/A/21/21 B 
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4,6-nicotine-d2 9, ICl 21 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 344.935 292.583 
2 337.111 292.529 
3 349.760 305.998 
Mean 343.935 297.037 
SD 6.384 7.761 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 3.686 4.481 
Standard error as % of mean 1.072 1.509 
 
Table 100: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 9 with ICl 21, shaken in stray 
field. Lab book reference no. WHD/A/21/21 B 
 
 
7.4.4 Mixing studies 
 
 (−)-nicotine 1, IMes 18 with magnetic shaker 
 
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 577.607 679.631 636.477 324.541 
2 676.202 611.555 667.711 278.195 
3 657.226 496.057 622.287 264.482 
Mean 637.012 595.747 642.158 289.073 
SD 52.313 92.802 23.239 31.472 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 30.203 53.579 13.417 18.171 
Standard error as % of mean 4.741 8.994 2.089 6.286 
 
Table 101: ‘shake and drop’ errors for 5 equivalents 6-nicotine-d1 4 with IMes 18, shaken in a 60 G 
magnetic shaker assembly. Lab book reference no. WHD/A/28/28 A 
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4,6-nicotine-d2 9, d22-IMes 19 
 
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 1492.728 2760.423 
2 1764.185 2947.070 
3 1619.669 2723.149 
Mean 1625.527 2810.214 
SD 135.823 119.977 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 78.418 69.269 
Standard error as % of mean 4.824 2.465 
 
Table 102: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 9 with d22-IMes 19, shaken in a 
60 G magnetic shaker assembly for six seconds. Lab book reference no. WHD/A/28/28 A 
 
 
7.4.5 Co-ligand ‘doping’ studies 
 
4,6-nicotine-d2 9, pyridine-d5 23, d22-IMes 19 
 
 
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 2565.540 2985.735 
2 2882.261 2572.397 
3 2914.442 2170.771 
Mean 2787.414 2576.301 
SD 192.821 407.496 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 111.325 235.268 
Standard error as % of mean 3.994 9.132 
 
Table 103: ‘shake and drop’ errors for 2.5 equivalents 4,6-nicotine-d2 9 with 2.5 equivalents coligand 
py-d5 23 and d22-IMes 19, shaken in a 60 G magnetic shaker assembly for six seconds. Lab book 
reference no. WHD/A/26/26 C 
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7.4.6 Variable pressure studies 
 
(−)-nicotine 1, IMes 18 
 
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 301.029 414.545 379.842 20.201 
2 302.959 410.413 354.783 19.899 
3 307.185 391.876 353.938 32.690 
Mean 303.724 405.611 362.854 24.263 
SD 3.148 12.073 14.718 7.299 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 1.818 6.970 8.497 4.214 
Standard error as % of mean 0.598 1.718 2.342 17.369 
 
Table 104: ‘shake and drop’ errors for 5 equivalents (−)-nicotine 1 with IMes 18, with 5 bar p-H2 
shaken in stray field. Lab book reference no. WHD/A/23/23 B 
 
 
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 521.466 456.189 417.485 25.580 
2 554.234 434.675 445.864 23.392 
3 591.065 459.542 455.583 12.882 
Mean 555.589 450.135 439.644 20.618 
SD 34.819 13.493 19.796 6.788 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 20.103 7.790 11.429 3.919 
Standard error as % of mean 3.618 1.731 2.600 19.009 
 
Table 105: ‘shake and drop’ errors for 5 equivalents (−)-nicotine 1 with IMes 18, with 6 bar p-H2 
shaken in stray field. Lab book reference no. WHD/A/23/23 A 
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4,6-nicotine-d2 9, IMes 18 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 679.958 983.195 
2 600.21 903.918 
3 689.671 910.465 
Mean 656.613 932.526 
SD 49.0873 44.0027 
No. of data points (n) 3 3 
Root n 1.73205 1.73205 
Standard error 28.3406 25.4049 
Standard error as % of mean 4.31617 2.72432 
 
Table 106: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 1 with IMes 18, with 5 bar p-H2 
shaken in stray field. Lab book reference no. WHD/A/23/23 C 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 521.466 25.580 
2 554.234 23.392 
3 591.065 12.882 
Mean 555.589 20.618 
SD 34.819 6.788 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 20.103 3.919 
Standard error as % of mean 3.618 19.009 
 
Table 107: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 1 with IMes 18, with 6 bar p-H2 
shaken in stray field. Lab book reference no. WHD/A/23/23 D2 
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4,6-nicotine-d2 9, IMes 18 with magnetic shaker 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 1179.599 1826.441 
2 1110.885 1737.346 
     
Mean 1145.242 1781.894 
SD 48.589 62.999 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 28.053 36.373 
Standard error as % of mean 2.449 2.041 
 
Table 108: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 1 with IMes 18, with 5 bar p-H2 
shaken in a 60 G magnetic shaker assembly. Lab book reference no. WHD/A/23/23 C 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 1187.903 25.580 
2 1235.533 23.392 
Mean 1211.718 24.486 
SD 33.679 1.547 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 19.445 0.893 
Standard error as % of mean 1.605 3.648 
 
Table 109: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 1 with IMes 18, with 6 bar p-H2 
shaken in a 60 G magnetic shaker assembly. Lab book reference no. WHD/A/23/23 D2 
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4,6-nicotine-d2 9, d22-IMes 19 with magnetic shaker 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 1326.195 2291.781 
2 1271.767 2139.874 
3 1342.555 2351.567 
Mean 1313.506 2261.074 
SD 37.061 109.136 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 21.397 63.010 
Standard error as % of mean 1.629 2.787 
 
Table 110: ‘shake and drop’ errors for 5 equivalents 4,6-nicotine-d2 1 with d22-IMes 19, with 6 bar p-
H2 shaken in a 60 G magnetic shaker assembly. Lab book reference no. WHD/A/23/23 E 
 
7.4.7 Variable temperature studies 
 
(−)-nicotine 1, IMes 18 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 308.301 364.235 281.798 8.018 
2 355.306 265.865 312.010 4.020 
Mean 331.804 315.050 296.904 6.019 
SD 33.237 69.558 21.363 2.827 
No. of data points (n) 2 2 2 2 
Root n 1.414 1.414 1.414 1.414 
Standard error 23.502 49.185 15.106 1.999 
Standard error as % of mean 7.083 15.612 5.088 33.211 
 
Table 111: ‘shake and drop’ errors for 4 equivalents (−)-nicotine 1 with IMes 18, shaken in stray field 
at 303 K. Lab book reference no. WHD/A/18/18 B 
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Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 506.633 225.320 394.821 8.514 
2 542.643 216.479 403.871 6.836 
Mean 524.638 220.900 399.346 7.675 
SD 25.463 6.252 6.399 1.187 
No. of data points (n) 2 2 2 2 
Root n 1.414 1.414 1.414 1.414 
Standard error 18.005 4.421 4.525 0.839 
Standard error as % of mean 3.432 2.001 1.133 10.932 
 
Table 112: ‘shake and drop’ errors for 4 equivalents (−)-nicotine 1 with IMes 18, shaken in stray field 
at 308 K. Lab book reference no. WHD/A/18/18 A 
 
  
Signal enhancement (relative to thermal) 
2-proton 6-proton 4-proton 5-proton 
1 406.008 265.804 327.373 12.071 
2 337.129 307.133 313.459 13.012 
3 408.197 252.753 352.730 14.350 
Mean 383.778 275.230 331.187 13.144 
SD 40.414 28.389 19.912 1.145 
No. of data points (n) 3 3 3 3 
Root n 1.732 1.732 1.732 1.732 
Standard error 23.333 16.390 11.496 0.661 
Standard error as % of mean 6.080 5.955 3.471 5.031 
 
Table 113: ‘shake and drop’ errors for 4 equivalents (−)-nicotine 1 with IMes 18, shaken in stray field 
at 308 K. Lab book reference no. WHD/A/18/18 C 
 
 
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 340.850 473.834 
2 315.248 447.800 
3 295.081 443.586 
Mean 317.059 455.073 
SD 22.938 16.384 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 13.243 9.459 
Standard error as % of mean 4.177 2.079 
 
Table 114: ‘shake and drop’ errors for 4 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field at 303 K. Lab book reference no. WHD/A/18/18 E 
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Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 280.600 400.263 
2 272.422 395.864 
3 265.342 375.732 
Mean 272.788 390.620 
SD 7.636 13.079 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 4.408 7.551 
Standard error as % of mean 1.616 1.933 
 
Table 115: ‘shake and drop’ errors for 4 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field at 308 K. Lab book reference no. WHD/A/18/18 D3 
 
  
Signal enhancement (relative to thermal) 
2-proton 5-proton 
1 247.715 354.717 
2 272.333 349.431 
3 259.020 370.905 
Mean 259.689 358.351 
SD 12.322 11.189 
No. of data points (n) 3 3 
Root n 1.732 1.732 
Standard error 7.114 6.460 
Standard error as % of mean 2.740 1.803 
 
Table 116: ‘shake and drop’ errors for 4 equivalents 4,6-nicotine-d2 9 with IMes 18, shaken in stray 
field at 313 K. Lab book reference no. WHD/A/18/18 F 
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8: Abbreviations 
 
2D – two-dimensional 
2DFT – two-dimensional Fourier transform 
2-py, 4-py, 5-py etc. – 2-pyridyl, 4-pyridyl, 5-
pyridyl etc. 
ALTADENA - Adiabatic Longitudinal 
Transport After Dissociation Engenders Net 
Alignment 
ANOVA – analysis of variance 
Ar – argon 
B0 – external magnetic field 
Bx, By, Bz – external magnetic field in x, y, z axis, 
respectively 
BuLi – butyllithium 
°C – Celcius 
CE – cross-effect 
CF – cystic fibrosis 
cm - centimeter 
COD – cyclooctadiene 
Co-D – deuterated co-ligand 
COPD – chronic obstructive pulmonary disease 
cos – cosine 
COSY – Correlation Spectroscopy 
CPL – circularly polarised light 
CSI – Chemical Shift Imaging 
d – doublet 
d – day(s) 
dd – doublet of doublets 
ddd – doublet of doublets of doublets 
dm - decimeter 
DMAE – dimethylaminoethanol 
DMF – dimethylformamide 
DNP – Dynamic Nuclear Polarisation 
DoM – directed ortho metalation 
DQ – double quantum 
DS – dummy scans 
e – exponential 
eq. – equivalents 
ESI – electrospray ionisation 
ETL – echo train length 
EtOAc – ethyl acetate 
EXSY – Exchange Spectroscopy 
FFT – fast Fourier transform 
FID – free induction decay 
FISP – free induction with steady-state free 
precession 
FOV – field of view 
FT-IR – Fourier-transformed infrared  
G – Gauss 
g – gram 
GHz – gigahertz 
ħ – ‘h bar’ reduced Planck’s constant i.e. h/2π 
h – Planck’s constant 
h – hour(s) 
HRMS – High Resolution Mass Spectrometry 
HSQC – Heteronuclear Single Quantum 
Coherence 
Hz – hertz 
I – nuclear spin quantum number 
ICl (as carbene ligand) - 1,3-bis(4-chloro-2,6-
dimethylphenyl)imidazole-2-ylidene 
IMes (as carbene ligand) - 1,3-bis(2,4,6-
trimethylphenyl)imidazole-2-ylidene 
IR – infrared 
ItBu (as carbene ligand) - 1,3-bis(4-tert-butyl-
2,6-trimethylphenyl)imidazole-2-ylidene 
J – rotational quantum number/energy level 
J – scalar coupling in Hz 
K – Kelvin 
kobs – observed rate constant 
kB – Boltzmann constant 
L – ligand 
LC-MS – tandem liquid chromatography and 
mass spectrometry 
ln – natural logarithm (base e) 
m – multiplet 
m/z – mass to charge ratio 
M0 – maximum/initial magnetisation 
Mes – mesityl 
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mg – milligram(s) 
mL – millilitre(s) 
MHz – megahertz 
mM – millimoles per dm3 
mm – millimetre(s) 
mmol – millimole(s) 
mol – mole(s) 
MRI – Magnetic Resonance Imaging 
M’ss – steady state magnetisation 
Mx, My, Mz – magnetisation in x, y, z 
NBS – N-bromosuccinimide 
NIC – (−)-nicotine 
NMR – Nuclear Magnetic Resonance 
NOESY – Nuclear Overhauser Effect 
Spectroscopy 
NS – number of scans 
OPSY – Only para-Hydrogen Spectroscopy 
OPSY-d – double-quantum OPSY 
OPSY-z – zero-quantum OPSY 
P – polarisation 
PASADENA - Parahydrogen And Synthesis 
Allow Dramatically Enhanced Nuclear 
Alignment 
PFG – pulsed field gradient 
p-H2 – para-hydrogen 
PHIP – para-Hydrogen Induced Polarisation 
ppm – parts per million 
prev. – previous 
PTF – polarisation transfer field 
Py – pyridine 
RARE – Rapid Acquisition with Relaxation 
Enhancement 
RF – radiofrequency 
RF – retention factor 
rt – room temperature 
s – second(s) 
SABRE – Signal Amplification By Reversible 
Exchange 
SE – solid effect 
Shyp – hyperpolarised signal 
SINO – signal-to-noise function in Bruker 
TopSpin 
SNR – signal-to-noise ratio 
SQ – single quantum 
SSFP – steady-state free precession 
Stherm – thermal signal 
Sub - substrate 
T - temperature 
T – Tesla 
TD – time domain 
TE – echo time 
THF – tetrahydrofuran 
TLC – thin-layer chromatography 
TM – thermal mixing 
TMP - 2,2,6,6-tetramethylpiperidine 
TOF – time-of-flight 
TR – repetition time 
wt. – weight 
ZQ – zero quantum 
δC – carbon chemical shift 
δH – hydrogen chemical shift 
ΔG300‡ - activation Gibbs’ free energy at 300 K 
ΔH‡ - activation enthalpy 
ΔS‡ - activation entropy 
τmix – mixing time 
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